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Abstract
Interleukin-12, a heterodimeric cytokine produced by activated monocytes and 
dendritic cells, plays a crucial role in regulating IFN-y production and in the 
generation of IFN-y producing T helper 1 cells. Here is shown that the IL-12RP2 
subunit, a recently cloned binding and signal transducing component of the IL- 
12R, is expressed on human Thl but not Th2 clones, and is induced during 
differentiation of human naive T cells along the Thl but not the Th2 pathway. IL- 
12 and IFN-a but not IFN-y induce expression of the IL-12RP2 chain during in 
vitro T cell differentiation following antigen receptor triggering, whereas IL-4 
inhibits IL-12Rp2 transcription. Conversely, IFN-y but not IFN-a can rescue IL- 
12Rp2 mRNA expression and restore IL-12 responsiveness in early developing 
mouse Th2 cells. IFN-a activity in humans is mediated by Stat4.
The DNase Hypersensitive Site analysis allowed the characterisation of chromatin 
structure and accessibility of the IL-12Rp2 locus. Naive T cells as well as Th2 cells 
show a relative “closed” chromatin configuration, whereas Thl cells displayed an 
accessible chromatin configuration with a complex pattern of DNase 
Hypersensitivity. The characterisation of the DH sites selectively present in Thl 
cells allowed the identification of: i) a TATA-less, CpG rich, IL-12RP2 minimal 
promoter ii) IL-12 and IFN-a responsive enhancer regions. These regions contain 
GAS binding sites that not only bind Stat4, but also that are transcriptionally 
active. These data provide strong evidence that Stat4 plays a key role in the 
regulation of the Thl-specific expression of IL-12Rp2. Furthermore, the IL-12RP2 
GAS. sites display a binding selectivity and do not efficiently bind Statl. Thus, the 
week effects exerted by IFN-y in humans on IL-12Rp2 gene regulation, and the 
consequent failure to induce Thl development, can be explained by the inefficient 
binding of the IFN-y -induced Statl to the IL-12Rp2 GAS sites.
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1) Introduction
1.1) T helper subsets
In a seminal study a decade ago, Mosmann et al. (Mosmann et al., 1986) showed 
that murine CD4+ T helper (Th) cells can be classified into two major subsets, 
termed Thl and Th2, according to the pattern of lymphokines they produce.
Thl cells secrete Interferon (IFN)-Y and predominantly promote cell-mediated 
immune responses, while Th2 cells, which produce IL-4, IL-5 and IL-13, provide 
help for some B cell responses (Seder and Paul, 1994).
The principal function of Thl cells is to elicit phagocyte-mediated defense against 
infection, because Thl cytokines promote the ability of macrophages to both 
phagocytose and destroy microbes. Thl dominant immune responses are often 
associated with inflammation and tissue injury, because two Thl cytokines, Tumor 
Necrosis Factor (TNF)-P and IFN-y, recruit and activate inflammatory leukocytes 
(Delayed Type Hypersensitivity reaction (DTH)). Some Thl cells acquire cytolitic 
activity and the cytokines produced by th l  cells promote the differentiation of 
CD8+ T lymphocytes into active cytotoxic cells (Abbas et al., 1996) (Fig. 1).
IL-4 and IL-5 are the signature cytokines of Th2 cells. IL-4 in particular is the 
major inducer of B-cell switching to IgE production (Coffman et al., 1993), and 
therefore plays a crucial role in allergic reactions involving IgE and mast-çells. IL-5 
is the principal eosinophil-activating cytokine and mice lacking IL-5 or its receptor 
are unable to clear helmints (Kopf, 1996) (Fig 1)
Th cells producing cytokines typical of both Thl and Th2 clones have been 
described in both the murine and human system, and they have been named ThO 
(Seder and Paul, 1994). The concept of polarized T helper cell subsets was later 
extended to the human system (Romagnani, 1991), and the balance between Thl 
and Th2 subsets was shown to be a major determinant in the outcome of
2physiological as well as pathological immune responses, including autoimmune, 
allergic and infectious diseases (Abbas et al., 1996; Romagnani, 1994) (Tab 1).
The role of various factors influencingthe development of T helper cells has been 
studied using T cell receptor (TCR) transgenic mice as a source of antigen-specific 
naive CD4+ T cells
Tab I . Pathological Thl and Th2 imnmne responses
Host Response Comments 
Autoimmunity
Psoriasis
vulgaris
EAE
IDDM
Rheumatoid
A rtritis
Tyroiditis
Allergy
Allergy
H
M
M
H
H
H
Atopic Asthma H
Vernal H
conjunctivitis
Omenn's
syndrome
H
Thl
response
Th1 cause 
desease
Thl, but not Th2 cells derived from the 
psoriasis sites
Th1 clones induce desease
anti-IL-12 ameliorates disease
Th1
Th1 Synovial fluids from RA patients
produced IFN-y ,but not IL-4
Th1 Thelper infliltrating cells secrete Th1
response cytokines
Th2 allergen specific clones shows a strong
response bias towards the Th2
phenotype
Th2 Th2 cytokines detected in bronchial
response lavage and in situ studies
Th2 T- cell clones from conjunctivits
response produce more IL-4
and less IFN^ y than CTRL cells
Th2 immunodeficiency accompanied by
response eosinophilia, high IGE levels
high IL-4 and IL-5
Modified from Mosmann et al, Immunology Today, (1996), 3:138-146
(Hsieh et al., 1993; Kaye et al., 1989; Seder et al., 1992) and with purified naive 
(Mel-144)  T cells stimulated in vitro with plate-bound anti-CD3 antibodies 
(Schmitt et al., 1994). In the human system, T helper cell development has been 
studied by analyzing T cell clones
CTL activity
)
Protection against 
intracellular parasites 
Organ specific 
autoimmune 
deceases 
Allograft rejection
A
DTH
1
Protection against 
metazoan parasites 
Atopic disorders
Me
Figure 1. T helper development. Upper panel, early production of IL-12 (and IFNs) by cells of the 
imiate immune system promotes the development of Thl cells, which induces the production of 
opsomsing antibodies and the activation of macrophages (ie. a DTH reaction). Thl responses,
4together with frequently associated CTL activity, are highly protective against infections caused by 
intracellular parasites and are responsible for acute allograft rejection, but may result in organ 
specific autoimmune diseases and other immunopathological disorders. Lower panel: early 
production of IL-4 promotes the development of Th2 cells, which stimulate high antibody 
production, including IgE, eosinophils and mast cell activity. Th2 responses are protective against 
metazoan parasites and can be responsible for the development of asthma, (Modified from 
Romagnani, Immunol. Today, 1997). MO= macrophage; DOdendritic cell; APC=antigen 
presenting cell; Mc=Mast cell
obtained either from peripheral blood specific to a variety of bacterial and parasite 
antigens or allergens, or from target organs of patients with immunopathological 
disorders (Del Prete et al., 1991; Parronchi et al., 1996; Wierenga et al., 1990). 
Important results have also been obtained with T cell lines generated by stimulation 
of cord blood derived neonatal (CD45RA+) T cells (Demeure et al., 1994; Somasse 
et al., 1996). A number of studies have shown that the dose and route of antigen 
administration, the type of antigen presenting cell (APC), and the costimulatory 
pathways, can influence Th cell differentiation (Bretscher et al., 1992; Constant et 
al., 1995; Guery et al., 1996; Kuchroo et al., 1995; Lenschow et al., 1996).
However, the cytokines present at the time of priming have a prominent role in 
inducing polarized Th cell responses (O’Garra, 1998; Seder and Paul, 1994).
1.2) Factors involved in T helper development
1.2.1) Antigen dose
In 1972 Parish and Liew showed that varying the dose of the immunising antigen 
gives rise to either a humoral or a cell-mediated type of response (Parish and FY, 
1972). Several studies were then performed to determine whether Thl- or Th2 
responses were elicited by high versus low doses of antigen, all obtaining 
conflicting results. In most of the studies in which parasites were used as 
immunogens low doses of antigen induced Th-1 like responses (Bancroft et al., 
1994; Bretscher et al., 1992; Parish and FY, 1972). Conversely, when soluble 
proteins were used instead, low doses of immunogen skewed towards Th2-type
5cells (Guery et al., 1996; Wang et al., 1996). These differences observed in vivo 
may be due to the involvement of other factors influencing T helper development, 
such as the induction of IL-12 production by macrophages after parasite uptake or 
recruitment of non CD4+ lymphocytes (Constant and Bottomly, 1997). Thus, in 
vitro differentiation systems using TCR transgenic mouse models were utilised to 
define the effect of antigen dose in T helper development. Bottomly and colleagues 
reported that high doses of cytocrome-c peptide generated Th2 effector cells, 
whereas low doses induced Thl cells (Constant et al., 1995). Using a different TCR 
transgenic model, O'Garra and colleagues obtained similar results, thus suggesting a 
direct role of the antigen dose in directing T helper differentiation (Hosken et al., 
1995). Nevertheless, the mechanisms underlying these effects are not well 
understood. An explanation of these findings could be that different antigen 
concentrations trigger distinct signals from the TCR which influence the 
differentiation pathway, but still no evidence for this has been documented. 
Alternatively, high antigen concentrations could lead to repeated T cell stimulation 
thus reaching a threshold of IL-4 production that would enhance Th2 development 
(see below).
Furthermore, O'Garra and colleagues also made the important observation that the 
antigen-dose dependent Th2 development was abrogated by addition of neutralising 
and IL-4 antibodies, thus indicating that antigen dose does not seem to be a 
dominant controller of T helper development (Hosken et al., 1995; O'Garra, 1998).
61.2.2) Costimulation
Since antigen presenting cells (APC) provide precursor Th cells with their first 
activation signal, the expression of costimulatory molecules on APC and their role 
in Th differentiation is subject to investigation.
In particular the role of the B7-1 and B7-2 costimulatory molecules investigated in 
several mouse models gave conflicting results in T helper development (Kuchroo et 
al., 1995; Lenschow et al., 1996).
In vitro differentiation studies suggested the involvement of B7-2 signalingin Th2 
development, while B7-1 failed to influence T cell differentiation (Freeman et al., 
1995), these findings where however challenged by other studies (Cause et al., 
1997).
Analysis of CD28, the B7 ligand expressed on T cells, supported the requirement 
of CD28 signaling for development of Th2 cells. CD28 V" mice infected with 
lymphocytic choriomeningitis virus showed a marked defect in Th2 dependent 
antibody responses, yet DTH and cytolytic responses were normal (Lenschow et 
al., 1996; Shainianet al., 1993). Human naive T cells stimulated with anti-CD3 in 
the absence of CD28 costimulation produced only IL-2 and IFN-y, whereas the 
addition of anti-CD28 mAbs induced both IL-4 and IL-5 (King et al., 1995). The 
message that can be derived from these studies is the requirement for high levels of 
costimulation for Th2 development. In this case stronger T cell activation could 
result in increased IL-4 production by T cells and favor Th2 development. But this 
is probably an oversimplification and the emerging view tends to emphasise timing 
and level of costimulation, rather than simply its presence or its absence. For 
example, costimulation requirements for differentiated Th cells are opposite, since 
Thl cells activity is costimulation dependent while Th2 cells do not seem to 
require any more costimulation (Constant and Bottomly, 1997). Furthermore, there 
is no direct evidence suggesting a role of CTLA-4 in T helper cell differentiation. 
CTLA-4 is the other identified receptor of B7 molecules, expressed on T cells. 
CTLA-4 V" mice show a severe lymphoproliferative phenotype, suggesting a
7general negative regulatory role of this receptor, rather than a role in T helper 
development (Alegre et al., 1998; Tivol et al., 1995). A possible explanation for the 
observation that CTLA-4 as well as for B7-1 appear not to be correlated to Th 
development, may be their delayed upregulation or that their major role is to 
downregulate ongoing immune responses rather than initiate new ones (Bluestone, 
1995).
1.2.3) Genetic background
Different murine genetic backgrounds are known to significantly alter the direction 
of Th subset development, resulting in resistance or susceptibility to pathogens 
(Güler et al., 1996; Hsieh et al., 1995; Reiner and Locksley, 1995). BALB/c, 
BALB/b and BALB/k mice, were described as Th2 prone, while B10.D2 and 
C57B1/6 are Th2-averse, and DBA/2 usually show an intermediate phenotype 
(Guery et al., 1996; Reiner and Locksley, 1995). Very little is known about the 
factors responsible for the genetic predisposition to develop a Thl versus Th2 
type of response, but the ones described so far mainly correlate with cytokine 
genes. For example the BALB/c default Th2 pathway has been attributed to an 
early IL-4 production when compared to resistant strains (Launois et al., 1995). 
Recently, it was observed that B10.D2 exhibit an intrinsically greater capacity to 
maintain IL-12 responsiveness under neutral conditions in vitro as compared to 
BALB/c T cells, allowing for longer capacity to undergo IL-12 induced 
development (Güler et al., 1996; Güler et al., 1997). Analysis of intercrosses 
between BALB/c and B10.D2 mice identified a locus on murine chromosome 11 
that controls the maintenance of IL-12 responsiveness (Gorham et al., 1996) (Fig. 
2).
19-
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Figure 2. Genetic map of chromosome 11 indicating the position of the locus that controls 
maintenance of IL-12 responsiveness (from Gorham et al. 1996 PNAS).
GM-CSF granulocyte-monocyte colony-stimulating factor, IRF-1 interferon regulatory factor-1; 
ITK, EL-2 inducible T-cell kinase; Tcfl, T-cell factor-1
This chromosomal region is syntenic with a locus on human chromosome 
previously 5q31.1 shown to be associated with elevated serum IgE levels, 
suggesting that the regulation of Thl/Th2 differentiation in mouse and of atopy 
development in humans may be controlled by similar genetic mechanisms (Marsh 
et al., 1994). Furthermore, multiple allelic forms of the IL-4 promoter were 
described that exhibit different transcriptional activities in EL-4 positive cells (Song 
et al., 1996).
1.3) Cytokines
1.3.1) Cytokine induced Thl development
Cytokines play a crucial role in T helper differentiation under most experimental 
conditions (Abbas et al., 1996; O'Garra, 1998; Seder and Paul, 1994) (Fig. 3).
IL-12 is a dominant factor in directing the development of Thl cells (Manetti et al., 
1993; Trinchieri, 1995). Consistent with the importance of ÏL-12 for induction of 
Thl differentiation is the finding that IL-12 has striking therapeutic effects, in a
9number of mouse models of infectious diseases. For example, responsiveness to IL- 
12 is impaired in BALB/c mice, resulting in a nonhealing Th2 response to 
Leishmania major infection. Administration of IL-12 at the time of infection gives 
rise to a Thl protective response (Heinzel et al., 1993; Locksley and Scott, 1991). 
Furthermore, both IL-12 p40'Z mice and 1L-12RP1 'A mice are defective in IFN-y 
production and almost completely lack the ability to generate a Thl response 
(Magram et al., 1996; Wu et al., 1997).
IL-12 is an heterodimeric cytokine composed of two disulfide-linked subunits, p35 
arid p40. IL-12 is produced by macrophages upon their encounter with microbial 
products and intracellular bacteria such as Listeria monocytogenes and protozoa 
such as Toxoplasma (Hsieh et al., 1993; Trinchieri, 1995). Recent studies have also 
shown that Dendritic cells (DC) can produce high amounts of IL-12 upon ligation 
of CD40 by the CD40 ligand (Celia et al., 1996). Both IL-4 and DL-IO inhibit IL-12 
production by APC, thus inhibiting Thl development (Hsieh et al., 1993). 
Interestingly, down regulation of IL-12 production by monocytes has been 
described as a mechanism developed by measles virus to evade destruction by the 
immune system (Karp et al., 1996).
In addition to IL-12, interferons act as cofactors in Thl cell development. Type I 
interferons are induced primarily as a result of viral infection of cells. IFN-a is 
largely synthesised by leukocytes, while IFN-p is produced by fibroblasts. IFN-y 
is induced by immune and inflammatory stimuli and is synthesised exclusively by 
T and NK cells (Wu et al., 1997). In mice, it has been shown that neutralization of 
endogenous IFN-y in cultures of naive CD4+ T cells differentiated in the presence 
of IL-12 resulted in a significantly reduced IFN-y production upon restimulation 
(Bradley et al., 1996; Schmitt et al., 1994). The contribution of IFN-y to Thl 
development can be partially attributed to the ability of this cytokine to induce IL- 
12 production by macrophages, but it also may have a minor Thl inducing effect 
which is independent of IL-12 (see discussion; (Güler et al., 1996)). Macatonia et 
al. investigated the ability of IFNs to guide Thl development in mice, revealing that
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neither IFN-y nor IFN-a alone can induce Thl development (Macatonia et al., 
1993; Wenner et al., 1996). The role of type I interferons in human Thl 
development is still unclear. Allergen specific T cell clones generated in the 
presence of IFN-a from peripheral blood of atopic patients show a skewing 
towards the ThO/Thl phenotype (Parronchi et al., 1996). Furthermore, stimulation 
of purified resting human T cells in the presence of IFN-a increased the frequency 
of IFN-y secreting CD4+ T cells (Brinkmann et al., 1993). ,
The IFN-y inducing factor (IGIF, also known as IL-18), a cytokine belonging to the 
IL-1 family, was also shown to potentiate IL-12 induced Thl development, despite 
being unable to drive Thl development on its own (Robinson et al., 1997). IGIF 
promotes proliferation as well as IFN-y production from committed Thl and NK 
cells in both humans and mice (Okamura et al., 1995; Robinson et al., 1997; Ushio 
et al., 1996).
IL-la has also been described to synergise with IL-12 in Thl development, but in 
contrast to IGIF, drives proliferation of Th2 but not Thl cells (Robinson et al., 
1997).
Both IGIF and IL-la signal through the IRAK pathway, which leads to the 
activation of NF-kB (Robinson et al., 1997). A molecular mechanism that explains 
the differential responsiveness to these two cytokines in Thl and Th2 cells has 
been recently identified in the differential expression of the IGIF receptor in Thl 
cells and in the presence the EL-IR in Th2 cells (O'Garra, 1998). Thus, IGIF and 
IL-la, by signaling through NF-kB, may differentially amplify Thl and Th2 
effector responses, respectively.
13.2) Cytokine induced Th2 development
IL-4 promotes Th2 development (Le Gros et al., 1990; Seder and Paul, 1994; Swain 
etal., 1990)(Fig. 3). Knockout of the IL-4 gene results in deficient Th2 responses 
(Kopf et al., 1993; Kühn et al., 1991).Since it was initially believed that only fully 
differentiated Th2 cells produce IL-4, it was not clear which cells would produce
IL-4 in order to induce Th2 development. NK1.1 cells are a small population that 
recognise antigens presented in association with the non polymorphic (32 
microglobulin-associated molecule GDI (Yoshimoto et al., 1995). These cells 
produce large amounts of IL-4 rapidly upon activation via anti-CD-3. However a 
number of studies on (32M-deficient mice failed to support the role of these cells in 
the development of a Th2 response to a variety of parasitic microbes (Bendelac et 
al., 1997). Mast cells, basophils, eosinophils and LAK-specific T cell were also 
indicated as possible sources of early IL-4 (Julia et al., 1996; Paul and Seder, 1994). 
A recent report suggests that IL-6, a component of inflammatory and acute-phase 
immune responses, is able to induce IL-4 production from naive T cells themselves 
(Rincon et al., 1997). However, the findings that IL-6 KO mice are capable of 
developing Th2 responses (Romani et al., 1996) contradict the theory that IL-6 is a 
good candidate for the Th2 pathway initiator.
DC
fia ive  
CD4+ 
J  cell
IL-4
IL-5
IL-13
IL-4NK1.
Figure 3. Cytokine induced T helper de\’elopment. MO= macrophage; DC=dendritic cell: 
APC=antigen presenting cell; Mc=Mast cell
12
Thus, the T cells should be still considered the original source of IL-4, beginning 
from the observation that T cells produce small amounts of IL-4 after their initial 
activation (Schmitz et al., 1994). Increasing lymphocytic activation would lead to 
the accumulation of IL-4 at the response site, thus reaching a threshold of IL-4 
concentration that initiates Th2 differentiation (Abbas et al., 1996). This would be 
consistent with the observation that Th2 responses become increasingly 
pronounced with repeated T cell stimulation (De Wit et al., 1993).
Taken together, these findings suggest a model of Th development in which, in the 
presence of stimuli that trigger macrophages and DC to produce IL-12, such as 
intracellular bacteria or viruses, a Thl differentiation pathway is initiated. 
Conversely, antigens that are persistent or are present at high concentrations, such 
as helminthic parasites, and do not elicit high amounts of IL-12, would tend to 
induce Th2 development.
Once T cells begin to differentiate along a particular pathway, the cytokines they 
produce amplify their growth and development, suppressing the reciprocal 
pathway. This implies that a selective gene activation pathway takes place along 
Th differentiation, which is yet almost unknown.
1.4) Transcriptional events controlling T helper cell differentiation
Very little is known about the molecular mechanisms by which expression of the 
IFN-y and IL-4 genes is restricted to the appropriate Th subset. The first 
important observation comes from the analysis of cytokine transcriptional profiles 
characteristic of Thl and Th2 subsets during in vitro differentiation. Lederer and 
colleagues investigated the kinetics of IL-2, IL-4, and IFN-y mRNA expression in 
early developing Thl and Th2 cells, after stimulating naive T cells in the presence 
of IL-12 or IL-4, respectively. IFN-y mRNA expression was induced as early as 6 
h after initial stimulation in the presence of IL-12, and IL-12 treated cultures 
expressed significantly higher levels of IFN-y transcripts than control or IL-4 
treated cultures. In contrast, IL-4 transcripts were not detected until 48 h after
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priming in the IL-4 treated cultures. IL-2 transcripts were detectable 6 h after 
stimulation in both Thl and Th2 cultures and expression of the IL-2 gene was not 
significantly affected by the presence of IL-12 or IL-4, thus indicating that IL-2 
expression is not restricted to the Thl subset (Lederer et al., 1996). This and other 
studies (Bird et al., 1998), demonstrated that the regulation of IFN-y and IL-4 gene 
expression are temporally distinct events and that they may be regulated by 
independent mechanisms. Thus, considerable efforts were made to identify the 
molecules, and in particular the transcription factors, that are either selectively 
present or active in developing Thl or Th2 cells. Among the few transcription 
factors characterised so far, most of them are involved in the regulation of the IL-4 
gene, while even less is known about the elements involved in T helper 1 
development.
1.4.1) NF-AT proteins
Previous studies have demonstrated that the nuclear factor of activated T cells (NF- 
AT) is critically involved in the induction of IL-2 gene expression in response to 
TCR-ligation (Shaw et al., 1988). NF-AT is a multisubunit transcription factor 
consisting of a pre-existing cytoplasmic subunit and an inducible nuclear 
component containing the activator protein (AP)-l family members Fos and Jun 
(Jain et al., 1992). It has been shown that the immuno-suppressive drugs 
cyclosporin A and FK506 block nuclear translocation of the pre-existing 
cytoplasmic subunit of NF-AT which occurs in response to antigen receptor 
triggering (Flanagan et al., 1991). Among the NF-AT family members, NF-ATp 
and NF-ATc are the predominant NF-AT proteins expressed in human and murine 
T cells (Lyakh et al., 1997; Rooney et al., 1994). Interestingly, all NF-AT family 
members have a region of sequence homology with the Rel homology domain of the 
NF-kB transcription factors. The NF-AT Rel homology domain is believed to 
interact with polypeptides of the basic region-leucinezipper families, such as Fos 
and Jun (Nolan, 1994). At least five NF-AT binding sites are present in the
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minimal IL-4 promoter and cooperative binding of NF-AT and AP-1 family 
members to specific sites within the proximal IL-4 promoter were described 
(Rooney et al., 1995; Szabo et al., 1993). These findings, however, cannot explain 
Th2-specific expression of the IL-4 gene, since 1) a reporter construct containing 
multimerised IL-4 promoter NF-AT sites is equally transactivated in both Thl and 
T2 clones (Rooney et al., 1995). 2) NF-ATp and NF-ATc are equally expressed in 
Thl and Th2 cells (Hoey et al., 1995; Rincon, 1997). 3) analysis of NF-ATp" ' 
mice revealed impaired expression of the genes encoding IL-2, IFN-y, GM-CSF, IL- 
13, and TNF-oc and, more surprisingly, increased IL-4 and IgE levels (Hodge et al., 
1996; Xanthoudakis et al., 1996). These findings also suggested a negative 
regulatory role of NF-ATp in IL-4 gene transcription, thus identifying in NF-ATc, 
the better candidates for IL-4 gene activation.
1.4.2) AP-1, o/wz/and NIP-45
A functional role for AP-1 family members in T helper differentiation is suggested 
by studies demonstrating that mutation of the AP-1 sites in the IL-4 promoter 
results in a 50% decrease in promoter activity (Rooney et al., 1995). Several 
studies described differential recruitment of AP-1 members to the NF-AT sites in 
Thl and Th2 cells, but none have been shown to be exclusively expressed or 
activated in a Th specific manner (Rincon et al., 1997; Rooney et al., 1995; Szabo 
et al., 1997).
In an attempt to identify factors that interact with the Rel-homology domain of 
NF-ATp using the yeast two-hybrid system. Ho et al. recently isolated the first 
Th2 specific transcription factor, the proto-oncogene c-maf (Ho et al., 1996). c-maf 
encodes a basic region-leucinezipper protein and shares homology with c-fos and 
c-jim. Similar to other AP-1 family members, c-wq/" can form homodimers and 
heterodimers with Fos and Jun. The evidence that c-maf is functionally involved in 
the regulation of the IL-4 gene stems from experiments in which the cDNA 
encoding c-wq/"was introduced into a murine Thl clone and a B cell line. Ectopic
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expression of c-wtf/ïnduced IL-4 gene expression in Thl and in B cells. In addition, 
overexpression of both c-maf and NF-ATp revealed a synergistic effect on the 
transactivation of the IL-4 gene (Ho et al., 1996). c-maf represents the first subset 
specific transcription factor identified to date. An additional factor interacting with 
the Rel-homology domain of NF-ATp was recently published by the same 
laboratory. This factor, designated NIP45 (for NF-ATp Interacting Protein), 
potentiates transactivation by NF-AT family members and synergises with c-maf 
in the induction of IL-4 mRNA expression (Hodge et al., 1996).
Even though these results can explain Th2-specific expression of the IL-4 gene, the 
observations that c-maf expressed late along Th2 differentiation and that c-maf 
does not regulate Th2 cytokine genes other than IL-4, raise the question whether c- 
maf 'xs involved in the early polarization of naive T cells towards the Th2 subset, or 
whether the Th2-specific expression of c-maf is a consequence of Th2- 
differentiation.
1.4.3) GATA-3
Recently, using the cDNA Representational Difference Analysis (RDA), the 
transcription factor GATA-3 was identified as differentially expressed in early 
developing Th2 cells (Zheng and Flavell, 1997). GATA-3 is a zinc finger DNA 
binding protein, selectively expressed in T cells and fundamental for T cell 
development (Tin et al., 1996). GATA-3 is specifically downregulated in 
developing Thl cells as early as day 2, thus suggesting a role of this factor in T 
helper differentiation. Furthermore, GATA-3 is thought to be a more general 
regulator of Th2 type cytokines since 1) long term Th2 clones expressed a high 
level of GATA-3 (Zheng and Flavell, 1997). and 2) In GATA-3 transgenic mice, 
Thl cells continue to express Thl type cytokines, but they also express IL-4, IL-5, 
IL-6 and IL-10 (Zhang et al., 1997; Zheng and Flavell, 1997).
GATA binding sites are present in the IL-5 promoter and GATA-3 activity is 
sufficient to drive IL-5 expression (Zhang et al., 1998). Less clear is the role of
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GATA-3 in the IL-4 regulation. Recent observations showed that the IL-4 
promoter is weakly transactivated by GATA-3 directly, but regions in the IL- 
13/IL-4 locus attribute GATA-3 responsiveness to the IL-4 promoter. Retroviral 
transduction of GATA-3 into developing T cells only partially restores IL-4 
production, thus indicating that GATA-3 is not sufficient to fulfill IL-4 
enhancement and additional factors are required (Ranganath et al., 1998; Zhang et 
al., 1998).
The signals that lead to the upregulation of c-maf and GATA-3 have yet to be 
defined. A potential role of Stat6 in this upregulation is suggested by its rapid 
activation upon IL-4 receptor ligation and by the demonstrated obligatory role of 
Stat6 in Th2 development (Kaplan et al., 1996; Shimodaet al., 1996; Szabo et al., 
1997; Takeda et al., 1996).
1.4.4) Stat factors
The crucial role of IL-4 and IL-12 signaling in the differentiation of Th subsets has 
been recently analyzed in Stat6 and Stat4 deficient mice. These proteins are 
thought to mediate functional responses to IL-4 and IL-12, respectively (see 
below). Although no significant differences in cell numbers or composition of T- 
and B-lymphocyte subsets were detectable between wild-type and Stat-deficient 
mice, Stat6-deficient T lymphocytes fail to differentiate into Th2 cells in response 
to IL-4 (Kaplan et al., 1996; Shimoda et al., 1996; Takeda et al., 1996). In contrast, 
the analysis of Stat4‘ ' T cells revealed an impaired production of IFN-y upon 
antigen receptor triggering,indicative of a defect in Thl differentiation (Kaplan et 
al., 1996; Thierfelder et al., 1996).
Although these studies clearly define a requirement for Stat factors in T helper 
differentiation, the relationship between Stat activation and T helper development 
is still uncertain. Lederer et al. recently reported that activated Stat6 isolated from 
Th2 cells could bind a region of the IL-4 promoter which contained a putative Stat6 
binding site(Lederer et al., 1996). Even though the functional role of STAT6 in the
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induction of IL-4 gene expression needs to be investigated in greater detail, the 
authors suggest that the observed constitutive activation of STAT6 in developing 
Th2 cells may be induced by the autocrine effect of secreted IL-4. There is, 
however, no direct evidence that Stat6 transactivates the IL-4 promoter in T cells 
or that the Stat6 site of the IL-4 promoter is required for promoter activity. 
Moreover, exogenous IL-4 does not enhance the expression of IL-4 in mature Th2 
cells (Szabo et al., 1997).
Transcriptional activation by Stat factors may also explain Thl-specific expression 
of the IFN-y gene. Xu et al. (Xu et al., 1996) analyzed the mechanisms of Stat 
regulation in response to IL-12. Since IL-12 induces IFN-y production in activated 
T and NK cells, they searched for natural Stat binding sites near the IFN-y gene 
DNase I footprinting analysis revealed binding of purified recombinant Stat 1 ,4 , 5, 
and 6 to multiple sites within the first intron of the IFN-y gene. Gel shift assays 
performed with oligonucleotides encompassing two adjacent Stat4 binding sites 
from the first intron of the IFN-y gene revealed strong binding of Stat4. Mutation 
of either site abrogated Stat4 binding, suggesting that Stat4 bind cooperatively to 
this element. The domain mediating tetramerization was subsequently mapped to 
the amino-terminal part of Stat4. Yet, the functional relevance of these findings for 
the regulation of IFN-y gene expression is not proven.
1.5) C ytokines signal through the Jak/Stat pathw ay
Unlike other growth factor receptors, cytokine receptors lack intrinsic catalytic 
activity. Instead they are associated with a structurally unique class of kinases, the 
Jaks (O'Shea, 1997).
In the presence of the ligand, receptor subunits oligomerise, the associated Jaks 
autophosphorylate and in turn phosphorylate tyrosines in the cytoplasmic part of 
the receptor. This leads to the recruitment of Stat proteins to the receptor where 
they are phosphorylated on specific tyrosine residues. Upon phosphorylation, 
Stat proteins dimerise and translocate to the nucleus, where they act as
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transcriptional activators by binding specific DNA sequences to the promoters of 
cytokine inducible genes (Fig. 4) (Darnell Jr, 1997; Ihle, 1996; O'Shea, 1997; Shuai 
et al., 1994).
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Figure 4. A model fo r IL-I2R(i2 signaling pathway.
The two IL-12R chains (il and (i2 are constitutively associated with the Janus kinases Tyk2 and 
Jak2. respectively. Binding of IL-12 induces aggregation of the receptor chains and activation of the 
associated kinases. The activated kinases phosphoiy late one or more tyrosine residues present in the 
cytoplasmic region of the IL-12R(J2 chain. These phosphotyrosine residues are docking sites for the 
latent form of Stat proteins. Once bound to the receptor. Stat4 becomes phosphory lated on a single 
tyrosine residue at the carboxy-tenninal region close to the SH2 domain. Reciprocal SH-2 
phosphoty rosine interactions between two Stat4 molecules result in the formation of active dimers 
that translocate to the nucleus and activate gene expression. (Modified from Rogge and Sinigaglia. 
The immunologist 1998)
1.5.1) Janus kinases
Jaks are intracellular tyrosine kinases with molecular masses of 120-140 kDa. Four 
members have been described in mammalian cells: Jakl, Jak2 and Tyk2, which are 
widely expressed, and Jak3, which is mainly found in cells of haematopoietic 
origin. The structural organization of Jaks consists of: 1) a kinase domain located at 
the C-terminus (JH-1 domain); 2) a kinasedike domain (JH2), besides JH-1 and 3) 
the N-terminal half of the Jaks containing five additional regions with high sequence
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similarity between the different Jaks (JH3-JH7) (Schindler and Darnell, 1995) (Fig.
5).
Ligand-induced receptor dimérisation is thought to bring the associated Jaks into 
close proximity, leading to their activation via inter- or intra-molecular 
phosphorylation at sites necessary for catalytic activity (Quelle et al., 1994). The 
finding that Jaks overexpressed in insect or mammalian cells become tyrosine- 
phosphorylated and display kinase activity even in the absence of an exogenous 
stimulus indicates that close contact between these enzymes may be sufficient to 
trigger their activation (Duhe' and Farrar, 1995).
The significance of the kinase-like domain is not clear. It lacks catalytic activity but 
it can have an influence on the kinase activity, although no clear picture emerges 
from the literature as to whether this is a positive or a negative one. For example, 
deletion of the Tyk2 kinase-like domain leads to a protein no longer able to 
phosphorylate an exogenous substrate (Velazquez et al., 1995). Conversely, 
mutation in the kinase-like domain of Jak2 resulted in a molecule with increased 
catalytic activity, suggesting a negative regulatory function of this region (Luo et 
al., 1997). The N-terminal half of the Jaks (regions JH7-JH3, Fig 5) is involved in 
receptor association involving different multiple and discontinuous regions. For 
example, specific binding of Jak2 to the IFNyR2 is determined by its JH7 and JH6 
domains at the very N-terminus (Kohlhuber et al., 1997), while the binding of 
Tyk2 to IFNaRl requires the JH7-JH3 domains, and within this region the JH3 
and JH6 domains appear to be of particular importance (Van et al., 1998).
Receptor association of Jaks is thought to be mediated by the membrane-proximal 
box l/box2 regions that are conserved among many cytokine receptors (Marukami 
et al., 1991). Boxl is a proline-rich motif of eight amino acid residues essential for 
Jak association, whereas box2, a cluster of hydrophobic amino acid residues 
followed by positively charged amino acids, is necessary for Jak association only 
with some receptors. Also, the region between the two boxes is variably important, 
depending on the receptor investigated. Some receptors, however, e.g. the IFNRs,
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do not fulfill the classical boxl/box2 criteria described above, but are still able to 
bind Jaks (Heinrich et al., 1998)
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Figure 5. Structural organisation o f  Jak-Stat factors, Tyrosine phosphatase SHP2 and SOCS. 
Important tyrosine and serine residues that can be phosphoiy lated are indicated with black bars 
SOCS=suppressor of cytokine signaling; SHP2= SH2 domain containing tyrosine phosphatase. 
(Modified from Heinrich et al, Biochem. J„ 1998).
1.5.2) The Stat family of transcription factors
Seven mammalian Stat genes have been identified so far: Statl, 2, 3,4, 5a, 5b and 6 . 
Homologous proteins were also found in Drosophila (D- Stat/marelle) (Hou et al., 
1996; Yan et al., 1996) and recently also in Dictyostelium (Kawata et al., 1997). 
The mammalian Stats localize in three chromosomal clusters, suggesting that this 
family of proteins has evolved by gene duplication. Since no Stat-like genes have 
been identified in the genomes of unicellular systems, including yeast. Stats might 
have evolved with the development of multicellular organisms (Darnell, 1994). 
Except for Stat2, alternatively spliced forms have been described (Darnel 1 Jr, 1997), 
however, in the case of Stat4 and Stat6, the corresponding proteins could not be 
identified
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Stat factors are ubiquitously expressed, with the exception of Stat4, whose 
expression is more restricted to myeloid cells and testis (Zhong et al., 1994). Stats 
are activated by cytokine receptors (Schindler and Darnell, 1995), but also by 
receptor tyrosine kinases (Chen et al., 1997; Park et al., 1996), and G-protein- 
coupled receptors (Bath et al., 1994).
Like Jaks, Stat proteins have a conserved structural organization that is comprised 
of: 1) at the C-terminal end an Src homology 3 (SH3)- like domain, an SH2 domain 
and a transactivation domain, 2) in the middle a DNA-binding domain, 3) at the N- 
terminus a leucine-zipper-like domain (Fig. 5).
Stat activity is predominantly regulated by post-translational modifications, i.e. 
tyrosine and serine phosphorylation.
In all Stats, a tyrosine residue near the C-terminus is phosphory lated upon 
receptor activation. The function of the highly conserved SH2 domain is well 
established. This domain is responsible for binding of the Stats to the tyrosine- 
phosphorylated receptor motifs (Chen et al., 1998; Heim et al., 1995) as well as for 
homo- and hetero-dimerization with other tyrosine- phosphory lated Stat molecules 
(Shuai et al., 1994).
The phosphorylation of Stat proteins on serine residues is less characterised. Serine 
phosphorylation is required for full transcriptional activity (Wen et al., 1995). The 
phosphorylation of serine residues of Stat factors has been associated with 
signaling components of the MEK/MAPK pathway, thus suggesting that Stat 
factors can integrate signals from both cytokine and antigen receptors (Ng and 
Cantrell, 1997; Stancato et al., 1998).
Stat dimérisation is a prerequisite for DNA binding (Chen et al., 1998; Shuai et al., 
1994). Stat dimers contact DNA over a 15 bp region (Chen et al., 1998; Horvath et 
al., 1995). Binding site selection experiments identified a common DNA core 
recognition consensus sequence defined as TTCN3GAA (O'Shea, 1997). Stat- 
binding sites are often arranged as a tandem, suggesting that Stat dimers might form 
multimers on clustered binding sites. Such multimerization was recently
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demonstrated for Stat4, and its N-terminus was found to be essential for this 
process (Vinkermeier et al., 1996; Xu et al., 1996).
Even though the sequence similarity to functional SH3 domains, the proposed SH3 
domain in Stats does not seem to be involved in binding proline-rich sequences, 
since crucial amino acids are lacking (Zhong et al., 1994).
STATs are activated in the cytoplasm, but they exert their function in the nucleus 
(Fig. 4), thus, after tyrosine phosphorylation, they have to be transported into the 
nuclear compartment. Only for Statl a nuclear localization sequence (NES) has 
been described (Sekimoto et al., 1997), while the other Stat proteins lack this short 
motif characterized by a cluster of basic amino acids. Thus, nuclear translocation of 
Stats is achieved either via an atypical NES or via a shuttle protein that binds to 
activated Stats and carries an NES. In this respect the finding that activated StatSb 
(Stocklin et al., 1996), as well as Stat3 (Zhang et al., 1997), form a complex with 
the glucocorticoid receptor (GR) is very interesting, since GR contains two NLSs. 
After dimérisation and nuclear translocation Stats bind to specific enhancer 
sequences and stimulate, and in certain cases possibly repress, transcription of 
target genes.
The analysis of the promoter region of Stat regulated genes showed that Stat- 
binding sites are often in close proximity to binding sites for other transcription 
factors, suggesting a co-operativity of these factors in gene regulation. For Stat3, 
possible co-operativity with C/EBP(3, nuclear factor (NF)-IL-6 (Schumann et al., 
1996) (Stephanou et al., 1998), NF-kB (Brown et al., 1995), activator protein 
(AP)-l (Schumann et al., 1996) and GR (Zhang et al., 1997), has been reported. 
Statl also associates with members of the IRF-1 family (Horvath et al., 1996) and 
SP1 (Look et al., 1995).
Even though detailed information concerning the Stat-enhancer interaction has 
become available, it is still not clear how Stat factors and co-operating transcription 
factors transfer their activation signal on to the basal transcription machinery. In 
this respect the observation that Statl interacts with CREB-bindingprotein (CBP)
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and p300 (Horvai et al., 1997) is very interesting, since CBP and p300 are believed 
to serve as bridges between transcription factors and RNA polymerase II 
(Kadonaga, 1998). Notably, these proteins are involved in chromatin 
silencing/activation through their deacetylase activity. This could represent a link 
between Stat factors and selective genes activation along T helper development. 
Thus, although to date some information on gene regulation by Stat factors has 
been accumulated, the picture emerging is far from clear, and it is expected that, 
within the next few years, many more details about this crucial process will be 
worked out.
1.6) IL-12 signal transduction
1.6.1) IL-12 Receptor
IL-12 exerts its biological activity through binding to specific IL-12 receptors that 
are primarily expressed on activated T and NK cells (Desai et al., 1992).
High affinity (Kd= 5-20 pM, 100-1000 sites per cell) and low affinity (Kd = 2-6 
nM, 1000-5000 sites per cell) IL-12 binding sites have been detected on mitogen - 
activated lymphoblasts (Chizzonite et al., 1992). Two IL-12R subunits have been 
cloned from human and mouse T cells and designated as LL-12Rpl and IL-12Rp2 
(Chua et al., 1994; Chua et al., 1995; Presky et al., 1996). A detailed analysis of 125 
I-labeled IL-12 binding to BA/F3 cells that had been stably transfected with 
expression constructs for human IL-12R(31 and IL-12R(32 revealed that each of the 
two recombinant subunits binds IL-12 with low affinity, while coexpression of 
both subunits is necessary to create high affinity IL-12 binding sites. Binding 
studies performed with the mouse IL-12R constructs revealed that, in contrast to 
human IL-12R(31, mouse IL-12R(31 can mediate high- and low- affinity IL-12 
binding (Presky et al., 1996). Both IL-12R(M and IL-12R(32 subunits are type I 
transmembrane glycoproteins, with molecular sizes of about 100 kDa (IL-12R(31)
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and 130 kDa (IL-12R[32) and belong to the cytokine receptor class I family. A 
general scheme is represented in Fig. 6. The extracellular domains are made up of a 
number of different structural domains. The N-terminus of IL-12R[31 consists of 
the cytokine receptor homology domain. This domain is about 200 amino acids 
long and contains the N-terminal Cys-Cys pair and the C-terminal WSXWS motif 
that are characteristic for all cytokine receptors (Stem et al., 1997). The remaining 
part of the extracellulardomains contains three fibronectin type III repeats, each 
100 amino acids long (Chua et al., 1994). The extracellular domain of the IL-12Rp2 
is 100 aa longer that the (31, due to the presence of an N-terminal immunoglobulin 
domain, similarly to gp!30 (Presky et al., 1996), to which both IL-12R subunits 
are highly related. This domain is followed by a 200 aa cytokine domain and three 
fibronectin type II repeats (Fig. 6). Like gp!30 subgroup cytokine receptors, the 
cytoplamic region of both IL-12R subunits contains the characteristic box 1 motif 
and a possible box 2 motif. Only the IL-12R(32 subunit contains three tyrosine 
residues. These residues are conserved also in the murine IL-12R(32 cytoplasmic 
region, which also contains additional seven tyrosines. Some of these tyrosines 
likely play a role in signaling within the cell (see below).
c/cxw wswxws
Box Box 
TM 1 2
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Figure 6. Schematic illustration o f  the structural features o f  IL-12Rf>l and IL-12R$2.
The amino acid sequence motifs characteristic of the cytokine receptor superfamily are indicated 
(C/CXW. WSXWS). TM=transmembrane region.Y= Cytoplasmic tyrosine residues. (Modified 
from Stem et a l , Chem. Immunol. 1997)
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1.6.2) IL-12 signaling pathway
Ritz and colleagues initially reported the IL-12 induced activation of MAP kinase 
in mitogen activated human T cells (Pignata et al., 1994), but no further reports 
confirmed these data. Instead, the IL-12 signaling through the Jak/Stat pathway is 
well characterised. IL-12 induces tyrosine phosphorylation of Tyk2, Jak2, StatS 
and Stat4 (Fig. 4) (Bacon et al., 1995; Jacobson et al., 1995; Szabo et al., 1995). A 
differential association between Jaks and IL-12R subunits has been described: Jak2 
associates with IL-12Rp2, while IL-12R(31 is most likely associated with Tyk2.
In contrast to StatS, which is activated by many different cytokines, Stat4 has, 
thus far, only been found to be activated through IL-12 (Bacon et al., 1995; 
Jacobson et al., 1995) and IFN-a (Cho et al., 1996). This rather tight link between 
Stat4 and IL-12 has also been demonstrated in Stat4 -/- mice: these mice are 
completely unresponsive to IL-12 showing a phenotype that resembles p40 -/- 
mice (Magram et al., 1996).
It is possible that IL-12 signals through different pathways such as the RAS/Raf 
one (Pignata et al., 1994). It is not known at the moment whether the different IL- 
12 activities, such as the induction of IFN-y production or induction of 
proliferation, use different signaling pathway.
1.6.3) Differential IL-12 signaling in Thl and Th2 cells
Using a murine TCR transgenic system, Szabo et al. (Szabo et al., 1995) have 
recently described a novel mechanism controlling the stable commitment to a Th2 
lineage. While IL-4 could reverse early Thl differentiation, IL-12 failed to reverse 
early Th2 development. In order to examine the reasons for the irreversibility of 
early Th2 responses, the ability of Thl and Th2 cells to induce tyrosine 
phosphorylation of Stats in response to several cytokines was analyzed. While 
IFN-a and IL-4 activated Stat-containing complexes to a similar extent in both Thl 
and Th2 cells, IL-12 selectively activated Jak2, StatS, and Stat4 in Thl cells, but
26
not in differentiated Th2 cells. Thus, reversibility of early Thl responses results 
from the maintenance of the IL-4 signaling pathway in the Thl subset, whereas 
commitment to the Th2 phenotype results from the rapid loss of IL-12 induced 
signalingin early developing Th2 cells (Szabo et al., 1995). The question whether 
IL-12 can reverse established Th2 responses into Thl/Th2 responses was also 
addressed in human allergen-specific CD4 T cell clones generated from the 
peripheral blood of atopic patients. This study showed that human allergen- 
specific Th cells with a strongly polarized Th2 cytokine profile are not able to 
phosphorylate Stat4 in response to IL-12, and cannot be induced to produce IFN-y 
(Hilkins et al., 1996).
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2) Materials and Methods
2.1) Cell culture
T cell lines were grown in RPMI 1640 medium containing 5% Fetal Clone and 100 
U/ml IL-2. Jurkat, CEM and 3DO cells were grown in RPMI 1640 medium 
containing 5% Fetal Clone. COS cells were grown in Dulbecco’s Modified Medium 
containing 5% FC. NK 3.3 cells were cultured in RPMI 1640 medium containing 
15% Fetal Calf Serum, 10% Lymphocult and 50 U/ml IL-2. NKL cells were cultured 
in RPMI 1640 medium containing 15% Fetal Calf Serum and 50 U/ml IL-2.
T2F cells were grown in RPMI1640-CG medium 1:1 containing 100 U/ml IL-2 and 
10 % FCS. KIT225/K6 cells were cultured in RPMI 1640 medium containing 5% 
Fetal Clone and 100 U/ml IL-2.
2.2) T cell lines generation
2.2.1) Generation of PHA blasts from peripheral blood cells
-isolate PBMC from a buffy-coat by Ficoll-Hypaque (Pharmacia Biotech) gradient 
centrifugation
-suspend PBMC to Ix 106/ml in complete medium supplemented with Ipg/ml PHA 
-incubate 3 days in a humified incubator 5% CO
-expand them in RPMI 1640 complete medium containing 100 U/ml IL-2 
(Hofifmann-La Roche)
2.2.2) Generation of Thl Th2 lines from cord blood leukocytes
-isolate human neonatal leukocytes from freshly collected, heparinised, neonatal 
cord blood by Ficoll-Hypaque density gradient centrifugation
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-remove CDS T cells by positive selection with a-CD 8 microbeads and magnetic 
activate cell sorting according to a protocol supplied by the manufacturer (Miltenyi 
Biotec)
-resuspend cells at 2 x 106/ ml in complete medium and stimulate them in the 
presence of:
Thl cultures: 2.5 ng/ml IL-12 (Hoffmann-La Roche) and 200 ng/ml 
neutralising anti-IL-4 antibodies (Pharmingen)
Th2 cultures: 1 ng/ml IL-4 antibodies (Pharmingen) and 2 pg/ml 
neutralising anti IL-12 antibodies 17F7 and 20C2 (kindly provided 
by Maurice Gately)
- on day 3 wash cells 3 times in PBS and expand them in RPMI 1640 complete 
medium containing 100 U/ml IL-2 (Hoffmann-La Roche)
2.3) Purification of naive CD4+ T cells
- purify CD4/CD45RO T cells from cord blood leukocytes by negative selection 
using a Pan T cell isolation kit and CD8 microbeads according to a protocol supplied 
by the manufacturer (Miltenyi Biotec) The purity of the CD47CD45RO" T cells 
using this procedure was typically >98% as determined by flow cytometry.
2.4) Single cell analysis of intracellular IFN-y and IL-4 production
Single cell analysis of IFN-y and IL-4 production was performed as described 
previously (PaninaBordignon et al., 1997). Briefly:
- collect T cell lines 7 days after priming, wash once in PBS
-restimulate 106 cells with PMA (50 ng/ml) (Sigma, St. Louis, MO) and ionomycin 
(1 pg/ml) (Sigma) for 2 h at 37 °C in complete medium
-add Brefeldin A (10 pg/ml) (Sigma) to the cultures and incubate for an additional 2 
h.
-fix cells with PBS 1% BSA, 2% paraformaldehyde and 0.5% saponin.
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-stain cells with anti-huIFN-y-FITC (Pharmingen, San Diego, CA) and anti-huIL-4- 
PE (Pharmingen) following the protocol provided by the manufacturer and analyzed 
with a FACScan flow cytometer (Becton Dickinson, Mountain View, CA).
2.5) Immunoprécipitations
-wash 5 x 106 cells and perform cytokine induction in 1 ml RPMI-5% FC 
- wash cells once in cold PBS 
-lyse cell pellet in 250 pi IP-buffer 
-incubate 30’ on a shaker at 4 °C
-remove insoluble debris by centrifugation (13000 rpm, 4 °C, 30 ')
-add lfil/ml rabbit polyclonal anti-Stat4 or anti-Statb antisera (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) and incubate 1 h on a shaker at 4 °C 
-add protein A Sepharose and incubate 1 h on a shaker at 4 °C. Cfg 3’ 3000 g 
-wash four times with cold IP buffer. Centrifuge as above, discart SN 
-add 30 pi o f loading buffer, boil samples before SDS-page
IP buffer
10 mM TRIS/HC1 pH 7.4 
150 mM NaCl 
1 mM EDTA pH 8.0 
1 mM EOT A pH 8.0 
1 % NP-40
0.25 % sodium deoxycholate
10 pg/ml Aprotinin, Leupeptin and NaF
1 mM AEBSF and sodium orthovanadate
2.6) Western blot analysis
-transfer gel to nitrocellulose 4h to o n. in transfer buffer
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-incubate o n. filter in TBST 5% not fat milk
-incubate filter in TBST 5% BSA containing Ijil/ml anti-phosphotyrosine antibody
4G10 (Upstate Biotechnology Inc., Lake Placid, NY) 1 h on a rotating platform
-wash in TBST 15’ on a rotating platform. Repeat three-times
-incubate filter in TBST 5% BSA containing 1 jill/ml anti-mouse IgG (H+L) HRP
conjugated (Amersham) 1 h on a rotating platform
-wash in TBST 15’ on a rotating platform. Repeat three-times
-visualise immunoreactive bands using the ECL Western blotting system
(Amersham, Italy), according to the company’s protocols.
To control for equal protein loading, blots were stripped and reprobed with anti- 
Stat4 or anti-Statb anti sera.
Transfer buffer
380 mM glycine 
50 mM Tris base 
0.1 % SDS 
20% methanol
Tris-buffered saline Tween
20 mM Tris Cl pH 7.4 
137 mM sodium chloride 
0.1% Tween 20
2.7) Titering Lambda phages
-inoculate 50 ml of LB broth supplemented with 0.2% (w/v) maltose and 10 mM 
M gS04 with E. Co/i XL 1-Blue MRA 
-grow overnight with shaking at 30 °C
-spin the cells down and resuspend them to OD60o = 0.5 in 10 mM M gS04
-make dilutions of the lambda phage in SM buffer
-add 10 ml of the dilutions to 200 ml of host cells for each 100 mm plate
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-incubate at 37 °C for 15 '
-add 3 ml of TOP agar (48°C) and plate on LB plates 
-incubate at 37 °C
LB broth (per liter)
10 g of NaCl 
10 g of bactotryptone 
5 g of yeast extract
LB plates (per liter) 
same as LB broth 
add 20 g of bactoagar
TOP agar
same as LB broth
add 0.7% (w/v) agarose
SM buffer (per liter)
5.8 g of NaCl
2 g of M gS04 . H20
50 ml of 1M Tris Cl (pH 7.5)
5 ml of 2% (w/v) gelatin
2.8) DNA screening of lambda phages
2.8.1) Primary screening
-plate on large 150 mm plates to 50,000 pfu/plate with 600 ml of OD60o = 0.5 host 
cells/plate and 9 ml of TOP agar/plate. Use 20 plates to screen IxlO6 pfu 
-incubate o n. at 37 °C ( don't leave them grow too much)
-transfer the plates at 4 °C for an hour
-leave NC filters (Amersham) on plates for 1 to 10 '
-mark filters and plates
-dry the filters on the benchtop for at least 10 '
-perform a second lift for each plate
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-lay 1-2' on 3MM saturated with
0.2 M NaOH
1.5 M NaCl
-lay 1-2' on 3MM saturated with
0.4 M TrisCl pH 7.6 
2x SSC
-lay 1-2' on 3MM saturated with
2x SSC
-dry filters in a oven at 80 °C for 90’-120’
-prehybridise filters Ih at 42 °C with shaking in
5xSSC
50%Formamide 
5x Denhardf s 
0.5% SDS 
400 pg/ml tRNA
-hybridise filters o n. at 42 °C with shaking in
5xSSC
50%Formamide 
5x Denhardf s 
0.5% SDS 
100 pg/ml tRNA 
boiled DNA probe
-wash filters once in 2x SSC 0.1 % SDS 10’ 65 °C 
-wash filters once in Ix SSC 0.1 % SDS 10’ 65 °C 
-wash filters twice in O.lx SSC 0.1 % SDS 10’ 65 °C 
-dry filters and carry out autoradiography
2.8.2) Secondary screening
-orient the filters, line up the film and mark “dots”(=putative positive clones) with 
a needle poked though on the corresponding plate
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-cut out a square centimeter “window” from the stock plate where the putative
clones lines up with the film spot
-put in 500 pi SM buffer and 20 pi chloroform. Vortex
-dilute and titer with host cells on 150 mm plates
-choose single plaque dilutions to make plaque lifts
-perform hybridisation as before
2.8.3) tertiary screening
-pick isolated plaques and perform a third round of screening to obtain phage 
isolates
-the isolated plaques are resuspended in 500 pi SM buffer and 20 pi chloroform and 
stored at 4 °C
20x SSC (per liter)
175.3 g of NaCl
88.2 g of sodium citrate
800 ml of water
adjust to pH 7.0 with NaOH
50x Denhardt's
BSA (bovine serum albumin) 1 %(w/v)
Ficoll 1 %(w/v) 
polyvinilpyrrolidone 1 %(w/v)
2.9) Lambda phage DNA minipreps
-plate 50,000 pfu/plate on 150 mm plate, grow o n. 37 °C
-add 10 ml of SM buffer to the plates and resuspend phages incubating on a 
platform shaker 2h at 4°C
-incubate the supernatant Ih at 37°C with 15 U of DNase I 
-centrifuge Ih 30’ at 27,000 rpm at 4 °C
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-resuspend the pellet in 200 pi of Tris Cl 50 mM pH 7.4 
-add 200 pi of phenol pH 8 and incubate with shaking 20' 
-extract twice with phenol-CHCl3 and once with CHC13 
-precipitate, dry and resuspend in TE pH 8
2.10) RNase protection assays
-RNA was extracted from T cell lines using Ultraspec total RNA extraction reagent 
(Biotecx Laboratories Inc., Houston, TX).
-radiolabelled antisense transcripts were synthesized with SP6 polymerase and a 
commercial kit according to the manufacturer’s protocol (Promega, Madison, WI). 
-the anti sense RNA probes were hybridized to 5 pg total RNA and Ribonuclease 
protection assays were performed with a commercial kit (Ambion Inc., Austin, TX) 
according to the company’s protocol.
-products were resolved on 6% denaturing polyacrylamide gels and the protected 
fragments were visualized by autoradiography
-the radioactivity present in the protected fragments was also quantified using a 
Molecular Imager (Biorad, Richmond, CA). An 18S RNA probe was used as a 
control for equal RNA loading.
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Table I. Vectors used to derive antisense RNA probes fo r  RNA protection assays
g en e  description ref
553 bp EcoRI/BamHI fragment (Chua et H J 1994) 
derived from the IL-12Rpl cDNA, 
subcloned into pGEM-3Z
containing a 327 bp DNA fragment (Presky et al., 1996) 
encompassing the cytoplasmic region 
of the human IL-12Rp2 subunit, 
cloned in pGEM-3Z
containing a 400 bp DNA fragment (Harada et al., 1994). 
derived from the pUC ERF-1 plasmid 
(a generous gift of T. Taniguchi), 
cloned into pBluescript/KS 
(Stratagene, La Jolla, CA)
hCR-1 Multi-probe template set, (Pharmingen, 1996)
(Pharmingen, San Diego, CA)
hCR-1 Multi-probe template set, (Pharmingen, 1996)
(Pharmingen, San Diego, CA)
700 bp Taq I fgm of IL-12RP2 this work 
genomic region, (see fig 1 )
t lm          i m r m  i ■ i i i i i r n w ii iH
2.11) E. Coli transformation
2.11.1) Electro-competent cell preparation
-inoculate 1 L B broth with 1/100 volume of fresh overnight culture 
-grow cells at 37 °C with vigorous shaking to OD600 of 0.5 to 0.8 
-harvest cells on ice for 15 ', cfg in a cold rotor at 4000g for 15 '
-resuspend pellets in a total liter of cold water. Cfg as above 
-resuspend pellets in 0.5 1 of cold water. Cfg as above 
-resuspend pellets in 20 ml of cold water. Cfg as above 
-resuspend pellets in 3 ml 10% glycerol. Cfg as above 
-freeze 40 pi aliquots on dry-ice ethanol. Store at -80 °C
hIL-12R(31
hIL-12R(32
hIRF-1
hIL-4Ra
hyc
pBET-7
2.11.2) Electro-transformation of E. Coli 
-chill Biorad 0.1 mm cuvettes on ice
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-set Biorad gene puiser to the 25pF capacitor, 1.6 KV and set pulse controller to 
200 Ohm.
-thaw 40 pi electro-competent cells and add 1 pi of DNA 
-mix and let on ice 1 '
-apply one pulse of the above settings 
-immediately add 1 ml SOC medium at room temp
-transfer the cell suspension to 17 x 100 mm polypropylene tubes and incubate 1 h
at 37 with moderate shaking
-plate the appropriate aliquots on selective medium
SOC medium
2 % Bacto tryptone
0.5 % Bacto yeast extract
10 mM NaCl
2.5 mM KC1
10 mM MgCl2
10 mM MgS04
20 mM glucose
2.12) DNA extraction
DNA was extracted using QIAGEN Plasmid Midi, Maxi, Mega and Giga kits, 
following the manufacturer’s instruction
2.12.1) Alkaline lysis minipreps
-pellet 5 ml of o n. E. Coli culture, wash once in TE
-resuspend in 120 pi o f the solution:
Tris 25 mM pH 8 
EDTA 10 mM 
Sucrose 15 %
2 mg/ml lisozyme
-incubate on ice for 10’
-add 240 pi of NaOH 0.2 M SDS 1%. Incubate on ice for 10’
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-add 150 nl Sodium Acetate 3 M pH 4.6. Incubate on ice for 20’
-Cfg 15’ full speed. Add 1 pi RNase A (1 mg/ml). Incubate 20’ at 37 °C
-phenol extract sample twice. Precipitate samples with 2 volumes 100% etOH.
Wash with 70% etOH
-dry pellets and resuspend in TE pH 8
When high quality DNA was required (i.e. for sequencing), QIAprep miniprep kit 
(QIAGEN) was utilised instead.
2.12.2) Dot blot screening
-inoculate singleE. Co//colonies in 200 pi LB + the appropriate antibiotic selection 
in a 96 well plate. Grow on at 37 °C.
-transfer 100 pi of the culture to a new 96 well plate, cfg for 5’ at 1400 g.
-discart SN and resuspend pellet in 50 pi NaOH 0.4 M 
-add 50 pi NH4COOH 2 M pH 7. Cfg 10’ at 1400 g.
-transfer SN to a fresh 96 well plate and add 50 pi 6x SSPE 
-prewet filters N+ in 6x SSPE
-set up dot-blot apparatus, wash with 100 pi 6x SSPE 
-load 50 pi DNA, wash with 100 pi 6x SSPE.
-dry filters, fix DNA incubating filters in NaOH 0.4 M for 5’
-perform Southern blotting
2.13) Polymerase chain reaction
To isolate and amplify genomic fragments of the IL-12Rp2 gene PCR reactions were 
performed utilising PWO DNA polymerase (Boehringer Mannheim) following 
customer's instructions
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Table II. PCR oligonucleotide primers 
The primers:
forward Nhe I 1223 5 -ATC GCT AGC AGT TAA GGT TGA ACA G-3’
backward Xho Î 1699 5 -TAG GGT ACC TAG AGC ATG ATA ATT TC-3
were used to isolate a 541 nt fragment from pHOP-3 (1223-1699) that contains GAS 3 and GAS 2. 
The primers:
forward Acc 65 I 2281 5’-TAC GOT ACC TAG AGC ATG ATA ATT TC-3’ 
backward Bgl II 2769 5’-ACA AGA TCT CAA ACT CCT GAC (CTC-3’ 
were used to isolate a 488 nt fragment from pHOP-3 (2281-2769) that contains GAS 1 and GAS 1.5.
2.14) Southern blotting
2.14.1) Alkali blotting of DNA
-electrophorese samples in agarose gel, stain with ethidium bromide and photograph 
with a ruler aid along the gel
-rinse the gel in distilled water and incubate in 0.25 HC1 30’ shaking slowly on a 
platform shaker
-rinse the gel in distilled water and incubate in 0.4 N NaOH 30’ shaking slowly onto 
a platform shaker
-lay the gel on a glass plate, place a positively charged nylon membrane (Hybond- 
N+, Amersham) and 3 pieces of 3MM Whatman filter paper, all prewetted in 0.4 N 
NaOH; avoid air bubbles
-stack paper towels on the top, lay a glass plate and place a weight on top 
-leave from 2h to overnight
-remove the paper towels and the 3MM Whatman filter paper and recover the 
membrane, rinse membrane in 2x SSC and allow to air dry
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2.14.2) Labeling of DNA
-digest the DNA with the appropriate restriction enzymes in order to obtain a 
fragment of 300-600 bp, run on a 1% agarose gel and purified using QUIAEX II gel 
extraction kit
-label DNA using Stratagene’s Prime-it II Random Primer Labeling Kit
-purify probe from unincorporated radioactive nucleotides using a nick column
(PharmaciaBiotech)
-denature probe 10’ at 90 °C just prior adding to the hybridisation solution
2.14.3) Filter hybridisation
-prehybridise filters in 10 ml of hybridisation buffer containing 400 pg/ml yeast 
tRNA at 65 °C for 4h-overnight
-hybridise filters in 10 ml of hybridisation buffer containing 100 pg/ml yeast tRNA 
and the denatured DNA probe at 65 °C overnight 
-wash filters at room temperature in 2x SSPE 0.1 % SDS 
at 65 °C in 1% SSPE, 0.1 % SDS 
at 65 °C in 0.1% SSPE 0.1 % SDS 
-dry filters and carry out autoradiography
Hybridisation buffer
Na2HP04 0.125 M
EDTA 0.5 M 1 mM
conc H 3 P O 4  3 .6 ml
0.5 M NaCl 0.25 M
SDS 7 %
PEG 10%
BSA 1 %
20x SSPE
NaCl 3.6 M
NaH2P04X 2H 20  0.2 M
EDTA 0.5 M 0.02 M
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2.14.4) Labeling oligonucleotides
Mix:
oligonucleotide(4pmol/|il) 2.5 pi
H 20 18.5 pi
Buffer T4 kinase 3 pi
g 32P-ATP (10 mCi/ml) 5 nl
30 nt
-incubate 40' at 37 °C.
-purify on a NICK column and use it immediately or store it at -20.
2.14.5) Filter hybridisation
-wash filters Ih at room temperature in 3x SSPE/ 0.1 % SDS
-prehybridise filters at least Ih at 42 °C in
6xSSPE 
0.5%  SDS 
5x Denhardt 
100 pg/ml yeast tRNA
-hybridise overnight at 42 °C in
6xSSPE 
Ix Denhardt 
100 pg/ml yeast tRNA 
the probe
-wash filters in
6x SSPE 10’ at 50 °C 
6x SSPE 20’ at 50 °C 
6x SSPE 15’ at 52 °C
Table in. Oligonucleotides used for Southern Analysis characterisation ofphage clones
B2 60-38 5 -CAC TTT GTT GAC AGC CAT CAG C-3’
B2 660-649 5 -GAT GGC ACA TAC TTT TAG AGG-3 ’
B2: 887-866 5 -GGC CAT GGT GAA AAT TGA TTC-3’
13:78-98 5’-GCA ATC AGT GCA AGT CTT CAC-3’
B9-3’ 5’-CGA ATA TCT TAG CCA CCT TC-3’
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2.15) DNAse I hypersensitive sites mapping
2.15.1) Nuclear extract preparation
-prepare buffer D for dialysis and store it in the cold room, prechill the Bounce 
homogeniseron ice
-collect cells and wash them twice at 4 °C in cold PBS (1300 x 10’)
-resuspend the cells in 5 Packed Cell Volume (PCV) volumes of buffer A 
- 10’ on ice
-cfg 10’ at 2300 rpm 4 °C
-resuspend the pellet in 2 PCV of buffer A
-transfer to the cooled Bounce, extract nuclei with 30-40 strokes avoiding bubbles,
keep constantly on ice. Check the lysis with Trypan Blue
-transfer to a 14 ml. Falcon tube and centrifuge 10’ at 3100 rpm at 4 °C
-remove carefully the SN (that is the cytoplasmic fraction that can be eventually
stored at -80)
-gently resuspend the pellet 
-add 2 PVC of buffer C 
-incubate at 4 °C for 15’-30’ minutes 
-centrifuge 3100 rpm for 30’
-collect the SN and Bialyse in a Slide-A-Lyzer (MW 10,000, 0.5-3 ml.) (PIERCE) 
-dialyse in the cold room 2 h. - o n.
-collect the extract and cfg 20’ at 4 °C
-freeze aliquot of the SN in dry ice/etOH , store at -80
Buffer A
Hepes OH pH 8 0.5 M 10 mM 
MgCl2 1 M 1.5 mM
KC1 2.5 M 10 mM
add just before use: AEBSF ImM final and BTT 1 mM final 
Buffer C
Hepes OH 0.5 M pH 8 20 mM
42
glycerol 25%
NaCl 0.42 M
MgCl2 1 M 1.5 M
EDTA 0.5 M 0.2 mM
add just before use: AEBSF ImM final and DTT 1 mM final 
Buffer D
Hepes 0.5 M pH 8 20 mM
glycerol 20 %
K C 12.5M  0.1 M
EDTA 0.5 M 0.2 mM
add just before use: AEBSF ImM final and DTT 1 mM final
2.15.2) DNase I treatment and genomic DNA extraction
-collect 1 x 108 cells and wash them twice at 4 °C in cold PBS (1300 x 10’) 
-resuspend the cells in 5 the Packed Cell Volume (PCV) volumes of buffer A 
- 10’ on ice
-centrifuge 10’ at 2300 rpm 4°C 
-resuspend the pellet in 2 PCV of buffer A
-transfer to the cooled Dounce, extract nuclei with 30-40 strokes avoiding bubbles, 
keep constantly on ice. Check the lysis with Trypan Blue 
-transfer to a 14 ml. Falcon tube and centrifuge 10’ at 3100 rpm at 4 °C 
- remove carefully the SN and gently resuspend the nuclei in 250 pi buffer B 
-divide in 5 aliquots of 50 pi each and add 100 pi of DNase I dilutions in buffer B 
(i.e.: none, 5U, 20 U, 100 U 400 U)
-incubate 2’ at RT
-stop immediately the reaction adding 100 ml of lysis buffer of the QUlamp Blood 
Kit (QIAGEN) and follow up the manufacturer ‘s protocol for the extraction of 
genomic DNA
-quantify the genomic DNA and digest 15 pg of each sample with the restriction 
enzyme of choice 
-perform Southern blotting
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Buffer A
Hepes OH pH.8 0.5 M 10 mM
MgCl2 1 M 1.5 mM
KC1 2.5 M 10 mM
buffer B
sucrose 150 mM
KC1 1 M 80 mM
Hepes OH 0.5 M pH 7.4 35 mM
K2P 0 4 1 M pH 7.4 5 mM
MgCl2 1 M 5 mM
CaCl2 1 M 2 mM
2.16) Electromobility shift assays
2.16.1) Labeling of double-stranded oligonucleotides
-label 12.5 pmoles of the forward oligonucleotide with T4 polynucleotide kinase
(see p.) and purify onto a NICK column. Elute in 400 ml TE pH 7.4
-add 40 pi of lOx annealing buffer (Tris Cl pH 7.4 lOOmM, EOT A 2.5 mM, NaCl 1
M) and 25 pmoles of the backward oligonucleotide
-incubate 5’ at 95 °C
-cool down slowly at room temperature and store at -20
2.16.2) Binding reaction
prepare the following master mix for 30 samples:
60 pi buffer D+
60 pi EMSA buffer 
60 pi poly(dl-dC) 1 pg/pl 
60 pi BSA lmg/ml 
300 pi H20
1 pi unspecific ss oligonucleotide
1 pi DTT 1M
2 pi AEBSF 100 mM 
2 pi NaOVa 100 mM
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add 50,000 cpm probe/sample 
-add 2 pi (= 8 mg total proteins) to 18 pi of reaction mix
-in the case of supershift preincubate the extract 20’ RT with 3 pg of concentrated 
antibody
in the case of competitions with cold ds oligoenucleotides add first the cold 
oligonucleotide to the reaction mix 
-incubate at room temperature 15’
-load on an a 5 % acrylamide native gel
Table IV. Oligonucleotides used fo r  gel shift assays Double stranded oligos were used to perform 
gel shift assays. Only the forward strands are indicated. Nucleotide positions are referred to Fig. 20. 
Nucleotides that matches to the Stat4 binding site are underlined.
-3984-3966 5’-TT ATG TTC ATT TA A CAA GG-3’*
-3292-3274 5’-GA GTT TCC TCA TTA TAA GT-3’*
-3135-3117 (P2GAS4) 5’-AG TTA TTC ATA GAA TAG TG-3’*
-3026-3006 (P2GAS2) 5’ TTG TAT TTC CTA GAA AAG ACT-3’
-2224-2204 ((32GAS3) 5 -CT GTA TTC TCA TAA TTT GT-3’*
-2158-2139 5’-AT CTG TTC CCT CAA AG A AT-3’*
-1965-1946 ((32GAS1) 5 -TTT TAT TTC CTT GAA AAA CAT-3’
IRFGAS 5 -G CCT GAT TTC CCC GAA ATG ATG-3’
FcyGAS 5 ’-GTA TTT CCC AGA AAA GGA C-3’
SRF 5 ’-GGA TGT CCA ATT AGG ACA TCT-3’
*the oligonucleotide used in gel shifts contains a dimer of this site.
D+ buffer
Hepes pH 7.91 M
glycerol
KC1 1M
EOT A 0.5 M pH 8 
NP 40
EMSA buffer
Tris pH 7.5 1 M 
N aC l5 M 
EOT A pH 8 0.5 M 
glycerol
20 mM 
2 0 %
100 mM 
0.5 mM 
0.25 % (w/v)
100 mM 
500 mM 
75 mM 
43%
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2.16.3) Whole cell extracts: TOTEX
-stimulate 2 x 107 cells in 10 ml of medium (Ih for IL-12, 20’ for IFN-y and IFN-a 
stimulation)
-spin cells 5’ 1400 rpm at 4 °C and discart SN 
-add 2 ml cold PBS ImM AEBSF, 1 mM NaOVa 
-spin cells 5’ 1400 rpm at 4 °C and discart SN 
-spin cells 30” 1400 rpm at 4 °C and discart last SN 
-add 50 pi of TOTEX buffer and keep on ice 20’
-spin 10’ 4 °C full speed to remove membranes 
-transfer SN to a new pre-cooled Eppendorf vial 
-add 1 volume Do buffer
-freeze aliquots in dry ice/ethanol and store at -80 °C
2.16.4) Protein assay
follow Bio-rad protein assay reagent instructions, briefly:
-dilute Bio-rad solution 1:5 in H20
-distribute 1 ml per cuvette and add 1 pi of protein extract
-as standards pi pet 1, 2,4 , 8, 16 pi of BSA (1 mg/ml)
-determine O.D. 595 nm
TOTEX buffer
Hepes OH 0.5 M pH 7.4 
N aC l5 M 
glycerol 
NP 40 
MgC12 1 M 
EDTA 0.5 M pH 8 
EOT A 0.5 M
Do buffer
Hepes OH 1 M pH 7.9 
glycerol
EDTA 0.5 M pH 8 
NP 40
20 mM 
350 mM 
2 0 %
1 %
1 mM 
0.5 mM 
0.1 mM
20 mM 
2 0 %
0.2 mM 
0.25%
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add just before use DTT 2 mM, AEBSF 2 mM, NaOVa 2 mM
2.17) Transfection of mammalian cell lines
2.17.1) Electroporation
-split cells the day before transfection 
-resuspend cells in RPMI at 1 x 108/ml
-add 28 pg of test DNA + 2 pi CMV p-gal DNA to 400 pi of cells (QIAGEN’s 
plasmid MEGA kit)
- transfer in a 0.4-cm gap Bio-rad cuvette and electroporatate at 960 pF and 300 V 
using a Gene Puiser (Bio-Rad Laboratories).
-add immediately 3.6 ml of complete medium and distribute in 2 wells of a 24 well 
plate
- incubate cells for 24 hours at 37 °C in 5% C 0 2 in a humified incubator, performing 
the inductions of choise
(20 h induction for IL-12, 4 h induction for IFN-a, IFN-y, PMA-ionomicine, a- 
CD3)
-collect cells and assay cell extracts for luciferase and p-galactosidaseactivity
2.17.2) Liposome mediated transfection of DNA into tissue culture cells
The following liposome based reagent were tested to transfect lymphoid cells: 
Lipofectamine(LifeTecnologies)
Lipofectin (Life Tecnologies)
DMRIE-C (Life Tecnologies)
Dosper (Boehringer Mannheim)
Lipotaxi (Life Tecnologies)
Superfect (QIAGEN)
The reagent of choice for Jurkat and CEM cells was DMRIE-C, with the following 
optimised conditions:
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-wash cells once in serum free medium (Optimem, Life Technologies)
- seed cells in six well plate at a density of 2 x 10b per well in 0. 2 ml Optimem 
-prepare the following solutions:
Solution A : for each transfection dilute 4 pg DNA in 500 ml Optimem. 
Solution B : for each transfection dilute 6 pi DMRIE-C in 500 pi 
Optimem
-mix solution A and B and incubate at room temperature 15 -30 '
-add drop wise to the cells and incubate 5 h at 37 °C in a 5% C 0 2 humified incubator 
-add 4 ml of complete medium to each well and incubate overnight 
-change medium and incubate for further 24 h, performing the inductions of choise 
-collect cells and assay cell extracts for luciferase and p-galactosidaseactivity 
First, in order to test IL-12 induced activation in transient transfectants, an IL-12 
responsive cell line was required. Various cell lines were tested for Stat4 
phosphorylation, transcription of IL-12Rp2 gene and how easy to transfect they 
were:
Table V. Characterisation o f  IL-12 signaling and optimisation o f  transfection efficiency o f  
lymphoid cell lines. pGL-pro vector and pCMVpgal vectors were cotransfectedusing electroporation 
or liposomes and transfection efficiencies were determined measuring luciferase and Pgal activity 
*constitutively phosphorv lated?
Cell line Stat4 P* IL-12R(32 Electroporation Liposomes
Jurkat +/- - + DMRIE-C lipofectin
CEM - - + DMRIE-C lipofectin
T2F - - +/- -
KIT 225 K6 + +/- +/-
NK 3.3 +/-*
NKL +/-* - - +/- DMRIE-C
3 DO +/- - + DMRIE-C
2.18) Promoter activity assays
2.18.1) Luciferase Reporter Gene Assay
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The Luciferase Reporter Gene Assay (Boehringer Mannheim) was used, following 
the company’s protocol. Briefly:
-wash cells twice in 2 ml PBS
-resuspend the cell pellet in 250 pi lysis buffer, incubate 15’ at room temperature 
-centrifuge the lysate in a microcentrifuge at full speed to remove cellular debris 
-transfer the SN to a new eppendorf and start immediately the chemiluminescent 
reaction
-measure light emission of a reaction containing 50 pi of extract plus 100 pi of 
luciferase assay reagent for 10” using a LB 9507 Lumat luminometer (EG & G 
Berthold)
-normalise luciferase activities against (3-Galactosidase activity.
2.18.2) (3-Galactosidase Reporter Gene Assay
(3-Galactosidase activity was measured using the (3-Gal Reporter Gene Assay 
(Boehringer Mannheim), according to the company’s protocol. Briefly:
-incubate 50 pi of the cell extract obtained to detect luciferase activity with 100 pi of 
substrate reagent for 15’
-transfer tubes in a luminometer and inject automatically 50 pi of initiation solution. 
After a delay of 5 sec read light emission for 10 sec
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Tale VI. Oligonucleotides cloned in pGL-pro
1-DEMluc 5’-GAT TTT CCT TGA AAA ACA TAT GTT TCC TTG AAA
AG-3’
2-DIMluc 5 -CGC GTA TTT CCT AGA AAA GAC AGT ATT TCC TAG
AAA AG-3’
B2-luc 5’-CGC GTG AGT ATT TCC TAG AAA AGA TCT GTA TTC
TCA TAA TTT GTT TTA TTT CCT TGA AAA AG-3’ 
B2-12-luc 5 -CGC GTG AGT ATT TCC TAG AAA AGA TCT TAT TTC
CTT GAA AAA-3’
Nc
pBET-9
pBET-6
p BET-7
pBET-8
pBET-10
pBET-11 
pBET-12
pBET-13
B E H
b  a  s a H H Ne H K S H [ S
77 I I I ! 1 I I  1 I I I |5P<?
SP6 T7 Sma 1 2.3 kb
T7 SP6 Taq 1 0.9 kb
SP6 T7 Sac 1 5.5 kb
SP6 T7 BamH I 3.1 kb
77 Sfd BamH I 3.1 kb
T7 EcoR I 7 kb
SP6 T7 BamH l-Sma 3 kb
1 kb
Figure 1. ÀFIX4 insert subclones. XFIX4 Sal I 16.5 kb insert was cloned in pGEM-3Z and 
restriction mapping analysis performed. This construct was further subcloned and the resulting 
vectors are indicated. (B=BamH I; Cl=Cla I; E= EcoR I; H=Hind III; K=Kpn I; Nc=Nco I; S=Sal 
I)
50
100 bp
EXON 1 EXON 2 EXON 3
12.6 kb i kb
\
ACGTG'GTGAG TTGCAAGGAAGAA ATAGGTAAGA TTGCAGATGCG
exon/ GTXXG-intron-AG/exon
Figure 2. Intron-exon organisation o f  the IL-12R(i2 gene as determined by subcloning and 
sequencing. The splice consensus donor and acceptor sites are indicated.
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3) Results and Discussion
3.1) Rapid extinction of the IL-12 signaling during Th2 
development: characterisation of the molecular mechanisms 
involved
3.1.1) Analysis of the IL-12 signaling pathway in human Thl and Th2 cells
To characterize the role o f IL-12 and other cytokines in the differentiation of T 
helper cell subsets, I have generated Thl and Th2 lines by stimulating human cord 
blood leukocytes with mitogen in the presence of IL-12 and neutralizing anti-IL-4 
monoclonal antibody (mAb) or IL-4 and neutralizing anti-IL-12 mAb, respectively. 
This protocol allows the establishment of human T cell lines with strongly 
polarized cytokine production (Fig. 1).
Cytokines added 
at priming:
IL-12, anti-IL-4
IL-4, anti-IL-12 E I
i----------1— i— y— i— i— i----------— i— i------- 1— i— i— i----- 1— i— i
1.2 0.8 0.4 0.4 0.8 1.2 1.6 [ng/ml]
stimulation with plate bound anti-CD3 antibodies
Figure 1. Cytokine profiles o f  cord blood derived Thl and Th2 lines. IFN-y and IL-4 production 
by Thl and Th2 lines generated from cord blood lymphocy tes. Cells were washed on day 10 after 
priming. 105 cells were restimulated in 96-well round-bottom plates for 24h with plate-bound anti- 
CD] antibodies (clone TR66 (Lanzavecchia and Scheidegger, 1987)), and IFN-y and IL-4 in culture 
supernatants were determined by ELISA assays. The results shown are representative of 5 
independent experiments.
Using a murine TCR transgenic system, Szabo et al. observed that IL-12 selectively 
activated the Janus Kinase Jak2 and the signal transducers and activators of 
transcription Stat3 and Stat4 in Thl, but not in differentiated Th2 cells (Szabo et 
al., 1995). To ascertain whether also human Thl and Th2 subsets differ in IL-12
13 IFN-y 
D IL-4
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signaling, I have examined Stat4 expression and its tyrosine phosphorylation in 
response to EL-12 in human Thl and Th2 lines. As shown in Fig. 2, IL-12 
treatment induced tyrosine phosphorylation of Stat4 selectively in Thl but not in 
Th2 cells, although both cell types expressed comparable amounts of the Stat4 
protein (Fig. 2, lower panel) required for IL-12 signaling (Bacon et al., 1995; 
Jacobson et al., 1995).
Th1 Th2
+ + IL-12 
Blot: 
anti-P-Y
anti-Stat4
IP:
ant i-Stat4
1 2  3 4
Figure 2. IL-12 dependent signaling in human Thl and Th2 cell lines. IL-12 induces Stat4 
phosphon lation in human Thl but not Th2 cells. Thl and Th2 lines generated from cord blood 
lymphocytes were harvested on day 10 after priming. 5 x 10° cells were washed and incubated 15 
min at 37 °C in medium w ith or w ithout 2 ng/ml IL-12 followed by the preparation of w hole cell 
extracts and immunoprécipitation w ith anti-Stat4 antiserum. Precipitated proteins were separated by 
SDS-PAGE (8%), transferred to nitrocellulose, and probed w ith anti-phosphotyrosine antibody 
4G10 (anti-P-Y, upper panel). As a control for Stat4 expression, blots were stripped and reprobed 
w ith anti-Stat4 antibodies (lower panel).
3.1.2) Selective expression of the IL-12R(32 chain in Thl cells
A possible explanation for the observed failure of human and mouse Th2 cells to 
respond to IL-12 could be the differential expression of IL-12 receptors on Thl and 
Th2 cells. To date, two IL-12R subunits, termed (31 and (32, have been identified. 
Both receptor subunits are required to obtain high affinity binding to IL-12, but
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only the IL-12R(S2 receptor subunit contains tyrosine residues in its cytoplasmic 
domain required for signaling(Chua et al., 1994; Presky et al., 1996). The mRNA 
expression levels for the IL-12R(31 and (32 subunits were analysed by Ribonuclease 
protection assays in both Thl and Th2 lines at different time-points after priming. 
While IL-12R(31 transcripts were expressed in similar amounts in both Thl and 
Th2 cells (Fig. 3, upper panel), the transcripts coding for the IL-12R(32 subunit 
were selectively expressed in Thl but not Th2 lines (Fig. 3). Maximum expression 
in Thl cells was seen between day 3 and day 8 and declined thereafter. Th2 cells, in 
contrast, expressed little IL-12R(32 transcripts on day 3, and none were detected 
after day 8.
d ay  3 d ay  5 d ay  8 d ay  21 d a y  19
+ IL-12
1 2 1 2 1 2 1 2 1 2 Th p h e n o t y p e
# #  #  #  # # # # # ' # # #  IL-12R p1
@ 0 0 0 0 0 0 0 %  ' #  IL-12R p2
1 8 S
1 2 3 4 5 6 7 8 9  10
Figure 3. Transcripts encoding IL-12 receptor subunits in human Thl and Th2 cells. IL-12R(32 
transcripts are selectively expressed in human Thl cells. Thl and Th2 lines generated from cord 
blood lymphocv tes were harvested on the indicated time after priming. In lanes 9 and 10 cells were 
washed on day 19 and incubated for 48h in medium containing 2 ng/ml IL-12 prior to RNA 
extraction on day 21. Transcripts encoding the IL-12R(31 subunit (upper panel), the IL-12R(32 
subunit (middle panel) and an 18S RNA gene fragment as loading control (lower panel) were 
quantitated with ribonuclease protection assays (RPAs) as described in Materials and Methods.
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A key question is whether cytokine signaling is required for IL-12R induction or 
whether stimulation via the TCR/CD3 complex is sufficient to induce DL-12R in 
naive T cells. IL-12R transcripts were therefore analyzed in purified CD45 RA T 
cells before and after stimulation with plate-bound anti-CD3 mAb. IL-12R 
transcripts were not found in naive T cells (Fig. 4, lane 2), but could be detected as 
early as 24h after T cell activation (Fig. 4, lane 9). Priming of naive T cells in the 
presence of IL-12 resulted in enhanced expression of IL-12Rp2 transcripts in this 
population (Fig. 4, lane 13); priming of cells in the presence of IL-4, in contrast, 
resulted in very low levels o f IL-12R(32 transcripts (Fig. 4, lane 14). These data 
indicate that antigen receptor triggering is sufficient to make naive T cells express a 
functional IL-12R, thus inducing IL-12 responsiveness.
f-
+
S  6h 12h 24 h 48 h 96 h
1 1 1 5 3 1 3 3 I 3 3 1 3 3 ! 3 3
#  £  *  ■  ■  f l  IL-12R pi
— •  « # #  — IL-12R p2
1 8 3
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Figure 4. Antigen receptor triggering induces expression o f  IL-12Rfil and (52 mRNAs in purified 
CD45Flf T cells. CD45RA T cells were purified by negative selection from buffy coats as 
described in Materials and Methods. Purified CD45RA T cells (5 x 10°) were stimulated with 
plate-bound anti-CD3 mAb with or w ithout the addition of IL-12 (2 ng/ml) or IL-4 (200 U/ml). 
RNA was extracted from unstimulated CD45RA T cells (lane 2) or at the indicated time after CD3- 
stimulation. Transcripts encoding IL-12R subunits were quantitated in RNase protection assays.
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To verify that the expression pattern observed at mRNA level was reflected at the 
cell surface, flow cytometry analysis of the IL-12Rpl and (32 subunits was next 
performed, as shown in figure 5. Cells were stained with both rat anti-huIL-12R(31 
mAb (2B10 (Wu et al., 1996)), and rat anti-huIL-12R(32 (2B6; (Rogge et al., 
1998)). Thl cell lines, analysed at day 5 after priming (Fig. 5, left panel), both IL- 
12R(31 and (32 subunits were detected. In contrast, only IL-12R(31 was found in 
Th2 cells lines (Fig. 5, right panel). These results demonstrate that the IL-12R(32 
subunit is selectively expressed in Thl cells where it is induced upon T cell
o
%
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Log Fluorescence Intensity
Figure 5. Cell surface expression o f  IL-12 receptor subunits on human T h l and rTh2 
lines. CD45RA T cells were purified by negative selection from cord blood and 
stimulated with plate-bound anti-CD3 mAb in the presence of the indicated cytokines 
and anti-cytokine mAbs. Cells were harvested 5 days after priming and cell surface 
expression of IL-12R(3l and (32 subunits was analyzed with rat-anti huIL-12R(3l mAb 
2B10 (dotted line), and rat-anti huIL-12R(32 mAb 2B6 (stippled line). The solid line 
represents staining with an isotype-matched control mAb.
activation. Moreover, these data suggest that the lack of IL-12R(32 chain expression 
could be the reason for the inability of EL-12 to activate the Jak2-Stat4 pathway in 
Th2 cells.
3.1.3) Regulation of IL-12R(32 mRNA expression during T helper cell 
differentiation.
The expression of several cytokine receptors has been shown to be regulated 
according to positive or negative feedback pathways (Stem et al., 1997). To
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determine whether IL-12 directly influences expression of the IL-12Rp2 
transcripts, IL-12 was added to Thl lines at day nineteen after activation. Culturing 
the cells in the presence of IL-12 for 48 hours resulted in a 7-fold increase in IL- 
12R(32 transcripts (Fig. 6, lane 2). The IL-12-induced upregulation of the IL-12R(32 
transcripts was not affected by the presence of the protein synthesis inhibitor 
cycloheximide (CHX) (Fig. 6, lane 3). These data indicate that IL-12 alone is able to 
upregulate its own receptor and that this is a direct effect that does not requires de 
novo protein synthesis. Furthermore, Time course experiments revealed that the 
IL-12 induced upregulation of the IL-12Rp2 mRNA in primed T cells was 
transient: maximal induction was seen 24h - 48h after the addition of IL-12 but 
returned to the level of the control cultures after 96h (data not shown).
Next was examined whether IL-4 also influence IL-12R^2 transcription. Neonatal 
human cells primed in the presence of IL-4 and neutralasing anti-IL-12 mAb 
completely lost IL-12R(32 expression (Fig. 3) and consequently, IL-12-mediated 
signaling (Fig. 2). The Th cells differentiated in the presence of both IL-4 and IL-12 
show a reduction in IL-12Rp2 expression as compared to Thl inducing conditions 
(IL-12 and anti-IL-4)(Fig. 25B).
IL-4 has been shown to block the development of mouse naive CD4 T cells into 
Thl effectors (Hsieh et al., 1992; Seder et al., 1992). IL-4 induces the expression of 
a number of genes of the immune system, such as Fee receptor II, germlineyl and 
IL-1R antagonist (Berton and Linehan, 1995; Kohler and Rieber, 1995; Ohmori et 
al., 1996), via the activation of the transcription factor Stat6 (Takeda et al., 1996). 
Inhibitory effects on the regulation of several genes have also been described. For 
example, Ohmori and colleagues described that DFN-y-induced activation of IFN 
regulatory factor-1 (IRF-1) gene is partially suppressed by IL-4 (Ohmori and 
Hamilton, 1997). This study indicated that the IL-4 suppressive effect is due to 
competition between IL-4 induced Stat6 and IFN-y-induced Stall for binding to 
the same GAS site in the IRF-1 promoter. Indeed, binding of DNA of Stall, but 
not of Stat6 is sufficient to induce transcription. Similarly, in the regulation of the
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E-selectin gene, IL-4 antagonises TNFa- activation of the gene (Rennet et al., 
1997). Again, this effect is achieved by competition between Statb and NF-kB for 
binding to the corresponding overlapping sites in the E-selectin promoter.
IL-12 treatment 
CHX treatment
I L 1 2 R p 2
#  #  #  #  1 8 5
1 2  3  4
Thl cells
+  +  - 
- +  +
Figure 6. IL-12 dependent regulation o f  IL-12Rf}2 transcripts. Thl cells generated from cord 
blood were harv ested 2 weeks after stimulation. The cells were treated as indicated with IL-12 (2.5 
ng/ml) followed by the extraction of total RNA. To determined w hether de novo protein synthesis 
is required for IL-12-induced upregulation of IL-12R[32 transcripts, cells were treated with the 
protein synthesis inhibitor Cycloeximide (CHX, 10 pg/ml) 45 min prior to the addition of IL-12 
(2.5 ng/ml) for 16 h. RNA was extracted 16 h after the addition of IL-12. Transcripts encoding IL- 
12R(32 (upper panel) and 18S RNA loading control (lower panel) were analysed by RNase 
protection assays as described in Materials and Methods.
To test whether IL-4 directly counteracts IL-12-mediated upregulation of IL- 
12Rp2 transcripts, established Thl lines (day 13 after priming) were pretreated for 
1 h with IL-4, stimulated with increasing concentrations of IL-12 and after 16h the 
transcripts for IL-12R(32, IL-4Ra and yc were analysed by Ribonuclease protection 
assays (Fig 7). IL-4 treatment led to Statb phosphorylation (Fig. 8) and to 
upregulation of IL-4R receptor (Fig. 7, middle panels) (Keegan et al., 1994), thus 
indicating that functional IL-4 signaling occurs in these cells. Conversely, IL-12- 
mediated upregulation of IL-12R(32 transcripts was not affected by IL-4
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pretreatment in all conditions tested (Fig. 7, upper panel). These data indicated that
IL-4 does not directly suppress IL-12R|32 expression, despite of the fact that these 
cells are IL-4 responsive.
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Figure 7. IL-4 does not directly suppress IL-12Rfi2 m-RNA expression in established T cell lines. 
Thl lines generated from cord blood lymphocytes on day 13 after priming were pretreated (lanes 
2,4,6„8 and 10) or not (lanes L3,5,7 and 9) with 1 ng/ml ÎL-4 for 1 h and then stimulated for 16 h 
with the indicated amounts of IL-12 (lanes 3 to 10). Transcripts encoding the IL-12R(32 subunit 
(upper panel), the IL-4Ra subunit (middle panel) and yc RNA gene fragments (lower panel) were 
quantitated with ribonuclease protection assays (RPAs) as described in Materials and Methods.
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Figure 8. Stat6 is phosphorylated in Thl and Th2 cells in response to IL-4. Thl and Th2 lines 
generated from cord blood lymphocv tes were han ested on day 13 after priming. 5 x 10° cells were 
washed and incubated 15 min at 37 C in medium with or without 1 ng/ml IL-4 followed by the 
preparation of whole cell extracts and immunoprécipitation with anti-Stat6 antiserum. Precipitated 
proteins were separated by SDS-PAGE (8%), transferred to nitrocellulose, and probed with anti- 
phospho tyrosine antibody 4G10 (anti-P-Y, upper panel). As a control for Stat6 expression, blots 
were stripped and reprobed with anii-Stat6 antibodies (lower panel).
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3.1.4) Discussion
T helper lymphocytes development is comprised of two spatially and temporally 
distinct phases of differentiation. Following the first developmental phase, which 
occurs in the thymus, a second phase, triggered by initial encounter with antigen in 
the periphery, leads to the development of effector Th subsets producing mutually 
exclusive pattern of cytokines and playing different roles in the immune response 
(Mosmann and Coffman, 1989; Paul and Seder, 1994).
Cytokines present at the time of the initial encounter with the antigen, drive the 
differentiation pathway of the precursor naive T cell. In particular, Thl 
differentiation is driven by IL-12, while Th2 differentiation is elicited by IL-4 
(Abbas et al., 1996; O'Garra, 1998).
To get insights into the molecular mechanisms underlying T helper cell 
differentiation, I have analysed IL-12 signaling in human Thl and Th2 cell lines. 
IL-12 treatment induces tyrosine phosphorylation of Stat4 in human Thl, but not 
Th2 cells, indicating an early extinction of IL-12 signalingin human Th2 cells. The 
analysis of the IL-12 signaling components in developing Th cells revealed that the 
IL-12R(32 subunit is selectively expressed in Thl cells, as observed both at the 
RNA and the protein level. Thus, the inability of IL-12 to activate the Jak2-Stat4 
pathway in Th2 cells is determined by the absence of functional IL-12 receptors on 
the T cell surface.
Similarly, the selective expression of the IL-12Rp2 subunit was evidenced in mouse 
Thl and Th2 cells differentiated in vitro (Szabo et al., 1997). The importance of the 
IL-12R(32 expression for IL-12 signaling was further demonstrated in vivo, in the 
Leishtnania model: maintenance or loss of the IL-12R(32 mRNA by CD4 T cells 
strictly correlates with responsiveness or lack of responsiveness in resistant 
C57BL/6 mice or susceptible BALB/c, respectively (Galbiati et al., 1998; Güler et 
al., 1996; Himmerlich et al., 1998).
The IL-12Rp2 chain appears to be the first Thl subset-specific non-cytokine gene 
to be isolated to date and it can represent an important marker to identify Thl
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cells. Indeed, it has been recently demonstrated in our laboratory that the anti- IL- 
12R(32 mAb recognises lung T cells from patients with sarcoidosis, a disease 
characterised by Thl type inflammatory response. In contrast, IL-12R(32 was not 
found on lung T cells from patients with allergic asthma, a desease characterised by 
type-2 inflammatory response (Rogge et al., 1999).
There is now a growing evidence that cell types other than CD4 T cells can 
differentiate in distinct cell subsets that produce type I or type II cytokines. CDS 
Tel or Tc2 subsets can be generated in vitro (Sad et al., 1995), this polarised 
phenotype is persistent in vivo and CDS subsets have been identified in humans 
as well as in mice in various immunopathological conditions (Cervenka et al., 1998; 
Seder and Le Gros, 1995). In addition, NK cells have also been recently described 
to differentiate in distinct cell subsets: NK grown in IL-12 produce DL-IO and IFN- 
y, whereas NK grown in IL-4 secrete IL-5 and IL-13 (Peritt et al., 1998). Thus, cell 
types that were though to be restricted to a type I pattern of cytokines can also 
produce cytokines of the type II subset, yet their functional significance is still 
unclear, as both Tc2 and NK2 cells maintain cytotoxic activity. Interestingly, IL- 
12R modulation in NK2 and Tc2 cells resembles the one observed in CD4 cells, 
confirming the key role of IL-12R(32 gene in the generation of different cells subsets 
producing distinct cytokine patterns (Peritt et al., 1998).
The analysis of the transcriptional regulation of the IL-12Rp2 subunit provided 
insights in how the expression of a functional IL-12R is obtained.
First, the IL-12R subunits are not expressed in naive T cells, but T cell activation is 
sufficient to induce their transcription. Second, depending on the cytokines present 
at the time of priming, positive or negative regulatory signals sustain or inhibit IL- 
12R(32 subunit expression thus allowing the development of either a Thl cell that 
responds to IL-12 by producing IFN-y in response to IL-12 or of a IL-12 
unresponsive Th2 cell (see Fig 9).
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Figure 9. IL-12Rfi2 subunit expression in cytokine-induced T helper development. The IL-12R 
subunits are not expressed in naive T cells, but T cell activation is sufficient to induce their 
transcription. Depending on the cytokines present at the time of priming, positive or negative 
regulatory signals will sustain or inhibit IL-12Rp2 subunit expression thus allowing the 
development of either a Thl cell that is IL-12 responsive and that produces IFN-y in response to 
IL-12 or of a IL-12 unresponsive Th2 cell.
IL-12 is a positive regulatory factor of the IL-12R(32 subunit. Not only T cell 
priming in the presence of IL-12 leads to a strong upregulation of IL-12R(32 
transcripts, but also IL-12 treatment alone, even when de novo protein synthesis is 
blocked, determines IL-12R(32 increased expression. These data indicate that IL-12- 
induced upregulation of the IL-12R(32 gene is a direct effect, that activates 
preexisting factors in the cell. However the identity of these factors remained 
unclear (see chapter 2).
T cells differentiated in the presence of IL-4 do not express IL-12Rp2 transcripts. 
Th cells differentiated in the presence of both IL-4 and IL-12 show a reduction in 
IL-12R(32 expression if compared to Thl inducing conditions.
/naive" 
O ( CD4+ 
XT cell
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I have been interested in determining whether IL-4 plays a direct role in 
downregulating IL-12R[32 expression. In particular, I have examined the possibility 
that Stat6, once activated by IL-4, acts as a negative regulatory factor (Bennet et 
al., 1997; Takeda et al., 1996). The data clearly demonstrated that IL-4 
pretreatment of Thl cells did not affect IL-12-induced upregulation of IL-12R(32 
transcripts. This is not due to a lack of IL-4 signaling in Thl cells since these cells: 
i) the IL-4R components are expressed, ii) Stat6 is phosphorylated in response to 
IL-4, in) Stat6 binds DNA in response to IL-4 and more importantly, iv) IL-4 
upregulates the IL-4Ra subunit. An IL-4 signaling impairment in Thl cells has 
been recently reported (Huang and Paul, 1997; Kubo et al., 1997). Huang and 
colleagues described that repeatedly stimulated mouse Thl cells, despite the 
expression of IL-4R subunits at their surface, do not efficiently phosphorylate 
Stat6 in response to IL-4. Nevertheless, they also describe that, after one-round of 
stimulation, Thl cells are still IL-4 responsive, in accordance with our findings in 
the human system and suggesting that IL-4 unresponsiveness is a consequence, 
rather than a cause of Thl development.
Although the mechanism by which IL-4 induces the generation of IL-12 non- 
responsive Th2 cells remains to be clarified, our data argue against a direct effect of 
IL-4 in the downregulation of the IL-12Rp2 gene. More likely, the inhibition of IL- 
12Rp2 transcription along Th2 development could be indirectly mediated by IL-4 - 
induced Th2 specific transcription factors. GATA-3 was shown to be selectively 
expressed by Th2, but not Thl cells and to augment Th2 cytokines (Ranganath et 
al., 1998; Zhang et al., 1998; Zhang et al., 1997). Recently, Ouyang and colleagues 
(Ouyang et al., 1998) evidenced that GATA-3 acts as a repressor of Thl 
development and IFN-y production. This is not simply a secondary effect of 
GATA-3 on IL-4 production since it occurs also in IL-4 deficient T cells. In 
addition, GATA-3 represses IFN-y production only when continuously expressed 
during initial T cell development but not when reintroduced into Thl cells after IL- 
12-induced development. These findings suggest that GATA-3 may regulate an
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early step in Thl development, rather than directly repressing the IFN-y promoter. 
This early step could be the regulation of the IL-12R(32, since they also show that 
GATA-3 expression and IL-12 signaling along Th2 development are mutually 
antagonistic. The analysis of the IL-12R(32 promoter region would provide insights 
in this regards. The observations that GATA-3 is enhanced by IL-4 addition 
(Zheng and Flavell, 1997) and that in Stat6 -/- mice GATA-3 expression is 
strongly reduced (Ouyang et al., 1998), suggest a role of IL-4 in GATA-3 
regulation.
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3.2) Cloning and characterisation of the IL-12R(32 promoter 
region
3.2.1) Cloning of the human IL-12Rp2 promoter region.
The data obtained so far indicated that the regulation of the signaling component of 
the IL-12R complex is the focal point for early maintenance or loss of IL-12 
responsiveness in developing Th cells. These findings support a model in which 
triggering of the antigen receptor on naive T cells is sufficient for the initial 
expression of functional EL-12 receptors on activated T cells. Depending on the 
cytokines present during the differentiation, T cells will develop into IL-12 
responsive Thl cells or IL-12 non-responsive Th2 cells. So far, two factors that 
positively influence IL-12R(32 expression were identified: TCR triggering and IL- 
12. However, the role of other cytokines, like interferons, in the development of T 
helper cells and consequently in the regulation of the IL-12Rp2 gene has to be 
clarified. More importantly, it still remains to be elucidated how positive and 
negative signals are integrated to obtain expression of the IL-12Rp2 gene and 
consequent development of IL-12 responsive Thl cells. In order to provide insights 
into the molecular mechanisms governing T helper development, I have isolated and 
characterised the IL-12R(32 promoter.
The EL-12R(32 promoter region was isolated by screening a human genomic library. 
The probe used was derived from a cDNA clone containing the 5’ untranslated 
region of the EL-12R(32 transcript (the 880 bp Nco I-Xba I fragment of clone B5- 
10, kindly provided by Ueli Gubler, Roche Nutley, (Presky et al., 1996)). Three 
positive clones were isolated after three rounds of screening: XFIX-1, AJFIX-3, 
XFIX-4. To characterise the inserts of the phages, phage DNA was extracted and 
Southern blot analysis performed. For mapping studies, oligonucleotide probes of 
the 5'-end of B5-10, of the start codon and of a downstream region across the Nco 
I site were derived from the IL-12R(32 cDNA (B2 60-38, B2 660-649, B2: 887-866, 
respectively; see materials and methods).
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Figure 10. Southern blot analysis o f  B5-10 positive phages isolated from a human placenta genomic 
libraty. Phage DNA was extracted from XFIX-1 (left panel) ÀFIX-3 (middle panel) and 1FIX-4 (right 
panel) and digested overnight with BamHI, Bgl II, EcoRI, Hind III, Not I, Sma I, Taq I Xba I (lines 1 to 8). 
Southern blot analysis was performed using as probes: A) the IL-12R[32 cDNA fragment B5-10 (see text), 
B) B2 60-38: 5 -CAC TTT GTT GAC AGC CAT CAG C-3’;C) B2 660-649: S’-GAT GGC ACA TAC 
TTT TAG A GG-3’; D)B2: 887-866 5 -GGC CAT GGT GAA AAT TGA TTC-3’.
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As shown in figure 10 (left panel) XFIX-1 did not hybridise with any of the 
oligonucleotides, indicating that it contained downstream sequences of the IL- 
12Rp2 gene.
XFIX-3 hybridised with oligonucleotides B2: 660-649 (ATG) and B2: 887-866 
(Nco I) but not B2 60-38 (5’), indicating that it contained the start codon, but not 
the 5’ end of the IL-12Rp2 gene (Fig. 10, middle panel). Conversely XFIX-4 
hybridised with the oligonucleotideB2: 60-38 (S’), but not B2: 660-649 (ATG) 
and B2: 887-866 (Nco I), indicating that it contained the upstream part of the gene 
(Fig. 10, right panel). The 16.5 kb XFIX-4 insert was excised with Sal I and cloned 
in pGEM-3Z, generating pBET-9. pBET-9 was further characterised by restriction 
mapping analysis (Fig. 11 see also materials and methods) and its subclone pBET- 
13, containing the 3 kb Sal I- Sma I fragment was entirely sequenced (see Fig. 19 
and 20).
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Figure 11. Restriction mapping analysis o f  pBET-9. Restriction map of pBET-9, containing the 9 
kb Sal I fragment derived from XFÏX-4. The position of the restriction enzyme cut sites was 
determined performing single and double digestions and Southern blot analysis as described in 
materials and methods. (B=BamH I; Cl=Cla I; E= EcoR I; H=Hind III; K=Kpn I; Nc=Nco I; 
S=Sal I).
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Since DNase I Hypersensitive site mapping analysis (see below) revealed that 
regulatory regions were located further upstream the sequence covered by pBET-9, 
an additional library screening was performed. In order to isolate this region, clones 
were selected that hybridised to an oligonucleotide probe chosen in the most S' 
region of pBET-9 (13:78-98 see materials and methods. Tab. Ill) but did not 
hybridise to a 0.5 kb EcoR I-Pvu II DNA fragment (located 3.7 kb downstream the 
RNA start site). Only XHOP-1 phage fulfilled these requirements and was further 
characterised. The Sal I-Pvu II 8 kb phage fragment that hybridised with the 
oligonucleotide probe was subcloned in pBluescript (pHOP-1), then Southern blot 
analysis and restriction mapping were performed. The restriction pattern of the 
pHOP-1 partially resembled the one of pBET-9 indicating an overlap between the 
two inserts. In particular the 3.5 kb Xba I fragment of pHOP-1 was identified 
through restriction analysis and Southern Blotting as a shorter fragment that 
contained the region where the hypersensitive site mapped; it was subcloned in 
pBluescript (pHOP-3) and entirely sequenced. As shown in figure 19 and 20, the 
sequence analysis of pHOP-3 and pBET-13 allowed the definition of a contig of 5 
kb, that contained, as described afterwards, the promoter and also enhancer regions 
of the IL-12Rp2 gene.
In order to characterise also the immediate downstream part of the gene and define 
its intron-exon organisation, I have also investigated whether XFDC-4 and XFIX-3 
were contiguous. For this purpose, an oligonucleotide derived from the most 3’ 
region of XFIX-4 ( B9-3’, see materials and methods) was used to perform 
Southern blot analysis of XFIX-3. The oligo probe hybridised to XFIX-3, indicating 
a partial overlap of the two phages. The 1.6 kb Bgl II fragment of XFIX-3 phage, 
which was hybridising with the oligonucleotide, was subcloned in pBluescriptSK II 
(pSK-1) and sequenced (see materials and methods. Fig 2 ).
The contig resulting from the overlap of the phages pHOP-1, XFIX-4 and X.FIX-3 
allowed the characterisation of a 16.5 kb region of the human genome that contains 
part of the LL-12R(32 gene, as summarised in Fig. 12. The comparison between the
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cDNA and the genomic sequences allows the definition of its intron-exon 
organisation. ThehIL-12Rp2 gene has a first untranslated exon of 547 bp which is 
separated by a long first intron (12.5 kb) from the second exon (112 bp) that 
contains the start codon of the gene. The third exon follows after a 1 kb second 
intron (Fig. 12).
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Figure 12. IL-12R$2 genomic organisation. A 16.5 kb region of the human genome that contains 
part of the IL-12Rp2 gene is shown. The characterisation of this region was obtained by restriction 
mapping and sequencing analysis of the phages pHOP-1. ÀF1X-4 and Â.FIX-3 Some of the phage 
subclones utilised for the analy sis of the region are also indicated (see text). The hIL-12R(32 gene 
has a first untranslated exon of 547 bp w hich is separated by a long first intron (12.5 kb) from the 
second exon (112 bp) that contains the start codon of the gene. The third exon follow s after a 1 kb 
second intron. The consensus binding sites for transcription factors are also indicated.
In order to verify whether the phage inserts were not containing cloning artifacts, 
genomic DNA from peripheral blood mononuclear cells (PBMC) was isolated and 
genomic Southerns were performed (Fig. 13). DNA fragments derived from pBET- 
9 were used as probes.
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The restriction pattern evidenced in the genomic Southern coincided with the one 
determined from the phage contig, indicating the absence of rearrangements in the 
phage inserts.
1 2 3 4 5 6
— 10 kb 
g w  w  -  7 kb
Figure 13. Genomic Southern analysis o f  the IL-12Rfi2 gene. Genomic DNA was extracted from 
PBMCs as described in materials and methods and digested with EcoR I, BamH I, Sac I, Hind III, 
Sma I and EcoR V (lanes 1-6). Digested DNA was run in a 0.8% agarose gel and Southern blot 
analysis performed using the 0.5 kb Pvu II-BamHI probe.
3.2.2) Identification of the RNA start site
Once the genomic region covering the IL-12R(32 gene was isolated the first step in 
the identification of the promoter was the determination of the RNA start site.
To identify the RNA start site of the hIL-12R(32 gene, the region in which the 5’ of 
the B5-10 cDNA mapped in the genomic sequence was investigated using Rnase 
Protection Assays. Radiolabelled sense and anti sense RNA probes were derived 
from a 900 bp Taq-1 fragment encompassing the 5’-end of B5-10 and hybridised to 
total RNA purified from Thl or Th2 cells. Transcripts were detected in Thl (Fig. 
14, lane 2), but not in Th2 cells (Fig. 14, lane 3), with the antisense probe. These 
results indicated that transcription of the IL-12R(32 gene starts from multiple sites
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in a 30 nt window located at the 5’ end of the cDNA clone B5-10 that was 
originally used to isolate the IL-12R(32 gene.
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Figure 14. Identification o f  the IL-12Rfi2 RNA start site. To identify the RNA start site of the hlL- 
12R(32 gene, the region in which the 5’ of the B5-10 cDNA mapped in the genomic sequence was 
investigated using Rnase Protection Assays. Radiolabelled sense (left panel) and antisense (right 
panel) RNA probes were derived from a 900 bp Taq I fragment encompassing the 5’-end of B5-10 
and hybridised to total RNA purified from Thl or Th2 cells.
3.2.3) Mapping of DNase I Hypersensitive sites within the IL-12Rp2 gene
Analysis of IL-12R(32 regulation at RNA and protein level indicates the presence of 
two major signaling pathways influencing IL-12R(32 expression. Triggering of the 
antigen receptor on naive T cells is sufficient for the initial expression of functional 
IL-12 receptors on activated T cells. The presence of IL-12 at the time of priming 
maintains IL-12R(32 expression and allows development of Thl cells.
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To identify the regulatory regions involved in TCR and IL-12 mediated regulation 
of the IL-12R02 gene, DNase I Hypersensitive Site (DHS) mapping analysis of the 
upstream region of the hIL-12Rp2 gene was performed. This technique is based on 
the principle that a short digestion of purified nuclei with DNase I leads to the 
preferential cut of chromatin in the most accessible sites. These sites often correlate 
with transcription factor binding sites (Weintraub and Groudine, 1976). In this 
approach a specific genomic probe that hybridises to one end of a restriction 
fragment was used to probe a Southern blot of Pvu II-digested DNA samples 
isolated from nuclei that had been digested with increasing concentrations of DNase 
I.
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naive T cells activated T cells
DNase
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mRNA
- f - r - t -
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- 9.0 kb
- 7.5 kb
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Figure 15. DNase Hypersensitive sites are present in the IL-12R(32 gene in activated PHA blasts, 
but not naive T cells. Nuclei were purified from CD4+ naive T cells (left panel) or PHA blasts 
(right panel) and briefly treated with increasing amounts of DNase I (lanes 2-5). Genomic DNA was 
extracted. 10 pg were digested with Pvu II and Southern blot analysis performed using the 0.5 kb 
Pvu II-BamH I genomic fragment as a probe.
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The resulting autoradiogram shows the genomic fragment of 9 kb flanked by Pvu II 
sites and specific subfragments generated by DNAse I digest. The position of the 
DNAse I hypersensitive sites with respect to the Pvu II restriction sites in the IL- 
12R(32 gene can be defined by the length of the respective subfragment Using this 
approach I mapped hypersensitive sites encompassing a region that extended 5 kb 
upstream and 4 kb downstream from the RNA start site (see Fig. 16).
First, I have analysed DNase I hypersensitive (DH) sites in naive CD4+ T cells. 
Only the parental 9 kb Pvu II fragment was evidenced, indicating the absence of 
DH sites in this region. These findings are consistent with our previous observation 
that no IL-12Rp2 transcripts were detected in naive CD4 T cells (Fig. 15, left 
panel).
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Figure 16. Mapping o f  DNase Hypersensitive sites in the IL-12R[i2 gene. In this figure are 
summarised the results obtained by the DHS analysis performed in the 9 kb Pvu II fragment across 
the IL-12R(32 promoter region. Thie DH sites identified were also conformed analysing a 9.5 kb Sea 
I fragment, which covers almost the same genomic region contained in the Pvu II fragment. The 
position of the DNAsel hypersensitive sites (indicated by arrows) with respect to the Pv u II 
restriction sites in the IL-12R(32 gene were defined by the length of the respectiv e subfragment and 
the position of the BamH I-Pvu II probe.
DHS analysis was then performed on PHA blasts at day 20 after activation. In 
addition to the parental 9 kb fragment, five subbands were detected in the Pvu II
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digestion (Fig. 15, right panel). The DH sites identified were also confirmed in a 9.5 
kb Sea I digestion fragment, which covers almost the same genomic region contained 
in the Pvu II fragment (Fig. 16). A strong DH site mapped in close proximity to the 
RNA start site, confirming the presence of a core promoter. Putative enhancer 
regions were identified by two additional DH sites located upstream the RNA start 
site, a strong one at -3000 and a weaker one at -1900. Two weak DH sites were 
also mapped in the first intron, at +1100 and at +2100.
T h 2 Th1
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Figure 17. DNase Hypersensitive sites are present in the IL-12R[52 gene in Thl, but not Th2 cells. 
Nuclei were purified from Thl (left panel) or Th2 (right panel) cells at day 6 after priming and 
treated with increasing amounts of DNase I (lanes 2-5) for 2 \  Genomic DNA was extracted. 10 pg 
were digested with Pvu II and Southern blot analysis was performed using the 0.5 kb Pvu II-BamH 
I genomic fragment as a probe.
Next, the DHS pattern of Thl and Th2 cell lines was investigated. Thl cells 
analysed at day 6 after priming showed a DHS pattern almost identical to the one 
observed with PHA blasts (Fig 17, left panel). Conversely, Th2 cells showed only
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one DH site corresponding to the RNA start site (Fig. 16 and Fig. 17, right panel), 
indicating a poor transcriptional activity of the IL-12R(32 gene in these cells, as 
expected from the previous findings. To test the effects of IL-12 and a-CD3 on the 
chromatin structure of Thl cells, lines were rested until day 20 after priming and 
then stimulated with a-CD3 mAh or IL-12. Both treatments resulted in an 
increased intensity of the sub-fragments, suggesting that these sites could indeed 
contain responsive elements for IL-12 and a-CD3 mediated regulation of the gene 
(data not shown).
3.2.4) Identification of the minimal promoter region
DHS analysis as well as RNA start site mapping evidenced the presence of a 
promoter region, positioned at 2.5 kb from the 5’ end of pBET-9. In order to verify 
and to characterise this potential promoter region, restriction fragments containing 
this region were clone upstream to a luciferase reporter gene(pXP; (de Wet et al., 
1987)) and used for transient transfections in a number of lymphocytic cell lines. 
CEM and Jurkat T cell lines were electroporated (or transfected using DMRIE-C) 
and luciferase activity was detected in the cell lysate 24 hours after transfection. 
Transfection efficiencies were normalised with p-galactosidasevalues.
As shown in figure 18, the pXP-23 construct, containing the 700 bp Dra Il-Sma I 
fragment, (covering the RNA start site) was found to be constitutively active in T 
cell lines, showing 60 fold of induction if compared to the empty vector. When 
pXP-23 insert was cloned in the opposite direction (pXP-24) no luciferase activity 
was detected. Extension at the 5’ of length of the fragments was not further 
increasing promoter activity in CEM and Jurkat cells (data not shown)
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Figure 18. An IL-12R [32 gene fragment o f  700 bp activates transcription in Jurkat cells, the 700 
bp fragment Dra Il-Sma I of the IL-12RP2 gene was cloned in both directions (pXP23 and pXP24) 
upstream the luciferase gene, in the pXP vector. These constructs were transiently transfected in 
Jurkat cells (left panel) or COS cells (right panel) and luciferase activity in cell lysates was 
measured 24 h after transfection. Variability of transfection efficiencywas normalised by measuring 
(3-galactosidase activity of a CMV-gal vector cotransfected in the cells. The results shown are 
representative of 5 independent experiments.
DNA sequence analysis of this region (see figure 20) revealed the absence of a 
TATA and a CCAAT box, (Conaway and Conaway, 1993), no initiator sites 
(Javahery et al., 1994), but the presence of a Multiple start site Element 
Downstream (MED)-l element (GCTCCc7g) (Ince and Scotto, 1995), consistent 
with the presence of multiple RNA start sites. In addition, a perfect consensus 
AP2 binding site (5 -CCGCAGGC-3’) and seven potential SP1 binding sites (5’- 
GGGCGG-3’) were identified. These features of the IL-12R(32 core promoter, 
rather unexpectedly, resemble a typical housekeeping gene promoter. Interestingly, 
transfection of pXP 23 into non-lymphoid cell lines like COS-7 cells (Fig. 18) 
resulted in promoter activity, suggesting that this region does not confer tissue- 
specificity to IL-12R[32 gene expression.
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Figure 19. Restriction map o f  the IL-12Rfi2 promoter region and o f  the 4.5 kb upstream. pBET- 
13 and pHOP-3 were sequenced as described in materials and methods. The inserts of the two 
clones partially overlaps. The resulting contig that contains the IL-12R|32 promoter and the 
enhancer regions El (that contains (32GAS1 and (32GAS3) and E2 (that contains (32GAS2 p2GAS4) 
are also shown.
Cutters: BamH I, BstX I. Dra II. EcoR V. Not I, Pst I, Sac I. Sac II, Sma I. Spe I. Xba I & Xma 
II.
Non-Cutters. Apa I, BsplOô, EcoR I. Hind III. Kpn L Sal I & Xho I.
- 4 5 2 5  GCTCTAGAACTAGTGGATCCCCCCTGGATGCCATGACTGGACAGGACTTTGGGTTGTCYCATTTGGGAAATCAGAGTAT 
- 4 4 4 6  TTTCTATGTATGAGAAGCATGGAAAAAAAGGACATTTGAAGCCAGAAGAGTGGAATGTAGAAAAGAATCTTAATGATTA 
- 4 3 6 7  TACATCCACATTTCAGAGTACTTCTCATAGGGCTTCTGTTGATGTACTCTACAACAAACCAAAAACAAACAAACAACAA 
- 4 2 8 8  CGACAACAAAAATGAGGAACATATGTGTGGTTTTATGTGGGAATGTTTGTGAGAAATTTGCCTTTTATGCAAATCACTC 
- 4 2 0 9  TCCTTTTTATAAGAACTTGCCAAAGTTTTGCACCACCAAAAGTTCTGGCTCTGATGATCAGGTAACCAGCCATGACATG 
- 4 1 3 0  ATGGAATCTGTGAATCCTGTAACATATGTTTAGATTTAGCTGCTAAGAATAGCAGAGCCAGTTTGTGAATAAAGTTTAT 
- 4 0 5 1  GTTGTGTAGGACCCTGCAGCTATCACAG CTTTA AATTTA CCTCATGTCTCACTTTACTCTTTAACCTTTATG TTCA TTT 
- 3 9 7 2  AACAAGGCATCCAGCAATCTAAAGACCTCTCAAAAACGCACTGCTGCTCTCCAAGACATGGCAATTTCCATGTGGTTTG 
- 3 8 9 3  TTCATCTTTTTTTTTTTTTTTTGG ACAGAGTCTTG CTCTGTTGCCCAGG CTG GAGTGCAA TGGTGCCATCTTGGCTCAC 
- 3 8 1 4  TGCAACCTCTGACTCCCGGGTTCAAGCCATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGTGAGTGCCACC 
- 3 7 3 5  ATGCCTGGCTAAGTTTTGTATGTTCAACAGAGATGGGATTTCTCCATTTTGGCCAGGCTGGTCTTGAACTCCTGACCTC 
- 3 6 5 6  AGGTGATCCACCTGCTTCAGCCTCCCAAAATGCTGAGATTATATGTATGAGCCACTGAGCCTGGCCAGTTTGTTCCTCT 
- 3 5 7 7  ATAAACAATGTTTGTGCTTGTTAAATGTCAGTTGTGGAGAAGGTATAAGTCTACATTTTAAGAATTATGGAGATTATTC 
- 3 4 9 8  ATAATCTGAGAATCTGGTATTGCACTATTTTAATTTTATATAAACTTTTTCAATACATAACACTACAAATATATTCAGG 
- 3 4 1 9  AGTTATGTTGCTGTCCTATAAGTTTAATACTTTGGAGAGATGAGTAAAACTAACAAAGTAATAACTTTTAGAAATGAAA 
- 3 3 4 0  CTTTTACAAAATGAAGCAGTTAAGGTTGAACAGTTAATCTTAGATTCTGAGTTTTCTCATTATAAGTAAAAGTTTAAAA 
- 3 2 6 1  TGATGTTAAAACCGTCTTACCAAGTTTAACGAGTGCCAGCATTCATTTGATGCCCTAAATGACTATGTTAGCAACCACC
P2GAS4
- 3 1 8 2  TCCTAGTATTTATCCTGACAAGTGACACTTTAGGAAAAGCACATCTCAGTTApTCA TA G Â Â tA GTGTGATTA CG TATTT 
- 3 1 0 3  TCAGGGTGTTTGGTATCAGCAATGAACCAAATTAGACATTTAAAGTAATGGAACTATACCAGAAATGGAAACTGAACTA
P2GAS2
- 3 0 2  4 GTAT[rTCCTAG AA^AGACTTTGTCACTGTCACTGTGGTTATCCACTTAATTGAGCTTTTGATTTACAAGTACATTCATT
- 2 9 4 5  TACCTAACAGCTACACAGAAGACCATATCATACCCATAGACTTAAAAATGATTACATTAACAATCACAGTTGACATTTT 
- 2 8 6 6  GGGTTGTATATTAGGCTCTTGCTTCATCAGGCATCGTCTACCATCTAGGGTTTATTCTTTAGAAAGCACAGAAGCAAGT 
- 2 7  8 7  TTGTCTTTG TTGTTATTTTTG TTTTCA TTG TTA TTTTTG TTTTTG TTTTTTTCTCTA A CTA G A CA G G CA A CCA CTG A CA  
- 2 7 0 8  AAAGCCATGCCTGTATTAGTGAAACTCCCAGATATTAATAGGAGGAGAAGGCAGAAAAAAGAAGTGGGGAAATAGAAAG 
- 2 6 2  9 GCCTCTACAGATGGTGATTTCATACAGAAAGGTTACCGACTTGCTAAGAAAAATTATATTTAATTTTCCAACTAATTTT 
- 2 5 5 0  TAACTGTCGAAAAGTGTGAAGATTGAACAACACCTACAATCCCGTTGAACTGGCCAAAAAGAATGGGATCTCTCCAGAA 
- 2 4 7 1  CAAGTCAGTTCAACTCAGTAAATACTTATTGACTACCTGCCCTGTACCACTCAGTGTGCCAGATGCTGAAGATGAGGGA 
- 2 2 6 2  TCCTTGCGTGCATAGAGTTTATAATCCAGGGAGCATGCAGGATAAGAGAACCACTGTTATCAATGGCAATCAGTGCAAG 
- 2 3 9 2  TCTTCACTTGATAATGTAAGTCTAAGTTAAACAATATACTGATGGACCTAGAGCATGATAATTTCTCAAATAATACTTA 
- 2 3 1 3  TGTAAGAGTTGTCATCTTCTGACTTTTTTTTTCTTGCATCTAGGGAAAAGAAGAGAATAAAGAAGATTATCATTGCTAC
P2GAS3
- 2 2 3 4  CTG CA TCTTACTGTAlrTCTCATAATTTGTTGTGCTTGCTTAACAACCAGATTCAAGTTCTTTCCTCAACAGCTCTCATC
- 2 1 5 5  TGTTCCCTCAAAGAATATGCCTTAGATGCATTTGAGACACCATTTTGTGTCTGACTTCTGCAATTTTGTAAGATGCTGC 
- 2 0 7 6  CATTAGAAGTTAATAGAGCAGTGGTCTTTCAACATTTTAGATGGTATACTCCTTCAGAAAAAAAAAAAAAGCATTTTTG
P2GAS1
- 1 9 9 7  AGA AACATCCCCAACATA TGTTTGG TTGTTTTTTTA TpTC CTTG A A jvAACATATGTATGCCGGGCGCGGTGGCTCACGC
- 1 9 1 8  CTGTAATCCCAGCACTTTGGGAGGCTGAGGTGGGCAGATCACGAGGTCAGGAGTTTGAGACCAGCCTGGCCAATATGGT 
- 1 8 3 9  GAAACCCCATCTCTACTATAAATACAAAAATTAGCCGGGCATGGTGGCGCGTGCCTGTAGTCCCAGCTACTCAGGAGGC 
- 1 7 6 0  TGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTGAGCTGAAATTGTGCCACTGTACTCTAGCCGGGGC 
- 1 6 8 1  AACAGAGTGAGACGCTGTTTCAAAAAAAAAAAAACAGAAAAACATATGTATATTTATATGTGTGTATATACACACACAC 
- 1 6 0 2  ACATATGCACACACAAATATATAAATTAAATTTTTAAATGAGATAGAGTAAAATGCATTTTTGAAATTATTGATTTATT 
- 1 5 2 3  AACAAAACTAAAAGCCTTCCTTCTCACTAAAAAGTGTTGAAAAATCCATGAATTATGCAAGATTGTTATAACATTTGGC 
- 1 4  4 4 TATCATAATCTTATTCTTGATATCAATCAGTTTTTAAAGTAATGAGAAGCTGCTGCATTTTTATATTTTTTAACAAATG 
- 1 3 6 5  GATTTAAAATCCACTGAACTGCTCAATTAAAAGATTGAAACAAAATAGCAAATTGTTTCCGAGTTTTTAAAAGCATTTT 
- 1 2 8 6  CTGTGATGACAATCATAAAATCTTCAGTAAGAAAAACACACAATAATGGGAACACTTCGAAATATTTGTTTTCAAATCG 
- 1 2 0 7  TCTCTTCATAACAACGTATCACTTGGTGTGAAAATTACCTTGAAGAAACAACAAATAAACCTCTGGGGTTTTTTGTTCT 
- 1 1 2 8  TCAAAAAGATCTATTAGATAACATGTACTGAGAGCCATATATCAATACAGAAAAGATCAGCAAATTTAGGATATTTGGG 
- 1 0 4 9  GTTTTTTTGTAAAAATAAAGAAAATAACTCACTTTAAGACAACTTTTAAAATCTTTGTTACAAATGATTTCTACAATTA 
- 9 7 0  TGTATCATCTCATTACAAAGTAATATTAAGATTCTAGATTCTACGATTTAAAAGATTTTAGTAAAATTATTCATGTAGA 
- 8 9 1  TAAATTACTAAAGCATGTAAACTACAGTATGTCACAATCCCATAAAGACAATCTACTGTACATTGTTGATTCCAAGATG 
- 8 1 2  TACATTTTTCATATTTAACATCTCAAACATTGAGAGCGGTTTTAAGGTAATGCCCAGAAGCGTGGTATGCAGTTGTCCA 
- 7  3 3  CTTCTGCGGGCTCAGCAAACCTGTACTGGGCTCAGTGGACTAGAAGAAAACTCCAGAGACAACGGGGTGGGGGAGGGGG 
- 6 5  4 GGGACTTAAAAAAAAATTCGATAGATAATATACATATGTTTAAAATCTAAATTTTATTTAGAGATATCTAAATAAAATC 
- 5 7 5  TCTAAACTAAATAAAATTTTAGTTTAAAAGATTCTAAATGTTGAGAAAGCATTGTTATTGTTTACCTGGCAGTTCTTTT 
- 4 9 6  TATTTCTTACTAGCGCATAAATAATGGTATATCTTATAATTAAGGAAGTCTTAGATTTAAAGAAATCTAAGCTGACGGG 
- 4 1 7  TGCAGAGGCTCAGGCCTGTATTCCCTGCACTTTGGGAAGCCAAGGCGGGAGGATTGCTTGAGGCCAGAAGTTTGAGACC 
- 3 3 8  AGCCTGGGTAACAGAGTGAGAGTCTGTCTTTACAGGTTTAAATACAGTTTTTTTCTAAGTAATATTGTCATAAATATTA 
- 2 5 9  TGTCATGAATATTATGCAGAGCTGCCGACCCCTCTGTACTCTGGGCAGTTTTCCCTCTTGCCTGAGAACACCACTTATA 
- 1 8 0  ACACGGGACCTATACGGGAGTGGTGACACGCCATCTGTTCAAGTTTAACTTTTTTCTCATTTTTTAGACAGCAAATACA
_SP1
- 1 0 1  AATGGAAGTTCCAGTATGTTCTGCCCGCACTCCAGTfG G C G G |CTTGTGCACAGCCCACTTGGGAGGCCTCGGCGCTCA 
SP1 RNA start window
- 2 2  GGTGTGGTAAGAGCTpG G CG G pGÇAGAGCAÇAGAGAAAGgAÇATÇTGCGAGGAAAGTTCCCTGATGGCTGTCAACAAAG
+ 5 8  TGCCACGTCTCTATGGCTGTGAACGCTGAGCACACGATTTTATCGCGCCTATCATATCTTGGTGCATAAACGCACCTCA 
+ 1 3 7  CCTCGGTCAACCCTTGCTCCGTCTTATGAGACAGGCTTTATTATCCGCATTTTATATGAGGGGAAACTGACGGTGGAGA 
+ 2 1 6  GAGAATTATCTTGCTCAAGGCGACACAGCAGAGCCCACAGGTGGCAGAATCCCACCCGAGCCCGCTTCGACCCGCGGGG
SP1 SP1 SP1
+ 2 9 5  TGGAAACCACGGGCGcFcG C C CfcGCTGCGCTTCCAGAGCTGAACTGAGAAGCGAGTCCTCT(|:C G C C C ÎGCGGCCAfC G C r| 
r - ,  SP1
+ 3 7 4  I c c K g c c c c g a c c c e c g c c c e g g c c c g a t c c t c a c t c g c c g c c a g c t c c c c g c g c c c a c c c c g g a g t t g g t g g c g c a g a g  
SP1
+ 4 5 3  GCGGGAGGCGGAGGCGGGApGGCGGfcCGCTGGCACCGGGAACGCCCGAGCGCCGGCAGAGAGCGCGGAGAGCGCGACAC 
+ 5 3 2  GTGCGGCCCAGAGCACCGGGGCCACCCGGTCcfjcGCAGGCfcCGGG
Figure 20. Sequence the IL-12R/32 promoter region and o f the 4.5 kb upstream region. pBET-13 
and pHOP-3 were sequenced as described in materials and methods. The sequence analysis and the 
resulting sequence contig was obtained using the Sequencher program. Transcription factor 
consensus binding sites are indicated.
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3.2.5) Identification of IL-12 responsive elements in the IL-12Rp2 gene
The transcription factors Stat4 and Stat6 have been shown to be essential for T 
helper development. Stat6 is activated by IL-4 in Th2 cells (Hou et al., 1994; 
Schindler et al., 1994), whereas IL-12 activates Stat4 in Thl cells (Bacon et al., 
1995; Jacobson et al., 1995). Studies on knockout mice for these transcription 
factors clearly indicate the pivotal role of Stat6 and Stat4 in T helper cell 
differentiation. Statô-deficient T lymphocytes fail to differentiate into Th2 cells in 
response to IL-4 (Kaplan et al., 1996; Shimodaet al., 1996; Takeda et al., 1996) 
and the analysis of Stat4‘ " T cells revealed an impaired production of IFN-y upon 
antigen receptor triggering,indicative of a defect in Thl differentiation (Kaplan et 
al., 1996; Thierfelder et al., 1996). More recently, additional transcription factors 
have been studied and characterized for their role in the Th2-specific expression of 
the IL-4 gene: the protoncogene c-Maf (Ho et al., 1996), the transcription factors 
NIP45 (for NF-ATp interacting protein) (Hodge et al., 1996), NF-IL6 (Davydov et 
al., 1995), and Nuclear Factor of Activated T cells (NF-AT), which has been 
shown to regulate IL-4 expression in Th2 cells through a cooperative binding with 
AP-1 family members (Rooney et al., 1995). In addition, the transcription factor 
GATA-3 has been found to be selectively expressed in differentiating and effector 
Th2 cells, whereas its expression is completely lost in Thl cells (Zheng and Flavell, 
1997). Less is known about the regulation of IFN-y gene in Thl cells that appears 
to involve the interaction of numerous transcription factors, includingNF-kB and 
NF-AT (Sica et al., 1997), or the cooperative binding of Stat4 dimers (Xu et al.,
1996).
In order to understand how the Thl specific expression of the IL-12R(32 gene is 
controlled, the putative enhancer regions evidenced by DHS analysis upstream the 
RNA start site at -3000 bp (E2) and -1900 bp (E l) were investigated for 
transcription factors consensus binding sites.
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Sequence analysis of E l and E2 regions (Fig. 19 and 20) revealed the presence of 
GAS (Gamma Activated Sequence) consensus binding sites in both regions, defined 
as TTCN(2.4)GAA (Ivashkiv, 1995) (see materials and methods).
In order to verify whether these sites were binding Stat factors gel shift assays 
were performed. Three oligonucleotides encompassing a GAS consensus sequence 
were derived from the IL-12Rp2 E2 sequence (E2: -3292-3273; E2: -3139-3115; 
E2: -3029-3005; and three oligonucleotides were designed in the E l region (El: - 
2224-2205; E l: -2158-2139; E l: 1969-1945, see materials and methods). An 
oligonucleotide representing the GAS element in the promoter of the IRF-1 gene, 
was used as positive control (Ivashkiv, 1995; Sims et al., 1993).
Gel shifts were performed using TOTEX protein extracts of Thl and Th2 cell lines 
at day 5 after priming that had been either unstimulated or stimulated for 1 h with 
2.5 ng/ml IL-12. The oligonucleotidesE2: -3029-3005 and E l: -1969-1945 (named 
(32GAS2 and P2GAS1 respectively) and the IRFGAS control formed a DNA- 
protein complex in IL-12 stimulated Thl, but not in Th2 cells (Fig. 21, lanes 1 and 
2, upper and lower panel, respectively).
These findings are consistent with the previous observation that IL-12 signaling in 
Th2 cells is extinguished (Hilkins et al., 1996; Szabo et al., 1995). Competition 
with an excess of cold Fey GAS oligonucleotide (Fig. 21, lane 3) confirmed Stat 
specificity. In order to identify which Stat factor caused the observed gel shift, 
supershift assays were performed using oc-Statl, a-Stat3 and a-Stat4 antibodies. 
Antibodies against Stat4 completely abolished the formation of the complex, while 
a-Stat 1 and a-Stat3 antibodies did not significantly affect binding to (32GAS1 and 
(32GAS2 oligonucleotides (Fig. 21, lanes 4, 5 and 6). These data indicated that IL- 
12 induced binding of activated Stat4 to a potential enhancer elements within the 
IL-12RP2 gene.
To test whether these GAS sites, that showed Stat4 binding capacity, were also 
able to promote IL-12-inducible transcription, transient transfection experiments 
were performed.
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Many lymphoid cell lines were tested for their ability to respond to IL-12 and their 
amenability to transfection using the IRF-luc vector. This construct was obtained 
by cloning 3 copies of the IRFGAS oligonucleotide upstream the SV 40 promoter
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Figure 21. IL-12 induces Stat4 binding to IL-12Rp2 GAS sites in Thl, but not Th2 cells. Thl and 
Th2 cells were harvested 5 days after priming, washed and resuspended in complete medium. 10 
cells were incubated at 37 °C in 4 ml complete medium with or without IL-12 (2.5 ng/ml) for Ih. 
follow ed by preparation of whole cell extracts as described in Material and Methods. Gel shifts were 
performed with P end-labeled double stranded oligonucleotides, comparing P2GAS1, (32GAS2 
and IRFGAS oligonucleotides binding pattern. Competition with an excess of cold Fey GAS 
oligonucleotide confirmed Stat specificity. In order to identify which Stat factor caused the observed 
gel shift, supershift assays were performed using a-Statl, a-Stat3 and a-Stat4 antibodies as 
described in Materials and Methods.
of the pGL-pro vector. All cell lines tested (see materials and methods Tab. V) 
showed no responsiveness to IL-12 and thus couldn’t be used for this study. To 
overcome this problem, IL-12 responsiveness was reconstituted in Jurkat or 3 DO 
cells by cotransfecting all the components of the IL-12 signalingmachinery missing 
in Jurkat and 3DO cells: the two IL-12 receptor subunits (pEF-BOS-(31 and pEF- 
BOS-P2) and Stat4 (pBOST4).
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Two copies of (32GAS1 (see Appendix 3), were cloned in the pGL-pro vector, 
upstream the SV40 promoter, obtaining the IDIM-luc construct. IDIM-luc was 
transiently cotransfected in Jurkat cells together with pEF-BOS-pl, pEF-BOS-(32 
and pBOST4. After electroporation, cells were stimulated for 24 h with IL-12 and 
luciferase activity measured in the cell lysate (Fig. 22). As a control, the IRF-luc 
construct was also tested. Variability of transfection efficiency was normalised by 
measuring (3-galactosidase activity of a CMV-(3gal vector cotransfected in the cells. 
Transfections were repeated at least three times. IDIM-luc constructs lead to a 3 
fold induction of luciferase activity when transfected cells were stimulated with IL- 
12 (Fig. 22, middle panel). When pEF-BOS-p2 was not transfected in the cells, the 
treatment with IL-12 did not result in any increase in the luciferase activity of the 
GAS-dimer constructs. Similar experiments were also performed using 2-DIM-luc 
construct, containing two copies of the (32GAS2 site, obtaining comparable results. 
These data evidenced that not only the (32GAS1 and (32GAS2 elements found in 
the IL -12Rp2 enhancers binds Stat4, but also that they are transcriptionally active 
and furthermore that their activity is IL-12 dependent. These data provide strong 
evidence that Stat4 plays a key role in the regulation of the Thl-specific expression 
of IL-12Rp2.
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Figure 22. IL-12 dependent activation o f  IL-12Rfi2 GAS elements requires a functional IL-12 
receptor. The ability of IDIM-luc construct, that contains 2 copies of the [32GAS1 oligonucleotide, 
to be activated in an IL-12 dependent manner was tested. Jurkat cells were transiently cotransfected 
with the IDIM-luc (middle panel) or the positive control IRF-luc (upper panel) or the vector alone 
(lower panel) together with: pEF-BOSfJl and pBOST-4 plus or minus pEF-BOS|32 (as indicated). 
Cells were either left untreated or stimulated for 20 h with IL-12. Luciferase activity was measured 
24 h after transfection. Variability of transfection efficiency was normalised by measuring fF 
galactosidase activity of a CMV-gal vector cotransfected in the cells.
It has recently been described that dimers of dimers of Stat4, can cooperatively 
bind tandem DNA sequences, stabilising the interaction with “weak” GAS sites 
(Vinkermeier et al., 1996; Xu et al., 1996). Thus the GAS like sequences, that were 
not showing binding to Stat factors in single copy, were also tested as dimers. E2> 
3139-3115 dimers and E 1 >2224-2205 dimers (that I will call from now on (32GAS4 
and [32GAS3 respectively) formed a week DNA-protein complex in the presence of 
IL-12. This complex is abolished by pretreatment with cc-Stat4 antibodies (data not 
shown). These data suggest that also these GAS sequences, despite of the fact that 
I did not detect binding of Stat factors when tested as single sites in gel shift 
assays, could participate to Stat binding in association with other GAS sites 
present in the IL-12R(32 gene.
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To verify this hypothesis the oligonucleotides (32GAS2 and (32GAS1 were cloned 
either alone (obtaining the B2-21-luc construct) or together with the p2GAS3 and 
(32GAS4 oligos (B2-luc) in the pGL-pro vector and compared for IL-12 inducibility 
in transient transfection assays (Fig. 23).
An IL-12 dependent 3 fold induction of luciferase activity was detected when B2- 
21-lue construct was tested, showing a comparable activity to the previously 
characterised IDIM-luc and 2DIM-luc vectors (Fig. 23). Interestingly, the B2-luc 
construct, that contains the (32GAS3 and (32GAS4 oligos in addition to (32GAS2 
and p2GASl, showed an even higher induction of luciferase activity in response to 
IL-12 (Fig. 23). This indicated that the (32GAS3 and (32GAS4 sites can contribute 
to transcriptional regulation of the IL-12R(32 gene when associated to other GAS 
binding sites.
The El and E2 genomic regions of the IL-12R(32 gene containing the GAS sites 
characterised so far were also tested for enhancing activity in response to IL-12.
IRF-luc
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□ IL-12
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Figure 23. (52GAS3 and (32GAS4 sites can contribute to transcriptional regulation o f  the IL- 
I2R(32 gene when associated with other GAS binding sites. The oligonucleotides [32GAS2 and 
(32GAS1 were cloned either alone (obtaining the B2-21-lue construct) or together with the p2GAS3 
and (32GAS4 oligos (B2-luc) in the pGL-pro vector. Ability to promote luciferase transcription in 
response to IL-12 was tested and compared to the IDIM-luc. 2DIM-luc and IRF-luc in transient 
transfection assays.
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The Xba I 3.5 kb fragments derived from pHOP-1 and PCR fragments 
encompassing the regions between -2368-1858 and -3326-2849 were cloned in 
pGLpro (see Mat. & Met ), and the new constructs were tested in transient 
transfection experiments. None of the constructs analysed showed IL-12-mediated 
upregulation of luciferase activity (data not shown). These results could be 
attributed to a not sufficient sensitivity of the experimental system, since it 
requires the coincident transfection of 4 constructs in a cell to reconstruct IL-12 
signaling.
3.2.6) Discussion
The DNase Hypersensitive Site analysis allowed the characterisation of chromatin 
structure and accessibility of the IL-12R(32 locus in naive and developing Thl and 
Th2 cells.
The DHS analysis of a 9 kb fragment encompassing the RNA start site in 
developing T helper cells evidenced marked differences in the chromatin 
configuration of Thl and Th2 . Early developing Th2 cells showed a relatively 
“closed” chromatin configuration with only one DH site in the proximity of the 
RNA start window.
Conversely, Thl cells displayed an accessible chromatin configuration with a 
complex pattern of DNase Hypersensitivity comprised of 5 DH sites: two strong 
DHS at the RNA start region and at -3000, and a weaker one at -1900; two weak 
DH sites were also mapped in the first intron, at +1100 and at +2100. The same 
hypersensitivity pattern was also evidenced in PHA blasts activated in the 
presence of IL-12.
The differences in IL-12R(32 locus accessibility evidenced in primary Thl versus 
Th2 cells could result from selective repression of the IL-12R(32 locus in Th2 cells 
or from selective activation of the locus in Thl cells. The previous finding that no 
IL-12R(32 transcripts were present in naive CD4 T cells would support the 
second hypothesis. Indeed, DNase I Hypersensitivity analysis of purified CD4
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naive T cells demonstrated that these cells displayed a chromatin configuration 
correspondent to a transcriptionally incompetent locus, exhibiting a very faint, if 
any, DH site. This site maps in the proximity of the RNA start window and it 
would be consistent with the presence of a paused RNA Polymerase II complex, as 
previously described for DH sites in the first intron of the IL-2 and the c-myc genes 
(Bentley and Groudine, 1986; Brunvand et al., 1993). Polymerase occupancy of 
resting genetic loci would allowed rapid gene transcription upon stimulation. Indeed 
IL-12R(32 transcripts can be detected as early as 6 h after TCR induced activation 
of naive T cells (see chapter 1).
The same DH site is also the only one observed in Th2 cells. Yet, this is again 
consistent with our previous observation (chapter 1) that small amounts of IL- 
12R(32 transcripts could be detected early on along differentiation. These data could 
be interpreted as an initial wave of IL-12R|32 gene transcription still taking place in 
Th2 cells after the initial T cell activation, that is extinguished soon afterwards. On 
the other hand, it could not be excluded an heterogeneity of the Th2 cell line that 
could contain small amounts of Thl/ThO cells, in which the IL-12Rp2 gene is 
transcribed.
The analysis of the hypersensitive site at the RNA start window, allowed the 
characterisation of the minimal promoter region. Promoters transcribed by RNA 
polymerase II are divided in two classes: those that contains a canonical TATA box 
and those that do not. TATA containing promoters usually direct transcription 
from a single initiation point, the location of which is determined by the TATA 
position (Conaway and Conaway, 1993). In TATA-less promoters start site 
selection is not well understood and has been investigated primarily in genes that 
use a single transcription start site, where the presence of an "initiator" element, at 
or near the start site, appears to be responsible for localising the pre-initiation 
complex (Javahery et al., 1994). Recently a new class of TATA-less promoters has 
been described that utilises a distinct window of multiple start sites defined by the 
presence of a Multiple start site Element Downstream (MED)-1 element (Ince and
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Scotto, 1995). The EL-12Rp2 appears to belong to this last class of promoters, 
since a perfect consensus MED-1 site can be found 152 nucleotides downstream 
the RNA start window of 30 nucleotides.
The minimal promoter contains a CpG rich region in which multiple recognition 
motifs for the transcription factor SP1 can be found. These GpC rich boxes have 
been described to be required for efficient transcription of TATA-less promoters 
(Blake et al., 1990; Kollmar et al., 1994). These characteristics of the IL-12Rp2 
promoter resembles in structure that of many housekeeping genes, but IL-12Rp2 
gene is expressed in a tissue specific manner (Chua et al., 1994; Chua et al., 1995; 
Desai et al., 1992). Indeed, few GC-rich and TATA-less promoters that show a 
tissue specificity were also described, such as the promoters of the Transcription 
Enhancer Factor (TEF)-l (Boam et al., 1995) and the nerve growth factor receptor 
gene(Sehgal etal., 1988). Interestingly, the IE-l2R^2 minimal promoter is equally 
active in lymphoid (Jurkat, CEM, NK3.3) and non-lymphoid (COS-7) cells. 
Several reasons may account for the apparent inability of the IL-12R(32 promoter 
to function in a tissue-specific manner in vivo, but not in vitro. Tissue specificity 
could be determined by selective downregulation of the promoter accessibility by 
CpG méthylation. If this was the case, transient transfection experiments would 
not reveal this mechanism since the DNA amplified in bacteria is almost 
unmethylated. Alternatively, tissue-specific c/5-acting sequences could be localised 
elsewhere. Also a selective degradation of the IL-12Rp2 mRNA could occur, but 
this is very unlikely, since analysis of IL-12R(32 transcripts in the presence of the 
RNA synthesis inhibitor Actinomicin D, didn't evidence post-transcriptional 
regulatory mechanism (data not shown).
Four GAS consensus binding sites were identified in the region upstream the 
minimal promoter. Gel shift assays revealed that two of them, (32GAS1 and 
P2GAS2, bind to IL-12 induced Stat4. Despite of the fact that also Stat3 
phosphorylation has been described to occur in response to IL-12 (Szabo et al., 
1995), anti-Stat3 antibodies did not significantly change the IL-12 induced DNA-
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binding complexes suggesting that Stat3 does not play a major role in activating the 
IL-12R(32 promoter in response IL-12. Transient transfection experiments in Jurkat 
cells demonstrated that the (32GAS1 and (32GAS2 elements found in the IL-12R(32 
enhancers not only bind Stat4, but also that they are transcriptionally active and 
furthermore that their activity is IL-12 dependent. These data provide strong 
evidence that Stat4 plays a key role in the regulation of the Thl-specific expression 
of the IL-12R(32 gene.
The other two GAS consensus sequences p2GAS3 and p2GAS4 were not binding 
any Stat factor in single copy, but this does not exclude the involvement of these 
sites in IL-12 mediated regulation of the IL-12Rp2. Dimers of dimers of Stat4 
cooperatively bind to "weak" GAS sites, as described in the IFN-y gene 
(Vinkermeier et al., 1996; Xu et al., 1996). As a matter of fact, dimers of (32GAS3 
and (32GAS4 bind to Stat4 (data not shown). Furthermore, a luciferase reporter 
construct containing all four IL-12R(32 GAS showed an increased upregulation in 
response to IL-12 if compared to the construct that contains only the (32GAS1 and 
(32GAS2. These finding suggest that also (32GAS3 and p2GAS4, could contribute 
to IL-12R(32 regulation.
F igu re 24. IL-12R[32 GAS sites binding specificity’
Binding to 
Stat4 Statl
STAT4 consensus T/ a TTC C % G  G A A ^ ,
IRFGAS T TTC CGC GAA A + +
(J2GAS1 T TTC ÇTT GAA A + -
(32GAS2 T TTC ÇTA GAA A + + / -
(32GAS3* A TTC ATA GAA T + + / -
(32GAS4* A TTC TÇA TAA T + / - -
IL-12R[32 GAS sites binding specificity. Nucleotides in the IL-12RP2 GAS sites that satisfy Stat4 
consensus binding sequence are underlined. Binding to Stat4 and Statl, determined by gel shift 
assays, is also indicated.
* (32GAS3 and [32GAS4 binding data are obtained performing gel shift with dimers
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The four IL-12R(32 GAS sites are located far from the minimal promoter, and are 
also distant one from the other. *The shortest distance between two GAS elements 
is 100 nucleotides. The attempt of demonstrating IL-12 mediated activation by 
these sites directly testing a 3.5 kb region containing all four GAS sites or shorter 
genomic regions in transient transfection assays was unsuccessful. These 
constructs might be inefficient in promoting transcription either because they 
contain silencing regions that can mask Stat4 mediated activation or alternatively 
because they cannot reproduce the correct chromatin conformation. Another 
possibility is that these results could be attributed to a not sufficient sensitivity of 
the experimental system. Indeed, the reconstitution of an IL-12 responsive cell line 
required the coincident transfection of 4 constructs in Jurkat cells, which is not the 
most efficient tool to test IL-12 responsiveness. The best cell types in which EL- 
12R(32 regulation should be ideally analysed are Thl and Th2 lines, but these 
primary T cells are not efficiently transferable. Indeed, much more efficient 
retroviral vectors are now substituting the transfection techniques (Dumbar and 
Young, 1996). The problem of using retroviral vectors in analysing the regulation of 
a promoter is that the strong retroviral promoters will interfere with the one under 
investigation. Self-inactivating retroviral vectors, potentially useful for promoter 
characterisations have also been developed, but they still present numerous 
limitations (Nakajima etal., 1993).
Yet some laboratories reported successful electroporation protocols (Hughes and 
Pober, 1996) that I tried to reproduce and I tested most of the new liposomes 
described to mediate transfection of primary non-adhesive cells (see materials and 
methods), but all these approaches gave too low transfection efficiencies.
Recently, Huang and colleagues (Huang et al., 1998) have been able to detect an IL- 
4 promoter specific activation in recently-differentiated Th2 helper cells, but this
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required antibody-mediated immobilisation of these cells and the use of particle 
mediated gene transfer.
The transcription factor Stat4 has been shown to be essential for T helper 
development. The analysis of Stat4 " T cells revealed an impaired production of 
IFN-y upon antigen receptor triggering, indicative of a defect in Thl differentiation 
(Kaplan et al., 1996; Thierfelder et al., 1996). Recently, Agarwal and colleagues 
(Agarwal and Rao, 1998) showed chromatin remodeling of the IL-4 locus along Th2 
differentiation. They demonstrated that this does not occur in Stat6 deficient mice, 
thus indicating that Stat6 is necessary for the “opening” of the IL-4 locus.
Loci that have been repressed can become transcriptionally active following 
hyperacetylation of hi stones and déméthylation of DNA (Hagstrom and Schedl, 
1997; Nan et al., 1998). Furthermore, it has been recently shown that cell cycle 
progression and cytokine signaling act in concert to relieve epigenetic repression 
and can be supplanted by agents that hyperacetyl ate hi stones and demethyl ate 
DNA (Bird et al., 1998).
Statl is associated with and requires the action of both CBP/p300 and pCAF 
(Korzus et al., 1998; Yang et al., 1996). These are transcriptional coactivators that 
exhibit strong hi stone acetyltransferase activities (Ogryzko et al., 1996).
It could be very interesting to investigate whether also Stat4 and Stat6 require for 
their activity the interaction with p300/CBP or similar proteins and whether their 
acetyltransferase action could be involved in chromatin remodeling along T helper 
differentiation.
Our findings that Stat4 binds and activates the IL-12R(32 locus in response to IL-12 
and yet that this locus is remodeled in Thl but not Th2 cells, suggests a direct role 
of Stat4, in analogy to Stat6 for the IL-4 loci, in chromatin remodeling of the IL- 
12Rp2 locus and thus in imprinting a “memory” which will be maintained through 
cell division. In this respect, the méthylation and acétylation state of the IL-12R(32 
locus and its chromatin accessibility in Stat4 deficient mice should be investigated.
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The data presented in the previous chapter evidenced the importance of stimulation 
through the antigen receptor for IL-12R(32 initial transcription. In this chapter, the 
DNase I hypersensitivity pattern evidenced that the coordinate action of antigen 
receptor stimulation and IL-12 results in a transcriptionally active IL-12R(32 locus. 
Which TCR-activated nuclear factors might play a role, in association with Stat4, in 
locus remodeling of the IL-12R(32 gene?
To investigate the role of TCR-activated transcription factors such as NF-AT and 
NF-kB, the effects of specific pharmacological inhibitors, such as Cyclosporine A 
and Dexamethasone, were studied, but no striking effects were observed (data not 
shown). Alternatively, TCR-activated MAP kinase signaling pathways could be 
involved. Recently, Yang and colleagues (Yang et al., 1998) described that JNK-2 
deficient CD4 T cells fail to differentiate in Thl cells. IL-12Rp2 expression in 
JNK-2 -/- CD4 T is reduced, but still remains to be elucidated whether this is a 
direct effect on EL-12R(32 gene or whether it correlates with the lower levels of 
IFN-y that these cells produce, since IFN-y was shown to upregulate IL-12R(32 in 
mice (see chapter 4). Also the p38 MAP kinase is involved in IFN-y gene 
activation in differentiated Thl cells, but no differences in its activation are 
detected among early differentiating Thl and Th2 cells (Rincon et al., 1998). Yet, 
the MAP kinases activated transcription factors that are involved in IFN-y 
regulation are to be identified, and it would be interesting to test whether they can 
act on the IL-12Rp2 gene. Further analysis of the yet uncharacterised Thl specific 
DH sites observed in the IL-12R(J2 locus could provide new insights to clarify this 
issue.
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3.3) R ole o f  IFN s in hum an T helper developm ent
3.3.1) IFN-a induces IL-12R|32 mRNA expression and IL-12 responsiveness 
in human T cells.
In addition to IL-12, IFN-a has also been shown to influence Thl cell 
development. Stimulation of resting human T cells in the presence of IFN-a 
increases the frequency of IFN-y secreting CD4" T cells (Brinkmann et al., 1993) 
and allergen-specific T cell clones generated in the presence of IFN-a from the 
peripheral blood of atopic patients demonstrate a shift towards the ThO/1 
phenotype (Parronchi et al., 1996). In contrast, IFN-y but not IFN-a has been 
shown to be an important co-factor for Thl development in mice (Bradley et al., 
1996; Schmitt et al., 1994). IFN-y can rescue IL-12Rp2 mRNA expression even in 
the presence of IL-4 and restore IL-12 responsiveness in early developing mouse 
Th2 cells (Szabo et al., 1997). Thus, the effects of IFN-y on phenotype 
development and on IL-12R(32 mRNA expression in humans were also analysed. 
The addition of IFN-a (Fig. 25 A) as well as IFN-(3 (data not shown) to human cord 
blood leukocytes stimulated under Th2-inducing conditions (IL-4 and anti-IL-12 
mAb) resulted in cells producing IFN-y (>1 ng/ml) upon restimulation with anti- 
CD3 mAb (Fig. 25A). IL-12R(32 mRNA was expressed in the IFN-a treated T cell 
lines (Fig. 25B) and IL-12 induced Stat4 phosphorylation in these cells (Fig. 25C).
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Figure 25. Function o f  type I  and II interferons in the de\’elopment o f  T helper cell subsets and on the 
expression o f  the IL-12Rp2 subunit. A) IFN-a induces Thl development. Tcell lines were generated by 
stimulating cord blood lymphocytes with PHA in the presence of the indicated cytokines or anti- 
cytokine antibodies. IFN-a or IFN-g (1000 U/ml) were added at the time of priming to the cultures as 
mdicated. Cytokine production was determined on day 10. IFN-a, but not IFN-g, induces a Thl 
phenoty pe even m the presence of IL-4 and neutralizing anti-IL-12 antibodies. B) IFN-a induced Thl 
cells express IL-12R b2 transcripts. RNA was extracted ffomT cell hues 10 days after primin° in the 
presence of the indicated cytokines or neutralizing anti-cytokine antibodies. RNase protection assays 
were performed as described m Materials and Methods. C) IFN-a induced Thl cells are IL-12 responsive 
T cell lines (Fig. ISA) were harvested on day 10 after priming. 8 x 106 cells were washed and incubated 
15 mm at 37 °C m medium with or without 2 ng/ml IL-12 in 1 ml RPMI-FCS. IL-12 induced Stat4 
phosphorylation was determined as described above.
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Addition of IFN-y to cultures containing IL-4 and anti-IL-12 (Th2-inducing 
conditions) or addition of neutralizing anti- IFN-y mAb at the time of Thl priming 
had no significant effect on the pattern of Th cell development (Fig. 25A and data 
not shown) and slight effects on IL-12Rp2 expression (Fig. 25B). Both IFN-a or 
IFN-y had no significant effect on the expression of the IL-12R(31 transcripts (data 
not shown). These findings suggested that type I and type II IFNs could have 
different functional effects on human as compared to mouse T cells.
The molecular basis for this species-specificity has been recently investigated by 
Rogge and coworkers (Rogge et al., 1998). In this study they showed that IFN- 
cc/p are able to induce directly Thl development, in the absence of IL-12, in human 
but not in mouse T cells. Conversely, IFN-y acts in both species in at least two 
ways: on the one hand IFN-y induces Thl development by enhancing IL-12- 
production by human and mouse phagocytic cells (Trinchieri, 1995), and on the 
other hand, it upregulates expression of functional IL-12 receptors on CD4" T 
cells, but at much higher levels in mouse rather than in human T cells (Rogge et 
al., 1998).
The findings that IFN-a efficiently induces phosphorylation of Stat4 in mitogen 
activated PBMC (Cho et al., 1996) and that IFN-o/p phosphorylate Stat4 in 
human but not in mouse T helper cells (Rogge et al., 1998) provided an 
explanation for the species specific activity of type I Interferons in human but not 
mouse T cells. On the contrary, these data did not explain why IFN-y does not 
play a significant role in human T helper development. The analysis of Stat binding 
specificity of the EL-12Rp2 GAS sites provided new insights in this respect.
3.3.2) Stat binding specificity of the IL-12Rp2 GAS sites.
The Stat4 binding sequence, determined by binding site selection (Yamamoto et al.,
1997), can satisfy also the more general consensus binding for Stat factors (see 
above). For example, the IRFGAS sequence, which is a perfect for Stat4 
recognition sequence, is not Stat4 specific, but binds also Statl, Stat3, StatS and
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Stat6 (Ivashkiv, 1995). Therefore, I wondered whether, in addition to Stat4, other 
Stat factors could bind to the IL-12Rp2 GAS sites. In particular, Statl has been 
shown to be activated by both type I and type II interferons (Meraz et al., 1996), 
thus its binding pattern to the IL-12R(32 GAS sites was investigated. The analysis 
of IFN-y signaling in T helper cells revealed that only Th2 cells resulted responsive 
to IFN-y (Bach et al., 1995; Remis et al., 1995). In order to investigate the binding 
of Statl to IL-12Rp2 GAS sites, Th2 cells were stimulated with IFN-y and gel 
shifts were performed comparing (32GAS1, (32GAS2 and IRFGAS oligonucleotides 
binding pattern (Fig. 26 lower panel). IL-12 induced binding of Stat4 to these oligos 
in Thl extracts was also performed as a control (Fig. 26 upper panel).
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Figure 26. IL-12Rfi2 GAS sites shows a binding specificity fo r Stat4. To test whether Statl binds 
to IL-12Rp2 GAS sites, Th2 cells were stimulated with IFN-y and gel shifts were performed 
comparing (32GAS1, (32GAS2 and IRFGAS oligonucleotides binding pattern (lower panel). IL-12 
induced binding of Stat4 to these oligos in Thl extracts was also performed as a control (upper 
panel). Supershifts with anti-Stat4 and anti-Statl antibodies evidenced that the IL-12- and IFN-y- 
induced complexes contained Stat4 and Statl respectively (lanes 3, 6 and 9).
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As previously shown, Stat4 binding was observed with all 3 oligonucleotides 
tested, whereas no EFN-y-induced complexes were detected in the presence of 
P2GAS1 oligo (Fig. 26, lower panel, lane 2), while (32GAS2 showed a very faint 
band if compared to the one observed for the IRFGAS oligonucleotide (Fig. 26, 
lower panel, lanes 5 and 8). The IFN-y induced complex formed with the IRFGAS 
probe contained Statl, as shown by supershifts with anti-Statl antibodies (Fig 26, 
lower panel, lane 9). These results demonstrated a scarce of even absent interaction 
of Statl with the IL-12R(32 GAS sites. In order to further investigate this issue, 
competition assays between (32GAS1 and IRFGAS in binding to Statl or to Stat4 
were performed, as shown in Fig. 27. Labeled IRFGAS probe was competed by a 
10- or 50-fold molar excess of unlabeled (32GAS1 oligonucleotide (Fig. 27, lanes 3 
and 4) or of unrelated control oligonucleotide(SRF, Fig. 27, lanes 7 and 8), with 
nuclear extracts from IFN-y-treated-Th2 cells in order to detect Statl binding (Fig. 
27, lower panel) or IL -12-treated Thl cells to reveal Stat4 binding (Fig. 27, upper 
panel).
The radioactivity of the bands of the resulting DNA-protein complexes was 
quantified in a Molecular-imager and the percentage of binding inhibition of 
IRFGAS to the Stats was calculated. A 10 fold molar excess of unlabelled (32GAS1, 
does not significantly modify IRFGAS binding to Statl in EFN-y-stimulated Th2 
cells (Fig. 28, lower panel, lanes 3 and 4), whereas the same amount of unlabelled 
(32GAS1 reduced 50 % of the IL-12 induced IRFGAS binding to Stat4 in Thl cells 
(Fig. 28, upper panel, lanes 3 and 4). These experiments confirmed that the binding 
of IL-12-induced Stat4 to GAS elements in the enhancers of the IL-12R(32 gene is 
much stronger than binding of IFN-y-induced Statl and provide first evidence for 
selective binding of Stat4 to specific GAS elements.
I next analysed whether this binding selectivity correlates with the observed failure 
of IFN-y to significantly induce IL-12R(32 gene expression in human T cells (see 
above). The transcriptional activity of the IL-12R(52 GAS elements in response to
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IL-12 and IFN-y was determined. The B2-luc construct, containing all four IL- 
12R(32 GAS sequences, was compared to the IRFluc construct for responsiveness 
to IL-12 and IFN-y mediated transcriptional activation in transient transfection 
experiments. Jurkat cells were transiently cotransfected as described before to 
reconstitute IL-12 signaling and with the test construct and either left untreated or 
stimulated for 20 h with IL-12. Luciferase activity was measured 24 h after 
transfection. B2-luc and IRF-luc were almost equally induced in response to IL-12.
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Figure 27. The p2GASl oligonucleotide competes binding o f  Stat4, but not o f  Statl, to the 
IRFGAS oligonucleotide. Competition assays between [32GASi and IRFGAS in binding to Statl 
or to Stat4 were performed. Labeled IRFGAS probe was competed with a 10- or 50-fold molar 
excess of unlabeled P2GAS1 oligonucleotide (lanes 3 and 4) or an unrelated control oligonucleotide 
(SRF, lanes 7 and 8), with nuclear extracts from IFN-y-treated-Th2 cells in order to detect Statl 
binding (lower panel) or IL-12-treated Thl cells to reveal Stat4 binding (upper panel). The 
radioactivity of the bands of the resulting DNA-protein complexes w as quantified with a Molecular- 
imager and the percentage of binding inhibition of IRFGAS to the Stats was calculated.
A 7 fold induction was observed for B2-luc and a 9 fold induction was detected 
with the IRF-luc (Fig. 28, left panel). IFN-y mediated induction of the B2-luc and
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the IRF-luc was also analysed in transiently transfected Jurkat cells. B2-luc gives a 
response to IFN-y that is 10 times lower than the one observed for the IRFluc 
construct (Fig. 28, right panel). These data demonstrated that the binding 
selectivity displayed by the IL-12Rp2 GAS sites is functionally significant and 
shared by all the GAS sites identified
In conclusion, the finding that Statl does not bind efficiently to the IL-12R(J2 
enhancer regions provides an explanation for the observation that IFN-y does not 
contribute to IL-12R(32 subunit upregulation and consequently to Thl 
development in human T cells (Rogge et a l , 1997; Rogge et al., 1998; Wenner et 
al., 1996). In addition, these data suggest that IFN-a-induced IL-12Rp2 expression 
and Thl development are mediated by Stat4.
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Figure 28. IL-12Rfi2 GAS elements inefficiently mediate IFN-y induced transcriptional 
activation. The B2-luc construct, containing all four IL-12R(32 GAS sequences, was compared to 
the IRF-luc construct for responsiveness to IL-12 and IFN-y mediated transcriptional activation in 
transient transfection experiments. Left panel: Jurkat cells were transiently cotransfected as described 
in materials and methods to reconstitute IL-12 signaling plus the test construct and either left 
untreated or stimulated for 20 h with IL-12. Luciferase activity was measured 24 h after transfection. 
Right panel: Jurkat cells were transfected w ith the B2-luc or IRF-luc constructs and stimulated for 
20 h w ith IFN-y. Luciferase activity w as measured 24 h after transfection. All transfections w ere 
performed in triplicates and this experiment is representative of three independent ones. Variability 
of transfection efficiency yvas normalised by measuring [J-galactosidasc activity of a CMV-gal vector 
cotransfected in the cells.
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3.3.4) Discussion
The functions of IFN-oc/p and IFN-y in inducing differentiation of human and 
mouse naive T cells to Thl-type effector cells have remained controversial.
Some previous findings in the human system suggested a role of IFN-a in T helper 
1 development (Brinkmann et al., 1993; Parronchi et al., 1996). In contrast, IFN-y, 
but not IFN-a, has been shown to be an important cofactor for Thl development 
in mice (Bradley et al., 1996; Wenner et al., 1996). Thus the effects of IFN-a/p and 
IFN-y in T helper differentiation were investigated. The data presented in this 
chapter demonstrate that the addition of type I interferons to human cord blood 
leukocytes, in the absence of IL-12, leads to the development of IFN-y producing 
Thl cells. It is interesting to note that IFN-a seems to dominate over IL-4, since 
IFN-a induced Thl development takes place even in Th2- inducing conditions. In 
contrast, addition of IFN-y to cultures containing IL-4 and anti-IL-12 (Th2- 
inducing conditions) or addition of neutralizing anti- IFN-y mAb at the time of Thl 
priming had no significant effect on the pattern of Th cell development. 
Importantly, the effect of IFN-a on T cells is direct, as it occurs in the absence of 
antigen presenting cells or exogenous factors other than IFN-o/p (Rogge et ah, 
1998). Together, these findings provide clear evidence that human Thl-type 
immune responses can develop in the absence of IL-12.
Like in IL-12 induced Thl development, interferon induced development is strictly 
correlated with the expression of the IL-12Rp2 gene. As shown in this chapter, 
IFN-a induces IL-12R(32 mRNA and the consequent development of IL-12- 
responsive human cells, while IFN-y only weakly increases IL-12RP2 
transcription. In analogy to the IL-12 induced Thl development, IFN-a effects are 
mediated by Stat4 (Rogge et ah, 1998).
In parallel, Szabo and colleagues observed that IFN-y can rescue IL-12R(32 mRNA 
expression even in the presence of IL-4 and restore IL-12 responsiveness in early 
developing mouse Th2 cells (Szabo et ah, 1997).
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Thus, IFN-y acts indirectly on Thl development in both species by enhancingIL- 
12-production by human and mouse phagocytic cells (Trinchieri, 1995), but its 
direct influence on T helper development can be evidenced in mouse cell only, since 
it regulates EL-12 receptor expression on CD4 at much higher levels in mouse 
rather than in human T cells (Rogge et al., 1998). However, these data do not 
explain is why IFN-y does not efficiently act in human Thl development as it does 
inmice.
The analysis of Stats binding to the human IL-12Rp2 GAS sites revealed that Statl 
does not efficiently bind the IL-12R(32 GAS sites, while Stat4 binds to them and 
mediates IL-12 induced upregulation of the gene, as previously described (chapter
2 ).
In addition, transient transfection experiments showed that the binding selectivity 
displayed by the IL-12R(32 GAS sites is functionally significant and shared by all 
the B2-GAS sites. The comparison of IL-12 and IFN-y induced activation of the 
B2-luc and IRF-luc constructs showed a reduced responsiveness of B2-luc to IFN- 
y, if compared to the IRF-luc, while a comparable responsiveness to IL-12 is 
displayed by both constructs.
Thus, the weak effects exerted by IFN-y in humans on IL-12Rf32 gene regulation, 
and the consequent failure to induce Thl development, can be explained by the 
inefficient binding of the IFN-y -induced Statl to the IL-12Rp2 GAS sites. In this 
respect it would be interesting to investigate the binding specificity of the mouse 
IL-12Rp2 promoter region and to analyse whether the binding specificity of the 
GAS sites present in the mouse gene is different.
The issue of Stat binding specificity to GAS sites is of great interest to answer the 
more general question of how Stats accomplish specific signalingfrom receptors to 
their target genes. The IL-12 signaling pathway represent a good example of how 
fine signaling modulation is obtained despite a limited repertoire of available Stat 
proteins.
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A first level of specificity is realised at the receptor level, where it transmits the 
specificity of the ligand-receptor interaction into the cell. Stat4 activation is strictly 
tuned in a cells specific way through the selective expression of functional IL-12R 
on T and NK cells. The picture is even more complicated than this, since Stat4 was 
shown to be phosphorylated in response to IL-2 in NK cells, but not in T cells, 
and this cell-specificity was correlated to the ability of IL-2 to phosphorylate 
uniquely Jak2 in NK cells (Wang et al., 1999). Conversely, this kinase is activated 
in T cells after IL-12 or IFN-a treatment. IFN-a mediated activation of Stat4 
occurs in a species-specific way. The differential signalingcan be also determined 
by different receptor complexes recognising the same cytokine, for example IL-12 
act on DC cells promoting NF-kB nuclear localisation and this has been correlated 
to the present of a different form of the IL-12R.pi subunit (Grohmann et al., 1998). 
The end point of the signaling cascade and thus the final level of specificity, 
resides in the induction of genes. Differences in the nature of the GAS elements in 
the promoters of genes may be a way to obtain specificity. The optimal binding 
sites of the different Stats, determined by immunoprécipitation and PCR 
amplification, evidenced a common consensus sequence: TTCN3GAA (O'Shea, 
1997), with the exception of Stat6 that recognises also TTCN4GAA (Kohler and 
Rieber, 1995; Schindler et al., 1994). The analysis of the natural binding sites 
evidenced that some DNA sequences indiscriminately bind all Stat, such as the 
GAS sequence present in the IRF-1 promoter utilised in this study. Few examples 
of Stat specificity were also described: the optimal binding sites for Statl and StatS 
are identical, yet studies with natural GAS sites have demonstrated different 
affinities for Stat dimers (Horvath et al., 1995; Rothman et al., 1994). The GAS site 
present in the serine protease inhibitor (SRI) promoter binds Stat5, but not Statl or 
StatS (Wood et al., 1997). The data presented in this chapter provide a first 
evidence for selective binding of Stat4 to specific GAS elements.
An additional way to gain specificity at the DNA level can come from the 
cooperative interactions that occur among Stat factors as described for the IFN-y
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gene (Xu et al., 1996). Such cooperative binding interactions may enable Stat 
proteins to recognise variations of consensus sites, promoting selectivity in 
transcriptional activation. The findings that the construct containing all four IL- 
12Rp2 GAS sites not only display an increased responsiveness to IL-12, but 
maintains Stat4 specificity suggest that also this mechanism is involved in IL- 
12R(32 Stat mediated activation.
Thus, GAS recognition sequences can either bind indiscriminately all Stat, like the 
IRF-1 GAS sequenced analysed in this chapter, a feature that could account for the 
overlapping biological effects of some cytokines, or conversely, display a selective 
recognition pattern like IL-12R(32 GAS sites that select among different Stats, 
activated by different cytokines.
A final point concerns the maintainanceof the T helper phenotype, starting from 
the two following observations. First, Stat4 can still be phosphorylated in response 
to IFN-a in Th2 cells, yet this does not alter the acquired Th2 phenotype any 
more (R o g g e  et al., 1998). Second, Stat4 nuclear localisation is rapidly terminated 
in the absence of continues stimulation (Darnell Jr, 1997). These findings strongly 
suggest that Stat4, while it could potentially initiate IL-12R(32 locus remodeling at 
priming, is unlikely to be involved in maintaining the accessible chromatin 
structure. Thus, taken together the data presented in the previous chapter and in 
parallel to the model recently proposed by Agarwal et al. for Th2 development 
(Agarwal and Rao, 1998), it could be hypothesised that Stat4 and antigen activated 
transcription factors, induced during primary stimulation, activate a differentiation- 
specific genetic program that results in the recruitment of chromatin remodeling 
enzymes at the IL-12R(32 locus. This would allow yet unidentified transcription 
factors to bind the locus, contributing to phenotype maintainance. These changes in 
chromatin configuration will be inherited by subsequent generations of 
differentiated cells, thus becoming independent of continued Stat4 activation.
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3.4) T he role o f  IRF-1 in T h l developm ent
Very little is known about the molecular mechanisms by which expression of the 
IFN-y and IL-4 genes is restricted to the appropriate Th subset. Considerable 
efforts were made to identify the molecules, and in particular the transcription 
factors, that are either selectively present or active in developing Thl or Th2 cells. 
As discussed in the introduction, the few transcription factors characterised so far 
are involved in the regulation of the IL-4 gene, while T helper 1 specific 
transcription factors are even less characterised.
Genetic background of the T cell can influence Th development (see introduction), 
with some murine strains favoring Thl development (e.g., B10.D2) and others 
favoring Th2 development (e.g., B ALB/c). It has recently been found that B10.D2 
T cells exhibit an intrinsically greater capacity to maintain IL-12 responsiveness 
under neutral conditions in vitro if compared to B ALB/c T cells (Güler et al., 1996; 
Güler et al., 1997). Analysis of intercrosses between BALB/c and B10.D2 mice 
identified a locus on murine chromosome 11 that controls the maintenance of IL-12 
responsiveness (Gorham et al., 1996).
This chromosomal region is syntenic with a locus on human chromosome 5q31.1 
previously shown to be associated with elevated serum IgE levels, suggesting that 
genetic control of Thl/Th2 differentiation in mouse and of atopy development in 
humans may be regulated by similar mechanisms (Marsh et al., 1994).
The murine locus contains genes for several cytokines that may influence Th 
development (see introduction Fig. 2). IL-4 is an obvious candidate, because it 
directly promotes Th2 development, but T cells and APCs derived from the two 
strains does not eliminate strain dependent differences in development, suggesting 
that the underlying genetic mechanisms couldn’t be entirely explained through 
distinct levels of cytokine production. In the same locus localise also transcription 
factors such as IRF-1 (Miyamoto et al., 1988) and t cell factor (tcf)-l (Verbeeket 
ah, 1995). IRF-1 may be a good candidate gene in controlling Thl responses since 
studies of IRF-1-deficient mice have revealed that this factor is implicated in the
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regulation of several immune processes, like T-cell selection and maturation 
(Penninger et al., 1997; White et al., 1996), development of NK cells (Duncan et al., 
1996; Ogasawara et al., 1998; Ohteki et al., 1998), and most importantly, 
development of Thl cells (Lohoff et al., 1997; Taki et al., 1997). The compromised 
Thl differentiation was associated with defects in the expression of p40 subunit of 
IL-12 by cells of myeloid origin (Lohoff et al., 1997; Taki et al., 1997). Indeed, a 
potential IRF-1-responsive element was found in the promoter region of the IL-12 
p40 gene (Ma et al., 1996; Murphy et al., 1995).
3.4.1) Regulation of IRF-1 expression in differentiating T helper cells
Two recent studies have demonstrated that IRF-1 deficient mice show a striking 
defect in the development of Thl cells (Lohoff et al., 1997; Taki et al., 1997). 
Interestingly, these two reports differ in their conclusions regarding the relevance of 
IRF-1 in CD4" T cells.
To determine the role of IRF-1 on the differentiation of human T helper cells, the 
expression of IRF-1 was analysed along the differentiation of naive T cells under 
neutral, or Thl or Th2 polarizing conditions. Purified CD4+, CD45 RO T cells 
isolated from cord blood were stimulated with plate-bound anti-CD3 mAb in the 
absence of exogenously added cytokines, in the presence of IL-12 and neutralizing 
anti-IL-4 mAb to induce Thl development, or in the presence of IL-4 to promote 
Th2 development. The expression of transcripts encoding IL-12Rp2 was used to 
monitor T helper cell differentiation (Fig. 29, lower panel). IRF-1 expression in 
differentiating Thl and Th2 cells was analyzed (Fig. 29, upper panel). IRF-1 
transcripts were detectable in naive CD4 T cells (lane 1) but were strongly 
upregulated by TCR-triggering (Fig. 29, upper panel, lane 2). 24 and 48 hours after 
priming, IRF-1 mRNA was more abundant in cells stimulated in the presence of 
Thl-inducing conditions than in cells stimulated in the presence of IL-4 or with 
anti-CD3 mAb alone (lanes 2 and 4). Only a slight downregulation of IRF-1 mRNA 
is detectable when comparing cultures stimulated in the presence of IL-4 or with
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anti-CD3 mAb alone (compare lanes 2, 4 and 5, 7). 96 hours after T cell 
stimulation, IRF-1 transcripts were clearly more abundant in cultures that had been 
stimulated in the presence of IL-12.
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Figure 29. Antigen receptor triggering induces expression o f  IRF-1 transcripts in naive C D f  T 
cells. CD47CD45 RO T cells were purified by negative selection from cord blood as described in 
Materials and Methods. Purified CD4 /CD45 RO T were stimulated with plate-bound anti-CD3 
mAb with or w ithout the addition of IL-12 (2.5 ng/ml) or IL-4 (1 ng/ml). RNA was extracted from 
unstimulated cells or at the indicated timeafter CD-3 stimulation. Transcripts encoding IRF-1 
(upper panel) and IL-12RP2 (lower panel) were quantitated in RNase protection assays.
3.4.2) IRF-1 expression in human Thl and Th2 cells
Expression of IRF-1 in response to TCR triggering, IL-12 and IL-4 mainly 
resembles expression of IL-12R(32, with two main differences in that IRF-1 
transcripts are already present in naive T cells and that they are much more
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strongly upregulated by TCR activation. The following question was whether IRF- 
1 transcripts, similarly to IL-12RP2 ones, are selectively expressed in differentiated 
Thl cells. Thus, expression of IRF-1 transcripts were investigated in Thl and Th2 
lines. RNase protection assays did not reveal significant differences of the IRF-1 
mRNA in human Thl and Th2 cells 2 weeks after stimulation (Fig. 30, lanes 1 and 
7).
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Figure 30. IL-12 induces IRF-1 transcripts in human Thl cells. Thl and Th2 lines generated from 
cord blood were harv ested 2 weeks after stimulation. The cells were treated as indicated with IL-12 
(2.5 ng/ml) or IFN-a (1000 U/ml) followed by the extraction of total RNA. To determined whether 
de novo protein sy nthesis is required for IL-12-induced upregulation of IRF-1 transcripts, cells were 
treated with the protein synthesis inhibitor Cycloheximide (CHX, 10 pg/ml) 45 min prior to the 
addition of IL-12 (2.5 ng/ml). RNA was extracted 16 h after the addition of IL-12. Transcripts 
encoding IRF-1 (upper panel) and 18S RNA loading control (lower panel) were analysed by RNase 
protection assays as described in Materials and Methods.
The effects of IL-12 and IFN-a on IRF-1 mRNA on established Thl and Th2 lines 
were also analysed. Interestingly, IRF-1 expression is clearly induced by IL-12 in 
Thl ,  but not in Th2 cells (Fig. 30 lanes 2, 3, 8, and 9). The IL-12-induced 
upregulation of IRF-1 transcripts is not blocked by cycloheximide indicating that 
de novo protein synthesis is not required for IL-2 action (lane 4). IFN-a induced
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IRF-1 transcripts in both T helper subsets (lanes 5, 6, 10 and 11). These results 
evidenced that the IRF-1 gene is not differentially expressed in Thl in Thl and Th2 
cells, nevertheless these data demonstrate that IRF-1 is a target gene of IL-12 in 
human Thl cells.
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Figure 31. IL-12 induced binding o f  Stat4 to the IRF-1 GAS elements in human Thl cells. Thl 
and Th2 cells were harvested 6 days after priming, washed and resuspended in complete medium. 
10 cells were incubated at 37 °C in 4 ml complete medium with or without IL-12 (2.5 ng/ml) for 
Ih or IFN-a (1000 U/ml) for 15 min, followed by preparation of whole cell extracts as described in 
Material and Methods. Gel shifts were performed with P end-labeled double stranded IRF-1 GAS 
oligonucleotide. Supershift assays were performed using a-Statl, a-Stat3 and a-Stat4 antibodies as 
described in Materials and Methods.
The data previously shown utilising the GAS site present in the IRF-1 promoter 
(see chapters 2 and 3) provided evidence that IL-12 induced expression is mediated 
by Stat4. Indeed, as shown in figure 31, the IRF-GAS forms DNA-protein 
complexes in gel shifts performed with IL-12 treated Thl cells. The complex is
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abrogated with Stat4 specific antibodies, while neither anti-Statl nor anti-StaG 
antibodies affect the DNA-protein complex.
Furthermore, as shown in figure 32, when the IRF-Zz/c construct (that contains 3 
copies of the IRFGAS oligonucleotide cloned upstream an S V40-luc reported gene) 
is transiently transfected in Jurkat cells, a strong upregulation of luciferase activity 
is detected in response to IL-12. These effects are IL-12Rp2 and Stat4 dependent, 
since the absence in the cotransfections of either IL-12Rp2 or Stat4 DNAs 
abrogates the IL-12 mediated upregulation of IRF-/z/c.
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Figure 32. The IL-12-induced activation o f  an IRF-1 GAS reporter gene construct is mediated by 
STAT-4. Jurkat T cells were transiently transfected with a reporter gene construct containing 3 
copies of the GAS element present in the IRF-1 gene promoter. Where indicated, cells were co­
transfected with expression vectors encoding IL-12R|3l. IL-12R[32, and/or STAT-4. Cells were left 
untreated (unstim.) or treated for 20 h with 2.5 ng/ml IL-12 (IL-12) prior to the preparation of 
lysates. Luciferase assays and normalization of results were performed as described in Experimental 
Procedures.
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To exclude that the upregulation of IRF-1 is secondary to IFN-y production 
induced in response to IL-12, the presence of IFN-y in the sumatants of the 
transfected cells was investigated by ELISA assays.
There was no detectable IFN-y production by the transfected cells, indicating that 
IL-12-dependent induction of luciferase activity is not mediated by IFN-y (data not 
shown).
These data provide strong evidence that IL-12 induced activation of the IRF-1 gene 
is mediated by Stat4 and depends on the presence of functional IL-12 receptors on 
the cell surface. Moreover, these data suggests that IRF-1 expression in human Thl 
cells is regulated by IL-12 through Stat4 activation.
3.4.3) Discussion
In this chapter the role of the transcription factor IRF-1 in the differentiation of 
human naive CD4+ T cells into polarized T helper cell subsets was analysed. 
Previous results obtained with IRF-1 deficient mice revealed a striking deficiency of 
Thl cell development. Compromised Thl development was shown to be 
associated with an impaired production of EL-12 by macrophages (Lohoff et al., 
1997; Taki et al., 1997) and defective development of natural killer (Duncan et al., 
1996; Ogasawara et al., 1998; Ohteki et al., 1998). It remained controversial 
whether compromised Thl development also resulted from a defect of CD4+ T 
cells from IRF-l" " mice to develop into Thl effector cells. Cell transfer experiments 
indicated that IRF-l"7* CD4+ T cells could develop into Thl cells when transferred 
to recombination activating gene (RAG)-1 deficient (IRF-1+/+) mice, lacking T and 
B cells (Lohoff et al., 1997). However, the analysis of CD4+ T cells purified from 
IRF-1"" TCR transgenic mice showed a deficiency in Thl development when 
stimulated in vitro with peptide presented by wild-type APCs (Taki et al., 1997). 
To determine the role of IRF-1 in the differentiation of T helper subsets, IRF-1 
expression was analyzed at different time intervals early after the stimulation of 
purified naive T cells under neutral, or Thl or Th2-inducing conditions. IRF-1
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expression was compared to the expression of the IL-12RP2 subunit, which is 
induced during differentiation of human naive cells along the Thl, but not the Th2, 
pathway. In contrast to IL-12Rp2, IRF-1 transcripts are detectable in naive CD4+ 
T cells. Crosslinking of the TCR strongly induces ERF-1 mRNA even in the 
absence of exogenously added cytokines. At later time intervals after T cell 
stimulation, IRF-1 transcripts are slightly more abundant in cultures which were 
stimulated in the presence of IL-12.
Analysis of IRF-1 transcripts in established human Thl and Th2 cells generated 
from cord blood leukocytes two weeks after stimulation revealed no significant 
differences in the two populations. However, after treatment with IL-12, IRF-1 
transcripts were strongly induced in Thl, but not in Th2 cells. This finding 
demonstrates that IRF-1 is a target gene of IL-12. The IL-12-induced upregulation 
of IRF-1 transcripts is not mediated by IL-12 induced IFN-y, since /*) IRF-1 mRNA 
could already be detected after 4 h and did not depend on de novo protein 
synthesis, it) previous results have shown that Thl cells do not respond to IFN-y, 
since they do not express the IFN-yR p subunit (Bach et al., 1995; Groux et al., 
1997; Pemis et al., 1995), iii) in the transfection experiments IL-12 stimulated 
Jurkat cells do not produce IFN-y, but IRF-luc transactivation is strongly increased 
in response to IL-12.
Previous studies have demonstrated that induction of the IRF-1 gene in response to 
interferons and IL-6 is mediated by the binding of activated Statl and StatS to the 
palindromic GAS element present in the promoter of the IRF-1 gene (Harada et al., 
1994; Harroch et al., 1994; Schindler et al., 1995; Sims et al., 1993; Young, 1996). 
The data presented in this chapter demonstrate that activated Stat4 is able to 
transactivate IRF-1 expression in differentiating Thl cells accounting for a 
sustained expression of IRF-1. First, gel shift experiments demonstrated that 
activated Stat4 binds to the GAS element in the ERF-1 promoter. Binding of Stat4 
to the IRF GAS element is induced by IL-12 selectively in Thl cells and by IFN-a
I l l
in both Thl and Th2 cells, confirming the previous observation that IFN-a signals 
in human Thl and Th2 cells (see previous chapter (Rogge et al., 1998)).
Second, transient transfection assays with a reporter gene construct containing 3 
copies of the IRF-1 GAS element in Jurkat cells provided strong evidence that the 
transcriptional activation of the IRF-1 gene in response to IL-12 is mediated by 
Stat4.
In conclusion, the findings analysed so far point to a potential hierarchy of 
transcriptional events during the differentiation of naive T cells into polarized Thl 
cells; TCR-ligation is an essential prerequisite for the initial expression of 
functional IL-12 receptors on developing Thl cells, although the mechanisms and 
factors regulating this phase have not yet been uncovered. In the second phase, IL- 
12 induces further upregulation of the DL-12Rp2, IRF-1 and other, yet to be 
identified, IL-12-regulated genes. The rapid tyrosine phosphorylation and 
activation of Stat4 by IL-12 and the phenotype of the Stat4‘/" mice predict that this 
phase is regulated by Stat4. In a third phase, transcription factors like IRF-1 and 
other, so far unknown, regulatory proteins induced by Stat4 may themselves 
regulate target genes which are important for the effector functions of Thl cells. 
IRF-1 appears to be the first member of a probably large family of regulatory 
proteins induced by IL-12. It will be of great interest to identify additional 
members of this family and to analyze their functions with respect to the 
differentiation and effector functions of T helper cells.
112
4) References
Abbas, A. K., Murphy, K. M., and Sher, A (1996). Functional diversity of helper 
T lymphocytes. Nature 383, 787-793.
Agarwal, S., and Rao, A. (1998). Modulation of chromatin structure regulates 
cytokine gene expression during T cell differentiation. Immunity 9 ,765-775.
Alegre, M. L., Shields, H., Thompson, C. B., and Gajeswski, T. F. (1998). 
Expression and function of CTLA-4 in Thl and Th2 cells. J. of Immunol. 161, 
3347-3356.
Bach, E. A., Szabo, S. J , Dighe, A. S., Ashkenazi, A., Aguet, M., Murphy, K. M., 
and Schreiber, R. D. (1995). Ligand-induced autoregulation of IFN-y receptor p 
chain expression in T helper cell subsets. Science 270 ,1215-1218.
Bacon, C. M., Petricoin HI, E. F., Ortaldo, J. R., Rees, R. C , Lamer, A. C , 
Johnston, J. A., and O'Shea, J. J. (1995). Interleukin 12 induces tyrosine 
phosphorylation and activation of Stat4 in human lymphocytes. Proc. Natl. Acad. 
Sci. USA 92,7307-7311.
Bancroft, A. J., Else, K. J., and Grencis, R. K. (1994). Low level infection with 
Trichuris muris significantly affects the polarisation of the CD4+ response. Eur. J. 
Immunol. 24 ,3113-3118.
Bath, G. J., Thekkumkara, T. J., Thomas, W. J., Conrad, K. M., and Baker, K. M. 
(1994). Angiotensin II stimulates sis inducing factor like DNA binding activity. 
Evidence that ATI A receptor activates transcription factor Stat-91 and/or related 
protein. J. Biol. Chem. 269,31443-31449.
113
Bendelac, A., Rivera, M , Park, S. H., and Roark, J. H. (1997). Mouse CD1 
specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 
75, 535-562.
Rennet, B. L., Cruz, R., Lacson, R. G., and Manning, A. M. (1997). Interleukin-4 
suppression of Tumor Necrosis Factor a-stimulated E-Selectin gene transcription 
is mediated by Stat6 antagonism of NF-kB. J. Biol. Chem. 272,10212-10219.
Bentley, D. L., and Groudine, M. (1986). A block to elongationis largely 
responsible for decreased transcription of c-myc in differentiated HL60 cells. 
Nature.
Berton, M. T., and Linehan, L. A. (1995). IL-4 activates a latent DNA-binding 
factor that binds a shared IFN-y and IL-4 response element present in the germline 
yl promoter. J. Immunol. 154,4512.
Bird, J. J., Brown, R. D., Mullen, A. C , Moskowitz, N. H., Mahowald, M. A., 
Sider, J. R., Gajeswski, T. F., Wang, C. R., and Reiner, S. L. (1998). Helper T cell 
differentiation is controlled by the cell cycle. Immunity 9, 229-237.
Blake, M. C , Jambou, R  C , Swick, A. G , Kahn, J. W , and Azizkhan, J. C. 
(1990). Transcriptional initiation is controlled by upstream GC-rich interactions in 
a TATA-less promoter. Mol. Cell. Biol. 10, 6632-6641.
Bluestone, J. A. (1995). New perspectives of CD28/B7-2-mediated T cell 
costimulation. Immunity 2, 555-559.
114
Boam, D. S., Davidson, I., and Chambon, P. (1995). A TATA-less promoter 
containing binding sites for ubiquitous transcription factors mediates cell type- 
specific regulation of the gene for transcription enhancer factor-1 (TEF-1). J. Biol. 
Chem. 270,19487-19494.
Bradley, L. M., Dalton, D. K., and Croft, M. (1996). A direct role for IFN-y in 
regulation of Thl cell development. J. Immunol. 157,1350-1358.
Bretscher, P. A., Wei, G., Menon, J. N., and Bielefeldt-Ohmann, H. (1992). 
Establishment of stable, cell-mediated immunity that makes "susceptible" mice 
resistant to Leishmania major. Science 257, 539-542.
Brinkmann, V., Geiger, T., Alkan, S., and Heusser, C. H. (1993). Interferon a
increases the frequency of interferon y-producing CD4+ T cells. J. Exp. Med. 178, 
1655-1663.
Brown, R. T., Ades, L Z , and Nordan, R. P. (1995). An acute phase response 
factor/NF-kB site downstream of the junB gene that mediates responsiveness to 
interleukin-6 in a murine plasmacytoma. J. Biol. Chem. 270,31129-31135.
Brunvand, M. W., Kromm, A., and Groudine, M. (1993). In vitro footprinting of 
the human IL-2 gene reveals a nuclear factor bound to the transcription start site in 
T cells. Nucleic Acid Res. 21,4824-4829.
Celia, M., Scheidegger,D., Palmerlehmann, K., Lane, P., Lanzavecchia, A., and 
Alber, G. (1996). Ligation of CD40 on dendritic cells triggers production of high 
levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via 
APC activation. J Exp Med 184, 747-752.
115
Cervenka, A., Carter, L. L., Reome, J. B , Swain, S. L., and Dutton, R. W. (1998). 
In vivo persistence of CD8 polarised T cell subsets producing type 1 or type 2 
cytokines. J. Immunol. 161, 97-105.
Chen, X , Vinkemeier, U., Zhao, Y., Jemzalmi, D., Darnell, J. E. j., and Kuriyan, J. 
(1998). Crystal structure of a tyrosine phosphorylated Stat-1 dimer bound to 
DNA. Cell 93.
Chen, X. H., Patel, B. K., Wang,L. M., Frankel, M., Ellmore, N., Flavell, R. A., 
LaRochelle, W. J., and Pierce, J. H. (1997). Jakl expression is required for 
mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor 
substrate and Stat6 signaling molecules. J. Biol. Chem. 272,6556-6560.
Chizzonite, R., Truitt, T., Desai, B. B., Nunes, P., Podlaski, F. J., Stem, A. S., and 
Gately, M. K. (1992). IL-12 receptor. I. Characterization of the receptor on 
phytohemagglutinin-activated human lymphoblasts. J. Immunol. 148, 3117-3124.
Cho, S. S., Bacon, C. M , Sudarshan, C , Rees, R. C , Finbloom, D., Pine, R., and 
O'Shea, J. J. (1996). Activation of Stat4 by IL-12 and IFN-a. Evidence for the 
involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 
157, 4781-4789.
Chua, A. O , Chizzonite, K , Desai, B. B., Truitt, T. P., Nunes, P., Minetti, L. J., 
Warner, R. R , Presky, D. H., Levine, J. F., Gately, M. K., and Gubler, U. (1994). 
Expression cloning of a human IL-12 receptor component: A new member of the 
cytokine receptor superfamily with strong homology to gpl30. J. Immunol. 153, 
128-136.
116
Chua, A. O , Wilkinson, V. L., Presky, D. H., and Gubler, U. (1995). Cloning and 
characterization of a mouse IL-12 receptor-beta component. J Immunol 155, 4286- 
4294.
Coffman, R. L., Lehman, D. A., and Rothman, P. (1993). The mechanism and 
regulation of immunoglobulin isotype switching. Adv. Immunol. 54 ,228-269.
Conaway, R  C , and Conaway, J. W. (1993). General initiation factors for RNA 
Polymerase IL Annu. Rev. Biochem. 6 2 ,161-190.
Constant, S., Pfeiffer, A , Woodard, T., Pasqualini, T., and Bottomly, K. (1995). 
Extent of T cell receptor ligation can determine the functional differentiation of 
naive CD4+ T cells. J. Exp. Med. 182, 1591-1596.
Constant, S. L., and Bottomly, K. (1997). Induction of Thl and Th2 CD4+ T cell 
responses: the alternative approaches. Ann. Rev. Immunol. 15, 297-322.
Darnell, J. E. j. (1994). Phosphotyrosine signaling and the single cell: metazoan 
boundary. Proc. Natl. Acad. Sci. U.S.A. 94,11767-11769.
Darnell Jr, J. E. (1997). Stats and gene regulation. Science 277,1630-1635.
Davydov, I. V., Krammer, P. H., and Li-Weber, M. (1995). Nuclear factor IL-6 
activates the human IL-4 promoter in T cells. J. Immunol. 155, 5273-5279.
de Wet, J. R , Wood, K. V., DeLuca, M., Helinski, D. R , and Subramani, S. (1987). 
Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. 
Biol. 7, 725-737.
117
De Wit, D., Van Mechelen, M., Zanin, C , Doutrelepont, J.-M., Velu, T., Gérard, 
C , Abramowicz, D , Scheerlinck, J.-P., De Baetselier, P., Urbain, 1 , Leo, O , 
Goldman, M., and Moser, M. (1993). Preferential activation of Th2 cells in chronic 
graft-versus-host reaction. J. Immunol. 750,1-6.
Del Prete, G. F., De Carli, M., Mastromauro, C , Macchia, D., Biagiotti, R., Ricci, 
M , and Romagnani, S. (1991). Purified protein derivative of Mycobacterium 
tuberculosis and excretory/secretory antigen(s) of Toxocara canis expand in vitro 
human T cells with stable and opposite (type 1 T helper or type 2 T helper) 
profile of cytokine production. J. Clin. Invest. 88, 346-350.
Demeure, C. E., Wu, C. Y , Shu, U., Schneider, P. V., Heusser, C , Yssel, H., and 
Delespesse, G. (1994). In vitro maturation of human neonatal CD4+ T 
lymphocytes. U. Cytokines present at priming modulate the development of 
lymphokine production. J. Immunol. 752, 4775-4782.
Desai, B. B , Quinn, P. M., Wolitzky, A. G , Mongini, P. K. A , Chizzonite, R., 
and Gately, M. K. (1992). IL-12 receptor. II. Distribution and regulation of 
receptor expression. J. Immunol. 148,3125-3132.
Duhe', R. J., and Farrar, W. L. (1995). Characterisation of active and inactive forms 
of Jak2 protein tyrosine kinase produced via the baculovirus expression vector 
system. J. Biol. Chem. 270, 23084-23089.
Dumbar, C. E., and Young, N. S. (1996). Gene marking and gene therapy directed at 
primaiy hematopoietic cells. Curr. Opin. Hematol. 3, 430-437.
118
Duncan, G. S., Mittrücker, Kâgi, D., Matsuyama, T., and Mak, T. W.
(1996). The transcription factor interferon regulatory factor-1 is essential for 
natural killer cell function in vivo. J. Exp. Med. 184,2043-2048.
Flanagan, W. M., Corthesy, B., Bram, R. J., and Crabtree, G. R. (1991). Nuclear 
association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. 
Nature 352, 803-807.
Freeman, G. J., Boussiods, V. A., Anumanthan, A., Bemstain, G. M., Ke, X -Y , 
Rennert, P. D., Gray, G S., Gribben, J G , and Nadlér, L M (1995). B7-1 and 
B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 
preferentially cosdmulates the initial production ofIL-4. Immunity 2, 523-532.
Galbiati, F., Rogge, L., Guery, J.-C., Smiroldo, S., and Adorini, L. (1998). 
Regulation of the IL-12R p2 subunit by soluble antigen and IL-12 in vivo. Eur. J. 
Immunol. 28 ,209-220.
Gause, W. C , Halvorson, M. J., Lu, P., Greenwald, R., Linsey, P., Urban, J. F., 
and Finkelman, F. D. (1997). The function of costimulatory molecules and the 
development ofIL-4 producing T cells. Immunology Today 1 8 ,115-120.
Gorham, J. D., Guler, M. L., Steen, R. G , Mackey, A. J., Daly, M. J., Frederick, 
K., Dietrich, W. F., and Murphy, K. M, (1996), Genetic mapping of a murine 
locus controlling development of T helper 1/ T helper 2 type responses. Proc. Natl. 
Acad. Sci. U S A 9 3 ,12467-12472.
Grohmann, U , Belladonna, M. L., Bianchi, R., Orabona, C , Ayroldi, E., Fiorctti, 
M. C , and Puccetd, P. (1998). IL-12 acts directiy on DC to promote nuclear 
localisation of NF-kB and primes DC for IL-12 production. Immunity 3, 315-323.
119
Groux, H., Somasse, T., Cottrez, F., deVries, J. E., Coffman, R. L., Roncarolo, M. 
G , and Yssel, H. (1997). Induction of human T helper cell type 1 differentiation 
results in loss of IFN-gamma receptor beta-chain expression. J Immunol 158, 5627- 
5631.
Guery, J. C , Galbiati, F., Smiroldo, S., and Adorini, L. (1996). Selective 
development of T helper (Th)2 cells induced by continuous administration of low 
dose soluble proteins to normal and beta(2)-microglobulin-deficientBALB/c mice. 
J. Exp. Med. 185, 485-497.
Güler, M. L., Gorham, J. D., Hsieh, C.-S., Mackey, A. J., Steen, R. G , Dietrich, 
W. F., and Murphy, K. M. (1996). Genetic Susceptibility to Leishmania: IL-12 
responsiveness in Thl cell development. Science 271,984-987.
Güler, M. L., Jacobson, N. G , Gubler, U., and Murphy, K. M. (1997). T cell 
genetic background determines mainteinanceof IL-12 signaling: effects on B ALB/c 
and B10.D2 T helper cell type I phenotype development. J. Immunol. 159 ,1767.
Hagstrom, K , and Schedl, P. (1997). Remembrance of things past: maintaining gene 
expression patterns with altered chromatin. Curr. Opin. Genet. Dev. 7, 814-821.
Harada, H., Takahashi, E.-L, Itoh, S., Harada, K., Hori, T.-A., and Taniguchi, T. 
(1994). Structure and regulation of the human interferon regulatory factor 1 (IRF-1) 
and IRF-2 genes: implications for a gene network in the interferon system. Mol. 
Cell. Biol. 14 ,1500-1509.
Harroch, S., Revel, M., and Chebath, J. (1994). Induction by interleukin-6 of 
interferon regulatory factor 1 (IRF-1) gene expression through the palindromic
120
interferon response element pIRE and cell type-dependent control of IRF-1 binding 
to DNA. EMBO J. 13, 1942-1949.
Heim, M. H., Kerr, I. M , Stark, G. R , and Darnell, J. E. J. (1995). Contribution of 
Stat SH2 groups to specific interferon signalingby the Jak-Stat pathway. Science 
267, 1347-1349.
Heinrich, P. C , Behrmann, I., Muller-Newen, G , Schaper, F., and Graeve, L. 
(1998). Interleukin-6-type cytokine signaling through the gpl30/Jak/Stat pathway. 
Biochem. J. 534,297-314.
Heinzel, F. P., Shoenhaut, D. S., Rerko, R. M , Rosser, L. E., and Gately, M. K.
(1993). Recombinant interleukin 12 cures mice infected with Leishmania major. J. 
Exp. Med. 177, 1505-1509.
Hilkins, C. M. U., Messer, G , Tesselaar, K., van Rietschoten, A. G. I., 
Kapsenberg, M. L., and Wierenga,E. A. (1996). Lack of IL-12 signalingin human 
allergen-specific Th2 cells. J. Immunol. 157,4316-4321.
Himmerlich, H., Parra-Lopez, C , Tacchini-Cottier, F., Louis, J. A., and Launois, P. 
(1998). The DL-4 rapidly produced in BALB/c mice after infection with Leishmania 
major down-regulates IL-12 receptor |)2 chain expression on CD4+ T cells resulting 
in a state of unresponsiveness to IL-12. J. Immunol. 161, 6156-6163.
Ho, I.-C., Hodge, M. R , Rooney, J. W., and Glimcher, L. H. (1996). The proto- 
oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 
85, 973-983.
121
Hodge, M. R , Chun, H. J., Rengarajan, J., Alt, A., Lieberson, R., and Glimcher, L. 
H. (1996). NF-AT-driven interleukin-4 transcription potentiated by NIP45. 
Science 274,1903-1905.
Hodge, M. R , Ranger, A. M., Charles de la Brousse, F., Hoey, T., Grusby, M., 
and Glimcher, L. H. (1996). Hyperproliferation and dysregulation of IL-4 
expression in NF-ATp-deficient mice. Immunity 4,397-405.
Hoey, T., Sun, Y.-L., Williamson, K., and Xu, X. (1995). Isolation of two new 
members of the NF-AT gene family and functional characterization of NF-AT 
proteins. Immunity 2, 461-472.
Horvai, A. E., Xu, L., Korzus, E., Brard, G , Kalafus, D., Mullen, T. M., Rose, D. 
W., Rosenfeld, M. G , and Glass, C. K. (1997). Nuclear integration of Jak/Stat and 
Ras/AP-1 signalingby CBP and p300. Proc. Natl. Acad. Sci. U.S.A. 94, 1074- 
1079.
Horvath, C. M., Stark, G. R , Kerr, I. M., and Darnell, J. E. j. (1996). Interaction 
between Stat and non-Stat proteins in the interferon stimulated gene factor 3 
transcription complex. Mol. Cell. Biol. 16 ,6957-6964.
Horvath, C. M., Wen, Z , and Darnell, J. E. j. (1995). A Stat protein domains that 
determines DNA sequence recognition suggests a novel DNA-binding domain. 
Genes Dev 9 ,984-994.
Hosken, N. A., Shibuya, K., Heath, A. W , Murphy, K. M , and A., O. G (1995). 
The effect of antigen dose on CD4+ T cell phenotype development in an afS-TCR- 
transgenic mouse model. J. Exp. Med. 182,1579-1584.
122
Hou, J., Schindler, U., Henzel, W. J., Ho, T. C , Brasseur, M., and McKnight, S. L. 
(1994). An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701- 
1706.
Hou, X. S., Melnick, M. B., and Perrimon, N. (1996). Marelle acts downstream of 
the Drosophila HOP/Jak kinase and encodes a protein similar to the mammalian 
Stats. Cell 84, 411-419.
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. P., O'Garra, A., and Murphy, 
K. M. (1993). Development of Tjjl CD4+ T cells through IL-12 produced by 
Listeria-\nduced macrophages. Science 260,547-549.
Hsieh, C. S., Heimberger, A. B., Gold, J. S., O'Garra, A., and Murphy, K. M. 
(1992). Differential regulation of T helper phenotype development by interleukins 
4 and 10 in an alpha beta T cell-receptor transgenic system. Proc. Natl. Acad. Sci. 
USA 89, 6065-6069.
Hsieh, C. S., Macatonia, S. E., O'Garra, A., and Murphy, K. M. (1995). T cell 
genetic background determines default T helper phenotype development in vitro. J. 
Exp. Med. 181, 713-721.
Huang, H , Pannetier, C , Hu-Li, J , and Paul, W E (1998). Transient transfection 
of primary T helper cells by particle-mediated gene transfer. J. Immunol. Methods 
215, 173-7.
Huang, H., and Paul, W. E. (1997). Impaired Interleukin 4 signalingin T helper 
type 1 cells. J. Exp. Med. 187, 1305-1313.
123
Hughes, C. C W , and Pober, J. (1996). Transcriptional regulation of the 
Interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 277, 
5369-5377.
Hile, J. N. (1996). Stats: Signal transducers and activators of transcription. Cell 84, 
331-334.
Ince, T. A., and Scotto, K. W. (1995). A conserved downstream element defines a 
new class ofRNA Polymerise II promoters. J. Biol. Chem. 270, 30249-30252.
Ivashkiv, L. B. (1995). Cytokines and Stats: How can signals achieve specificity? 
Immunity 3, 1-4.
Jacobson, N. G., Szabo, S. J., Weber-Nordt, R. N., Zhong, Z , Schreiber, R. D., 
Darnell, J. E., and Murphy, K. M. (1995). Interleukin 12 signaling in T helper type 
1 (Thl) cells involves tyrosine phosphorylation of signal transducer and activator 
of transcription (Stat) 3 and 4. J. Exp. Med. 181, 1755-1762.
Jain, J., McCaffrey, P. G., Valge-Archer, V. E., and Rao, A. (1992). Nuclear factor 
of activated T cells contains Fos and Jun. Nature 356, 801-804.
Javahery, R.? Khachi, A., Lo, K., Zenzie-Gregory, B., and Smale, S. T. (1994). 
DNA sequence requirements for transcriptional Initiator activity in mammalian 
cells. Mol. Cell. Biol. 1 4 ,116-127.
Julia, V., Rassoulzadegan, M., and Glaichenhaus, N. (1996) Resistance to 
Leishmania major induced by tolerance to a single antigen. Science 274,421-423.
124
Kadonaga, J. T. (1998). Eukariotic transcription: an interlaced network of 
transcription factors and chromatin-modifying machines. Cell 92 ,307-313.
Kaplan, M. H., Schindler, U., Smiley, S. T., and Grusby, M. J. (1996). Stat6 is 
required for mediating responses to IL-4 and for the development of Th2 cells. 
Immunity 4, 313-319.
Kaplan, M. H., Sun, Y. L., Hœy, T., and Grusby, M. J. (1996). Impaired IL-12 
responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 
382, 174-177.
Karp, C. L., Wisocka, M., Wahl, L. M., Aheam, J. M., Cuomo, P. J., Sherry, B., 
Trinchieri, G , and Griffin, D. E. (1996). Mechanism of suppression of cell- 
mediated immunity by measles virus. Science 273,228-231.
Kawata, T., Shevchenko, A., Fukuzawa, M., Jermyn, K. A., Totty, N. F., 
Zhukovskaya, N. V., Sterling, A. E., Mann, M., and William, J. G (1997). SH2 
signaling in a lower eukaryote: a Stat protein that regulates stalk cell differentiation 
in dictyostelium. Cell 8 9 ,909-916.
Kaye, J., Hsu, M.-L., Sauron, M.-E., Jameson, S. C , Gascoigne, N. R. J., and 
Hedrick, S. M. (1989). Selective development of CD4+ T cells in transgenic mice 
expressing a class II MHC-restricted antigen receptor. Nature 341, 746-749.
Keegan, A. D., Nelms, K., White, M., Wang, L.-M., Pierce, J. H , and Paul, W. E.
(1994). An IL-4 receptor region containing an insulin receptor motif is important 
for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76, 811-820.
125
King, C. L., RJ., t., Craighead, N., June, C H., and Thyphronitis, G. (1995). CD28 
activation promotes Th2 subset differentiation by human CD4+ T cells. Eur. J. 
Immunol. 25, 587-595.
Kohler, I , and Rieber, E. P. (1995). Allergy associated le and Fee receptor II 
(CD23b) genes activated via binding of a Interleukin-4-induced transcription factor 
to a novel responsive element Eur. J. Immunol. 23,3066.
Kohlhuber, F., Rogers, N. C , Watling, D., Feng, J., Guschin, D , Briscoe, J., 
Witthuhn, B. A., Kotenko, S. V., Petska, S., Stark, G. R , Bile, J. N., and Kerr, I. 
M. (1997). A Jakl/Jak2 chimera can sustain alfa and gamma interferon responses. 
Mol. Cell. Biol. 17,695-706.
Kollmar, R , Sukow, K. A., Sponagle, S. K., and Famham, P. J. (1994). Start site 
selection at the TATA-less carbamoyl-phosphate synthase (glutamine- 
hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. J. Biol. 
Chem. 269,2252-2257.
Kopf, M. (1996). Immunity, 15-24.
Kopf, M., Le Gros, G., Bachmann, M., Earners, M. C., Bluethmann, H., and 
Kôhler, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine 
responses. Nature 262, 245-248.
Korzus, E., Torchia, J., Rose, D. W., Xu, 1., Kurokawa, R , Mclnemey, E. M., 
Mullen, T .-M , Glass, C. K., and Rosenfeld, M. G. (1998). Transcription factor- 
specific requirements for coactivators and their acetyltransferase functions. Science 
279.
126
Kubo, M., Ransom, J., Webb, D., Hashimoto, Y., Tada, T., and Nakayama, T.
(1997). T-cell subset-specific expression of the IL-4 gene is regulated by a silencer 
element and Stat6. EMBO J. 16,4007-4020.
Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. 
A., Weiner, H. L., Nabavi, N., and Glimcher, L. H. (1995). B7-1 and B7-2 
costimulatory molecules activate differentially the Thl/Th2 developmental 
pathways: Application to autoimmune disease therapy. Cell 80, 707-718.
Kühn, R., Rajewsky, K., and Müller, W. (1991). Generation and analysis of 
interleukin-4-deficient mice. Science 254,707-710.
Lanzavecchia, A., and Scheidegger,D. (1987). The use of hybrid hybridomas to 
target human cytotoxic T lymphocytes. Eur. J. Immunol. 17, 105-111.
Launois, P., OHteki, T., Swihart, K., MacDonald, H. R., and Louis, J. A. (1995). 
In susceptible mice, Leishmania major induce very rapid IL-4 production by CD4+
T cells which are NK 1.1". Eur. J. Immunol. 25, 3298-3302.
Le Gros, G , Ben Sasson, S. Z , Seder, R. A., Finkelman, F. D., and Paul, W. E. 
(1990). Generation of interleukin-4 (EL-4)-producing cells in vivo and in vitro: IL-2 
and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 
172, 921-929.
Lederer, J. A , Perez, V. L., DesRoches, L., Kim, S. M., Abbas, A. K., and 
Lichtman, A. H. (1996). Cytokine transcriptional events during helper T cell subset 
differentiation. J. Exp. Med. 184, 397-406.
127
Lenschow, D. J., Herald, K. C , Rhee, L., Patel, B., Koons, A., Qui, H.-Y., Fuchs, 
E., Singh, B., Thompson, C. B., and Bluestone, J. A. (1996). CD28/B7 regulation 
of Thl and Th2 subsets in the development of autoimmune diabetes. Immunity 5, 
285-293.
Lenschow, D. J., Ho, S. C , Sattar, H , Rhee, L., Gray, G., Nabavi, N., Herald, K. 
C , and Bluestone, J. A. (1996). Differential effects of anti-B7-l and and-B7-2 
monoclonal antibody treatment on the development of diabetes in the nonobese 
diabetic mouse. J. Exp. Med. 181, 1145-1155.
Lenschow, D. J., Walunas, T. L , and Bluestone, J. A. (1996). CD28/B7 system of 
T cell costimulation. Annu. Rev. Immunol. 14,233-258.
Locksley, R. M., and Scott, P. (1991). Helper T cell subset in mouse 
Leishmaniasis: induction, expansion and effector function. Immunol. Today 12, 58- 
61.
Lohoff, M., Ferrick, D., Mittrücker, H.-W., Duncan, G.-S., Bischoff, S., 
Rôllinghof, M., and Mak, T. W. (1997). Interferon regulatory factor-1 is required 
for a T helper 1 immune response in vivo. Immunity 6, 681-689.
Look, D. C , Pelletier, M. R., Tidwell, R. M., Roswit, W. T., and Holtzmann, M. 
J. (1995). Statl depends on transcriptional syneigy with SP1. J. Biol. Chem. 270, 
30264-30267.
Luo, H., Rose, P., Barber, D , Hanratty, W. P., Lee, S., Roberts, T. M., D'Andrea,
A. D., and Dearolf, C. R. (1997). Mutation in the Jak kinase JH2 domain
128
hyperactivates Drosophila and mammalian Jak-Stat pathway. Mol. Cell. Biol. 77, 
1562-1571.
Lyakh, L., Ghosh, P., and Rice, N. R. (1997). Expression of NF-AT family 
proteins in normal human T cells. Mol. Cell. Biol. 77,2475-2484.
Ma, X. J , Chow, J. M., Gri, G , Carra, G , Gerosa, F., Wolf, S. E., Dzialo, R., and 
Trinchieri, G. (1996). The interleukin 12 p40 gene promoter is primed by 
interferon gamma in monocytic cells. J Exp Med 753,147-157.
Macatonia, S. E., Hsieh, C.-S., Murphy, K. M., and O'Garra, A. (1993). Dendritic 
cells and macrophages are required for Thl development of CD4+ T cells from ap  
TCR transgenic mice: IL-12 substitution for macrophages to stimulate LFN-y 
production is IFN-y dependent. .
Magram, J., Connaughton, S. E., Warner, R. R., Carvajal, D. M., Wu, C.-Y., 
Ferrante, J., Stewart, C , Sarimiento, U., Faherty, D. A., and Gately, M. K. (1996). 
IL-12 deficient mice are defective in IFNy production and type I cytokine 
responses. Immunity 4, 471-481.
Manetti, R., Parronchi, P., Giudizi, M. G , Piccinni, M.-P., Maggi, E., Trinchieri, 
G , and Romagnani, S. (1993). Natural Killer Cell Stimulatory Factor (Interleukin 
12 [IL-12]) induces T helper 1 type (Thl)-specific immune responses and inhibits 
the development of IL-4-producing Th cells. J. Exp. Med. 777, 1199-1204.
Marsh, D. G , Meyers, D. A., Breazeale, D. R , Ghosh, B., Freidoff, L. R., Ehrlich- 
Kautzky, E., Shou, C , Krishaswamy, G , and Beaty, T. H. (1994). Linkage
129
analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE. 
Science 264,1152-1156.
Marukami, M , Narazaki, M., Hibi, M., Yawata, H., Hamaguci,M., Taga, T., and 
Kishimoto, T. (1991). Critical cytoplasmic region of the interleukin 6 signal 
transducer gpl30 is conserved in the cytokine receptor family. Proc. Natl. Acad. 
Sci. U.S.A. 8 8 ,11349-11353.
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. 
S., Kaplan, D. H., Riley, J. K., Greenlund, A. C , Campbell, D , Carver-Moore, K., 
DuBois, R. N., Clark, R., Aguet, M., and Schreiber, R. D. (1996). Targeted 
disruption of the Statl gene in mice reveals unexpected physiologic specificity in 
the Jak-Stat signaling pathway. Cell 84 ,431-442.
Miyamoto, M., Fujita, T., Kimura, Y , Mamyama, M., Harada, H., Sudd, Y., 
Miyata, T., and Taniguchi, T. (1988). Regulated expression of a gene encoding a 
nuclear factor, IRF-1, that specifically binds to IFN-p gene regulatory elements. 
Cell 54.
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffinan, R. 
L. (1986). Two types of murine T helper T cell clone. I. Definition according to 
profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348- 
2357.
Mosmann, T. R , and Coffman, R  L. (1989). Thl and Th2 cells: Different patterns 
of lymphokine secretion lead to different functional properties. Annu. Rev. 
Immunol. 7 ,145-173.
130
Murphy, T. L., Cleveland, M. G , Kulesza, P., Magram, J., and Murphy, K. M.
(1995). Regulation of interleukin 12 p40 expression through an NF-xB half-site. 
Mol. Cell. Biol. 75, 5258-5267.
Nakajima, k., Bcenaka, K., Nkajira, K., Morika, N., and Mikoshiba, K. (1993). An 
improved retroviral vector for assaying promoter activity. Analysis of promoter 
interference in pIP211 vector. FEBS lett. 375, 129-133.
Nan, X., Ng, H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R  N., 
and Bird, A. (1998). Transcriptional repression by the CpG-binding protein 
MeCPs involves a histone deacetylase complex. Nature 393, 386-389.
Ng, J., and Cantrell, D. (1997). Stat3 is a serine kinase target in T lymphocytes. J. 
Biol. Chem. 272,24542-24549.
Nolan, G. P. (1994). NF-AT-AP-1 and Rel-bZIP: Hybrid vigor and binding under 
the influence. Cell 77,795-798.
O'Garra, A. (1998). Cytokine induce the development of functionally 
heterogeneous T helper cell subsets. Immunity 5,275-283.
O'Shea, J. J. (1997). Jaks, Stats, cytokine signal transduction, and 
immunonegulation: are we there yet? Immunity 7,1-11
Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y , Sato, T., Yokochi-Fukuda, T., 
Waldmann, T. A., Taniguchi, T., and Taki, S. (1998). Requirement for IRF-1 in the 
microenvironment supporting development o f natural killer cells. Nature 397, 700- 
703.
131
Ogryzko, V. V , Schütz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. 
(1996). The transcriptional coactivators p300 and CBP are histone 
acetyltransferases. Cell 8 7 ,953.
Ohmori, Y., and Hamilton, T. A. (1997). IL-4 induced Statô suppresses IFN-g- 
stimulated Statl-dependent transcription in mouse macrophages. J. Immunol. J59, 
5474-5482.
Ohmori, Y., Smith, M. F., and Hamilton, T. A. (1996). IL-4 induced expression of 
the IL-1 receptor antagonist gene is mediated by Stat6. J. Immunol. 157,2958.
Ohteki, T., Yoshida, H., Matsuyama, T., Duncan, G. S., Mak, T. W., and Ohashi, 
P. S. (1998). The transcription factor interferon regulatory factor 1 (IRF-1) is
important during the maturation of Natural Küler 1.1+ T cell receptor-o/P"1"
(NK1+) cells. Natural Killer cells, and intestinal intraepithélial T cells. J. Exp. 
Med. 187, 967-972.
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., 
Torigoe, K., Okura, T., Nukada, Y., Hattori, K., Akita, K., Namba, M., Tanabe, F., 
Konishi, K., Fukada, S., and Kurimoto, M. (1995). Cloning of a new cytokine that 
induces IFN-y production by T cells. Nature 378, 88-91.
Ouyang, W , Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L , Sha, 
W. C , and Murphy, K. M. (1998). Inhibition of Thl development mediated by 
GATA-3 though an IL-4-independent mechanism. Immunity 9, 745-755.
132
PaninaBordignon, P., Mazzeo, D., DiLucia, P., DAmbrosio, D., Lang, R , Fabbri, 
L., Self, C , and Sinigaglia, F. (1997). beta(2)-agonists prevent Thl development by 
selective inhibition of interleukin 12. J Clin Invest 100,1513-1519.
Parish, C , and FY, L. (1972). Immune response to chemically modified flagellin HI. 
Enhanced cell-mediated immunity during high and low zone antibody tolerance to 
flagelline. J. Exp. Med 135,298-311.
Park, O. K., Schaefer, T. S., and Nathans, D. (1996). In vitro activation of Stat3 by 
epidermal grow factor receptor kinase. Proc. Natl. Acad. Sci. U S A. 93, 13704- 
13708.
Parronchi, P., Mohapatra, S., Sampognaro, S., Giannarini, L., Wahn, U., Chong, P., 
Mohapatra, S., Maggi, E., Renz, H., and Romagnani, S. (1996). Effects of 
interferon-a on cytokine profile, T cell receptor repertoire and peptide reactivity 
of human allergen-specific T cells. Eur. J. Immunol. 26,697-703.
Parronchi, P., Mohapatra, S., Sampognaro, S., Giannarini, L., Wahn, U., Chong, P. 
L., Mohapatra, S., Maggi, E., Ranz, H., and Romagnani, S. (1996). Effects of 
interferon-alpha on cytokine profile, T cell receptor repertoire and peptide 
reactivity of human allergen-specific T cells. Eur J Immunol 26 ,697-703.
Paul, W f i , and Seder, R A (1994) Lymphocyte responses and cytokines. Cell 
76,241-251.
Penninger, J. M., Sirard, C , Mittrücker, H.-W., Chidgey, A., Kozieradzki, I., 
Nghiem, M., Hakem, A., Kimura, T., Timms, E., Boyd, R , Taniguchi, T., 
Matsuyama, T., and Mak, T. K. (1997). The Interferon regulatory transcription
133
factor IRF-1 controls positive and negative selection of CD8+ thymocytes. 
Immunity 7, 243-254.
Peritt, D., Robertson, S., Gri, G , Showe, L., Aste-Amezaga, M., and Trinchieri, G 
(1998). Differentiation of human NK cells into NK1 and NK2 subsets. J. Immunol. 
161, 5821-5824.
Pemis, A., Gupta, S., Gollob, K. J., Garfein, E., Coffman, R. L., Schindler, C., and 
Rothman, P. (1995). Lack of interferon y  receptor p chain and the prevention of 
interferon y signaling in TH1 cells. Science 269,245-247.
Pharmingen (1996). Riboquant Multi-probe RNase protection assay system, 
instruction manual.
Pignata, C , Sanghera, J. S., Cossette, L., Pelech, S. L., and Ritz, J. (1994). 
Interleukin 12 induces tyrosine phosphorylation and activation of 44-kDa mitogen 
activated protein kinase in human T cells. Blood 8 3 ,184-190.
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O , Nabavi, N., Wu, C. Y , 
Gately, M. K., and Gubler, U. (1996). A functional interleukin 12 receptor 
complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad 
Sci USA 93,14002-14007.
Quelle, F. W., Sato, N., Witthuhn, B. a., Inhom, R. C , Eder, M., Miyajima, A., 
Griffin, J. D., and Dile, J. N. (1994). Jak2 associates with the beta c chain of the 
receptor for granulocyte-macrophage-colony-stimulating-factor, and its activation 
requires the membrane proximal region. Mol. Cell. Biol. 14,4335-4341.
134
Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W. C , Grupe, A., Peltz, G , 
and Murphy, K. M. (1998). GATA-3 dependent enhancer activity in IL-4 gene 
regulation. J. Immunol. 161 y 3822-3826.
Reiner, S. L., and Locksley, R. M. (1995). The regulation of immunity to 
Leishmania major. Ann. Rev. Immunol. 1 3 ,151-177.
Rincon, M., Anguita, J., Nakamura, T., Fikrig, E., and Flavell, R. A. (1997). 
Interleukin (DL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. 
Exp. Med. 185, 461-469.
Rincon, M., Derijard, B., Chow, C. W , Davis, R. J., and Flavell, R. A. (1997). 
Reprogramming the signaling requirement for AP-1 activation during differentiation 
of precursor CD4+ T cells into effector Thl and Th2 cells. Genes and function 1, 
61-68.
Rincon, M., Enslen, H., Raingcaud, J., Recht, M., Zapton, T., Su, M. S.-S., Penix, 
L. A., Davis, R. J , and R.A., F. (1998). Interferon-y expression by Thl effector T 
cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17, 2817- 
2829.
Rincon, M. a. F., R. (1997). Transcription mediated by NF-AT is highly inducible 
in effector CD4+ T helper 2 (Th2) cells but not in Thl cells. Mol. Cell Biol. 17, 
1522-1534.
Robinson, D , Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S.
B., Menon, S., Kastelein, R., Bazan, F., and O’Garra, A. (1997). IGIF does not 
drive Thl development but synergizes with IL-12 for interferon-gamma production 
and activates IRAK and NF kappa B. Immunity 7, 571-581.
135
Rogge,L., Baiberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., 
and Sinigaglia, F. (1997). Selective expression of an interleukin-12 receptor 
component by human T helper 1 cells. J. Exp. Med. 185, 825-832.
Rogge, L., D’Ambrosio, D., Biffi, M., Penna, G., Minetti, L. J., Presky, D. H., 
Adorini, L., and Sinigaglia, F. (1998). The Role of Stat4 in species-specific 
regulation of T helper cell development by type I interferons. J. Immunol. 161,6567- 
6574.
Rogge, L., Papi, A., Presky, D. H., Biffi, M., Minetti, L. J., Miotto, D , 
Semenzato, G , Fabbri, L. M., and Sinigaglia^. (1999). Antibodies to interleukin 
12 receptor b2 chain marie human Thl but not Th2 cells in vitro and in vivo. J. 
Immunol.
Romagnani, S. (1991). Human Thl and Th2: Doubt no more. Immunol. Today 12, 
256-257.
Romagnani, S. (1994). Lymphokine production by human T cells in disease states. 
Annu. Rev. Immunol. 12,227-257.
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R , Toniatti, C , Puccetti, P., 
Bistoni, F., and Poli, V. (1996). Impaired neutrophil response and CD4+ T helper 
cells 1 development in interleukin-6 deficient mice infected with Candida Albicans. 
J. Exp. Med. 183, 1345-1355.
Rooney, J. W., Hodge, M. R , McCaffrey, P. G , Rao, A., and Glimcher, L. H. 
(1994). A common factor regulates both Thl- and Th2 specific cytokine gene 
expression. EMBO J. 13, 625-633.
136
Rooney, J. W., Hoey, T., and Glimcher, L. H. (1995). Coordinate and cooperative 
roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2, 
473-483.
Rothman, P., Kreider, B , Azam, M., Levy, D., Wegenka, U., Eilers, A., Decker, 
T., Horn, F., Kashleva, H., Pile, J., and Schindler, C. (1994). Cytokines and growth 
factors signal through tyrosine phosphorylation of a family of related transcription 
factors. Immunity 1, 457-468.
Sad, S., Marcotte, R , and Mosmann, T. R. (1995). Cytokine-induced 
differentiation of precursors mouse CD8+ T cells into cytotoxic CD8+ T cells 
secreting Thl or Th2 cytokines. Immunity 5, 271-279.
Schindler, C., and Darnell, J. E. (1995). Transcriptional responses to polypeptide 
ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64, 621-651.
Schindler, C , Kashleva, H., Pemis, A., Pine, R., and Rothman, P. (1994). STF-IL- 
4: a novel IL-4-induced signal transducing factor. EMBO J. 1 3 ,1350-1356.
Schindler, U , Wu, P., Rothe, M., Brasseur, M., and McKnight, S. L. (1995). 
Components of a Stat recognition code: evidence for two layers of molecular 
selectivity. Immunity 2, 689-697.
Schmitt, E., Hœhn, P., Huels, C , Goedert, S., Palm, N., Rude, E , and Germann, T.
(1994). T helper type 1 development of naive CD4+ T cells requires the coordinate 
action of interleukin-12 and interferon-y and is inhibited by transforming growth 
factor-p. Eur. J. Immunol. 2 4 ,793-798.
137
Schmitz, J., Thiel, A., Kuhn, R., Rajewsky, K., Muller, W., Assenmaker, M., and 
Radbmch, A. (1994). Induction of IL-4 expression in Th cells is not dependent on 
IL-4 from non T cells. J. Exp. Med. 779,1349-1353.
Schumann, R. R , Kirschninbg, C. J., Unbehaund, A., Aberie, H. P., Knope, H. P., 
Lamping, N., Ulevitch, R  J., and Herrmann, F. (1996). The Hpo-polysaccaride 
binding protein is a secretory class 1 acute-phase protein whose gene is 
transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear 
proteins. Mol. Cell. Biol. 76, 3490-3503.
Seder, R , and Le Gros, G. G. (1995). The functional role of CD8+ T helper type 2 
cells. J. Exp. Med. 757, 5-8.
Seder, R  A., Boulay, J. L., Finkelman, F., Barbier, S., Ben-Sasson, S. Z , Le Gros,
G. G , and Paul, W. E. (1992). CD8+ T cells can be primed in vitro to produce DL-
4. J. Immunol. 148,1652-1656.
Seder, R. A., and Paul, W. E. (1994). Acquisition of lympholdne-producing 
phenotype by CD4+ T cells. Annu. Rev. Immunol. 72, 635-673.
Seder, R  A., Paul, W. E., Davis, M. M., and Fazekas de St. Groth, B. (1992). The 
presence of interleukin-4 during in vitro priming determines the lympholdne- 
producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp. 
Med. 776, 1091-1098.
Sehgal, A., Patil, N., and Chao, M. (1988). A constitutive promoter directs 
expression of the nerve growth factor receptor gene. Mol. Cell. Biol. 8 ,3160-3167.
138
Sekimoto, T., Imamoto, N., Nakajima, K., Hirano, T., and Yoneda, Y. (1997). 
Extracellular signal dependent nuclear export of Statl is mediated by nuclear pore- 
targeting complex formation with NPI-1, but not Rchl. EMBO J. 16, 7067-7077.
Shainian, A., Pfeffer, K., Lee, K. P., T.M., K., Kishiara, K., Wakeham, A., Kawai, 
K., Ohashi, P. S., Thompson, C. B., and Mak, T. W. (1993). Differential T cell 
stimulatory requirements in CD28-deficient mice. Science 261,609-612.
Shaw, J.-P., Utz, P. J., Durand, D. B., Toole, J. J., Emmel, E. A., and Crabtree, G. 
R. (1988). Identification of a putative regulator of early T cell activation genes. 
Science 241,202-205.
Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., 
Tripp, R  A., Chu, C , Quelle, F. W., Nosaka, T., Vignalli,D. A. A., Doherty, P. 
C , Grosveld, G , Paul, W. E., and Dile, J. N. (1996). Lack of IL-4-induced Th2 
response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 
630-633.
Shuai, K., Horvath, C. M., Tsai Huang, L. H., Qureshi, S. A., Cowbum, D., and 
Darnell, J. E. (1994). Interferon activation of the transcription factor Stat91 
involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76, 
821-828.
Sica, A , Dorman, N., Viggiano, V., Cippitelli, M., Ghosh, P., Rice, N., and Young,
H. A. (1997). Interaction of NF-kB and NF-AT with the interferon-gamma 
promoter. J. Biol. Chem. 272, 30412-30420.
139
Sims, S. H., Cha, Y., Romine, F., P.E., G , Gottleib, K., and Deisseroth, A. B. 
(1993). A novel interferon-inducible domain: structural and functional analysis of 
the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13,690.
Song, Z , Casolaro, V., Chen, R., Georas, S. N., Monos, D , and Ono, S. J. (1996). 
Polymorphic nucleotides within the human EL-4 promoter that mediate 
overexpression of the gene. J. Immunol. 156,424-429.
Somasse, T., Larenas, P. V., Davis, K. A., de Vries, J. E., and Yssel, H. (1996). 
Differentiation of T helper 1 and 2 cells derived from naive human neonatal CD4+ 
I  cells, analyzed at the single cell level. J. Exp. Med. 184,473-483.
Stancato, L. F., Yu, C.-R., Petricoin, E. F. I ,  and Lamer, A. C. (1998). Activation 
of Rafl by interferon g and oncostatin M requires expression of Statl transcription 
factor. J. Biol. Chem. 273 ,18701-18704.
Stephanou, A., Isembeig, D. A., Akira, S., Kishimoto, T., and Latchman, D. S.
(1998). NF-IL6 and Stat3 signalingpathways co-operate to mediate the activation 
of the hsp90(3 gene by IL-6 but have opposite effects on its inducibility by heat 
shock. Biochem. J. 330, 189-195.
Stem, A. S., Gubler, U., Presky, D. H., and Magram, J. (1997). Structural and 
functional aspects of the EL-12 receptor complex. Chem. Immunol. 68,23-37.
Stocklin, E., Wissier, M., Gouilleux, F., and Groner, B. (1996). Functional 
interactions between StatS and the glucocorticoid receptor. Nature 383,726-728.
Swain, S. L., Weinberg, A. D., English, M , and Huston, G. (1990). IL-4 directs the 
development of Th2-like helper effectors. J. Immunol. 145,3796-3806.
140
Szabo, S., Glimcher, L., and Ho, I.-C. (1997). Genes that regulate interleukin-4 
expression in T cells. Curr. Opin. Immunol. 9, 776-781.
Szabo, S. J , Dighe, A. S., Gubler, U., and Murphy, K. M. (1997). Regulation of 
the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Thl) 
and Th2 cells. J Exp Med 185, 817-824.
Szabo, S. J., Gold, J. S., Murphy, T. L., and Murphy, K. M. (1993). Identification 
of CM-acting elements controlling interleukin-4 expression in T cells: roles for NF-Y 
and NF-ATc. Mol. Cell. Biol. 13 ,4793-4805.
Szabo, S. J., Jacobson, N. G , Dighe, A. S., Gubler, U., and Murphy, K. M (1995). 
Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. 
Immunity 2, 665-675.
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S - 
L, Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. (1996). Essential role 
of Stat6 in IL-4 signaling. Nature 380,627-630.
Taki, S., Sato, T., Ogasawara, K., Fukuda, T., Sato, M., Hida, S., Suzuki, G., 
Mitsuyama, M., Shin, E. H., Kojima, S., Taniguchi, T., and Asano, Y. (1997). 
Multistage regulation of Thl-type immune responses by the transcription factor 
IRF-1. Immunity 6, 673-679.
Thierfelder, W. E., van Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. 
R., Carson, R. T., Sangster, M. Y., Vignali, D. A. A., Doherty, P. C , Grosveld, G. 
C , and Dde, J. N. (1996). Requirement for Stat4 in interleukin-12-mediated 
responses of natural killer and T cells. Nature 38 2 ,171-174.
141
Tin, C.-N., Olson, M  C , Barton, K. P., and Leiden, J. M. (1996). Transcription 
factor GATA-3 is required for development of the T-cell lineage. Nature 384, 474- 
478.
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and 
Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and 
fatal multiorgan destruction, revealing a critical negative regulatory role of CTLA-4. 
Immunity 3, 541-547.
Trinchieri, G. (1995). Interleukin-12: A proinflammatory cytokine with 
immunoregulatory functions that bridge innate resistance and antigen-specific 
adaptive immunity. Annu. Rev. Immunol 73,251-276.
Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Aldta, K., Tanabe, F., 
Konishi, K., Micallef, M., and Fujii, M. (1996). Cloning of the cDNA for human 
IFN-y inducing factor, expression in Escherichia Coli and studies on the biological 
activities of the protein. J. Immunol. 156, 4274-4279.
Velazquez, L., Mogensen, K. E., Barbieri, G , Fellous, M., Uze, G , and Pellegrini,
S. (1995). Distinct domains of the protein kinases Tyk2 required for binding of 
interferon alfa/beta and for signal transduction. J. Biol. Chem. 270,3327-3334.
Verbeek, S., Izon, D., Hofhuis, F., Robanus-Maandag, E., te Riele, H., van de 
Wetering, M., Oosterwegel, M., Wilson, A., McDonald, H. R , and Clevers, H.
(1995). An HMG-box containing T cell factor for thymocytes differentiation. 
Nature 374, 70-74.
142
Vinkermeier, U., Cohen, S. L., Moraefi, L, Chait, B. T., Kuriyan, J., and Darnell, J. 
(1996). DNA binding of in vitro activated Static*, Statl(3 and truncated Statl: 
interaction between NH2-terminal domains stabilizes binding of two dimers to 
tamdem DNA sites, the EMBO journal 15, 5616-5626.
Wang,K. S., Ritz, J., and Frank, D. A. (1999). IL-2 induces Stat4 activation in 
primary NK cells and NK cell lines, but not in T cells. J. Immunol. 162,299-304.
Wang, L. F., Lin, J. Y., Hsieh, K. H., and Lin, R. H. (1996). Epicutaneus exposure 
of protein antigen induce a predominant Th2 like response with high IgE 
production in mice. J. Immunol. 156,4079-4082.
Weintraub, H., and Groudine, M. (1976). Chromosomal subunits in active genes 
have an altered conformation. Science 193,848-856.
Wen, Z , Zhong, Z , and Darnell, J. E. (1995). Maximal activation of transcription 
by Statl and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241- 
250.
Wenner, C. A., Guler, M. L., Macatonia, S. E., O'Garra, A., and Murphy, K. M. 
(1996). Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 
development. J. Immunol. 156, 1442-1447.
Wenner, C. A., Güler, M. L., Macatonia, S. E., O'Garra, A., and Murphy, K. M. 
(1996). Roles of IFN-y and IFN-a in IL-12 induced T helper cell-1 development. J. 
Immunol. 1156,1442-1447.
143
White, L. C , Wright, K. L., Felix, N. J , Ruffher, H., Reis, L. F. L., Pine, R., and 
Ting, P.-Y. (1996). Regulation of LMP2 and TAPI genes by IRF-1 explains the 
paucity of CD8+T cells in IRF-1-/-mice. Immunity 7, 243-254.
Wierenga, E. A., Snœk, M , de Groot, C , Chretien, I , Bos, J. D., Jansen, H. M., 
and Kapsenberg, M. (1990). Evidence for compartmentalization of functional 
subsets of CD4+ T lymphocytes in atopic patients. J. Immunol. 144, 4651-4656.
Wood, T. J., Sliva, D., Lobie, P. E., Goullieux, F., Mui, A. L., Groner, B., Norstedt, 
G , and Haldosen, L. A. (1997). Specificity of transcription enhancement via die 
Stat responsive element in the serine protease inhibitor 2.1 promoter. Mol. Cell. 
Endocrinol. 130,69-81.
Wu, C.-Y., Ferrante, J., Gately, M. K., and Magram, J. (1997). Characterisation of 
IL-12P1 chain deficient mice: IL-12Rpl is an essential component of the functional 
mouse IL-12R. J. Immunol. 159,1658-1665.
Wu, C.-Y., Warner, R. R., Carvajal, D. M., Chua, A. O., Minetti, L. J., Chizzonite, 
R., Mongini, P. K. A., Stem, A. S., Gubler, U., Presky, D. H., and Gately, M. K.
(1996). Biological function and distribution of human interleukin-12 receptor chain. 
Eur. J. Immunol. 26 ,345-350.
Xanthoudakis, S., Viola, J. P. B., Shaw, K. T. Y., Lou, C , Wallace, J. D., Bozza, P. 
T., Luk, D. C., Curran, T., and Rao, A. (1996). An enhanced immune response in 
mice lacking the transcription factor NF-AT1. Science 272,892-895.
Xu, X., Sun, Y. L., andHoey, T. (1996). Cooperative DNA binding and sequence- 
selective recognition conferred by the Stat amino-terminal domain. Nature 273, 
794-797.
144
Yamamoto, K., Miura, O , Hirosawa, S., and Myasaka, N. (1997). Binding 
sequence of Stat4: Stat4 complex recognizes the DFN-y activation site (GAS)-like 
sequence (T/A)TTCC(C/G)GGAA (T/A). Biochemical and Biophysical Research 
Communications 233,126-132.
Yan, H., Piazza, F., Krishnan, K., Pine, R., and Krolewski, J. J. (1998). Definition 
of the interferon-alfa receptor-binding domain on the Tyk2 kinase. J. Biol. Chem. 
273, 4046-4051.
Yan, R., Small, S., Desplan, C , Dearolf, C. R , and Jr, D. J. E. (1996). Identification 
of a Stat gene that function in Drosophila development. Cell 84, 421-430.
Yang, D. D , Conze, D , Whitmarsh, A. J., Barret, T., Davis, R. J., Rincon, M , and 
Flavell, R. A. (1998). Differentiation of CD4+ T cells to Thl cells requires MAP 
kinase Jak2. Immunity 9, 575-585.
Yang, X. J., Ogryzko, V. V., Nishikawa, J., Howard, B. H., and Nakatani, Y.
(1996). a p300/CBP associated factor that competes with the adenoviral 
oncoprotein El A. Nature 382, 319.
Yoshimoto, T., Bendelac, A., Watson, C , Hu-Li, J., and Paul, W. E. (1995). Role 
of NK 1.1+T cells in a Th2 response and in immunoglobulin E production. Science 
75, 1845-1847.
Young, H. A' (1996). Regulation of interferon-gamma gene expression. J. Interferon 
cytokine Res. 76, 563-568.
145
Zhang, D -H., Yang, L., and Ray, A. (1998). Differential responsiveness of the IL-5 
and IL-4 genes to transcription factor GATA-3. J. Immunol. 161, 3817-3821.
Zhang, D. H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. (1997). Transcription 
factor GATA-3 is differentially expressed in murine Thl and Th2 cells and 
controls the Th2 specific expression of the Interleukin-5 gene. J. Biol. Chem. 272, 
21597-21603.
Zhang, Z , Jones, S., Hagood, J. S., Puentes, N. L., and Fuller, G. M. (1997). Stat3 
acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272, 
30607-30610.
Zheng, W. P., and Flavell, R. A. (1997). The transcription factor GATA-3 is 
necessary and sufficient for Th2 cytokine gene expression in CD4+ T cells. Cell 89, 
587-596.
Zhong, Z , Wen, Z , and Darnell, J. E. (1994). Stat3 and Stat4: Members of the 
family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. 
USA 97,4806-4810.
